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ABSlBACr
The multielemental technique of inductively coupled plasma source mass 
spectrometry (ICP-MS) was used to measure the elemental concentration 
of boron and 28 other elements within blood and its fractions, saliva, 
urine, hair, nails, sjmovial fluid, brain and bone samples. A number 
of biological standard reference materials were also analysed: IAEA
A13 animal blood and H4 animal muscle, NIST 1577A bovine liver and 
SRM909 human serum, and SINR 0920 Chinese hair. Boron levels were 
found to be in the order of 30-40ng/mL in saliva and synovial fluid, 
150ng/mL in blood, Ijjg/mL in urine, 2-4ug/g in hair, bone and brain, 
and lOjLig/g in nails. Other elements ranged in concentration from sub- 
nanogram/gram (or mL) to percentage (%w/w) levels. Associations of 
boron with other trace elements, such as boron and calcium in blood, 
were also investigated in the various tissues and fluids, as were 
variations due to age and sex.
Frequency distribution curves were plotted for trace elements and 
micronutrients in all tissues and fluids. Since most elements 
demonstrated a symmetrical distribution in blood, this was thought to 
be indicative of the amount of homeostatic regulation, rather than the 
essentiality of the element. The distribution of elements among the 
various sample matrices, and occurrences of elemental or matrix 
interdependence, were investigated. Rubidium and caesium, also calcium
11
and strontium, for example, were consistently found to behave in 
similar ways among the clinical specimens. In addition, alterations in 
elemental levels due to factors such as age and sex were assessed in 
the range of tissues and fluids.
Full descriptions of the elemental content of brain, bone and synovial
fluid samples were obtained. Comparisons were made between rheumatoid 
arthritic (RA) and control subjects for brain and bone, and between RA 
and osteoarthritic (OA) patients for the synovial fluid. Boron was 
shown to be "very highly significantly" depleted in RA bone (at the
0.1% level). Other elements showing variations in bone and brain were 
lithium and iron. Iron was also at lower levels in RA synovial fluid
compared to OA, in contrast to phosphorus, copper and zinc, where
increases were seen. Elemental levels were linked with other clinical 
parameters in synovial fluid, such as crystal content and white blood 
cell count (a measure of the extent of inflammation), to assess any 
possible variations. Fluid containing crystals displayed elevated 
levels of scandium, strontium and caesium. Several elements showed a 
positive correlation with white blood cell count; these were caesium, 
magnesium, phosphorus, copper, zinc and rubidium.
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1. INTRODUCTION
1.1. Introduction to Trace Elements
1.1.1. Essentiality
Most, if not all, elements in the Periodic Table are found within the 
body at various levels of concentration. The major, structural 
elements comprise carbon, hydrogen, nitrogen and oxygen; also, calcium 
and phosphorus in hard tissue. Minor elements, which maintain the 
electrolyte balance, consist of calcium, chlorine, potassium, 
magnesium, phosphorus and sodium. All other elements within the body 
can be designated trace elements, accounting for less than 1% of the 
total (1). The word "trace" originates from the fact that early 
workers were unable to measure the precise concentration using the 
analytical methods then available (2).
Among the trace elements, 15 are currently thought to be essential: 
arsenic, chromium, cobalt, copper, fluorine, iodine, iron, manganese, 
molybdenum, nickel, selenium, silicon, tin, vanadium and zinc. Cotzias 
(3) gives a very full description of essentiality. He maintains that 
for an element to be essential, it must meet the following criteria:-
i) it is present in all healthy tissue of all living 
things.
ii) its concentration from one animal to the next is
fairly constant.
iii) its withdrawal from the body induces reproducibly
the same physiological and structural abnormalities 
regardless of the species studied.
iv) its addition either reverses or prevents these
abnormalities.
v) the abnormalitues induced by deficiency are always 
accompanied by pertinent, specific biochemical 
changes.
vi) these biochemical changes can be prevented or cured
when the deficiency is prevented or cured.
Numerous other elements are found in the body, which do not meet the
above criteria, for example bromine, caesium, rubidium, strontium and
titanium. They are believed to be acquired by the animal body as
environmental contaminants and to reflect the contact of the organism 
with its environment. These non-essential elements have been shown to 
follow skewed (log-normal) distribution patterns of concentration 
within human organs, while essential elements are normally or 
symmetrically distributed (4,5). Some elements, including lead, 
mercury and cadmium, have been placed into a third classification of 
"toxic" elements since they impair health at even minute levels 
(1). It must be remembered, however, that all trace elements are toxic
if ingested or inhaled at sufficiently high levels and for long enough 
periods (2).
1.1.2. Discovery of trace elements
Essentiality of iron to life has been known since the 17th century. 
Similarly, the role of iodine as an essential part of human health has 
been recognised since 1850. Most discoveries linked with trace 
elements, however, have been in this present century. During the first 
25 years, further work was carried out on iron and iodine (6). 
Moreover, the advent of emission spectrography allowed simultaneous 
estimation of approximately 20 elements at low concentrations, thus 
permitting extensive investigation of soils, plants, animal and human 
tissues (7,8,9).
In the 1920’s, first attempts were made to use purified diets in 
animal studies, where the levels of certain elements were strictly 
controlled (10,11). These were largely unsuccessful due to 
deficiencies in other nutrients, particularly vitamins. However, 
within the next few years, a group used rats fed a special diet to 
show that supplementary copper, in addition to iron, was necessary for 
growth and haemoglobin formation. The same group followed this by 
using special and purified diets to prove the essentiality of 
manganese and zinc in rodents and other species (12-15).
During the 1930's, a large number of nutritional disorders of man and 
livestock were found to be caused by deficient or excess intakes of 
trace elements from the natural environment. By discovering such 
deficiencies, the essentiality of cobalt was shown (16,17), and 
further confirmation was given for elements such as manganese and 
copper (18-22). Symptoms caused by excessive intakes of fluoride,
selenium and molybdenum were also noted (23-28). While devising
practical means of prevention and control of the disorders just
described, it became evident that, in addition to the acute conditions
first noticed, there were a series of minor maladies affecting more 
animals in a greater number of regions. It was also shown that the
severity of these deficiency or toxicity states was altered by
presence or absence of other elements or nutrients. An example of this 
is the three-way interaction of copper, molybdenum and inorganic
sulphate discovered in the early 1950’s. Also in that decade, the 
purified diet technique was used to identify molybdenum, selenium and 
chromium as essential (29-33),
In the following years, advances in analytical methods continued with 
the development of atomic absorption and neutron activation techniqes, 
and the use of radioactive isotopes to follow metabolic movements and 
kinetics. Due to such research, many metalloproteins with enzymatic
activity were discovered, for example, the role of copper in elastin
biosyntheses (34). In the 1970’s, six more elements were identified as 
having an essential role: tin, vanadium, fluorine, silicon, nickel and 
arsenic. This became possible by confining animals, on purified diets, 
to a plastic "isolator", free from any metal, glass or rubber 
components, and from the contaminating effects of dust (35). Since 
1977, no further significant advances have taken place, and no 
additions have been made to the fifteen trace elements.
1.1.3. Role of chemical elements
Despite their low concentrations, the essential elements are of great 
importance for growth and development (2). In some cases, they act as 
constituents of vital biological molecules, for example, iron in 
haemoglobin and iodine in thyroid hormones. In other situations, they 
are either part of an enzyme system, or act as cofactors for various 
reactions mediated by enzymes. Table 1 summarizes the biological roles 
of all known trace elements.
There are narrow limits within which the characteristic concentrations 
and functional forms of the trace elements must be maintained. 
Otherwise, the functional and structural integrity of the tissues and 
the growth, health eind fertility of the animals (or humans) may be
Table 1: Mode of action of the essential trace elements (1)
Element
Iron (17th century)
Iodine (1850) 
Copper(1928)
Manganese (1931) 
Zinc (1934)
Cobalt (1935) 
Molybdenum (1953)
Selenium (1957) 
Chromium (1959)
Tin (1970) 
Vanadium (1971)
Fluorine (1971)
Silicon (1972) 
Nickel (1976) 
Arsenic (1977)
Some functions and deficiency aspects
Involved in oxygen and electron transport
Deficiency results in anemia, which is widespread on a global scale - 
Excess is dangerous in hemochromatosis 
Constituent of thyroid hormones
Deficiency results in goiter and depression of thyroid function
Excess leads to thyrotoxicosis
Linked to oxidative enzymes, interacts with iron
Essential for cross-linking of elastin (e.g., connective tissue)
Deficiency results in anemia and changes in ossification and is widespread in malnourished 
populations and in patients receiving total parenteral nutrition (TPN); pregnant women 
are easily susceptible to deficiency
Participates in mucopolysaccharide metabolism and is connected with superoxide dismutase
No deficiency effects in humans are known
Toxic if inhaled and excess results in neurological disorders
Constituent of over 100 enzymes involved in a variety of fundamental metabolic processes 
Deficiency has grave consequences and is reflected in growth depression, sexual immaturity, 
skin lesions, depression of immunocompetence, taste acuity, etc.
Deficiency in several parts of the world, including Turkey, is suspected, proven in Iran 
and Egypt, and risked by vegetarians, malnourished populations, patients on TPN, and 
those suffering from certain genetic disorders of metal transport; subjects under traumatic 
stress are seriously affected by the imbalance 
Part of vitamin B-12 whose deficiency in humans is established 
Low intake from vegetarian diets seriously affects some sections of the population 
Linked to xanthine, aldehyde, and sulfide oxidases 
Deficiency symptoms in humans are not ^own  
Excessive exposure results in gout-like syndrome (seen in U.S.S.R.)
Component of glutathione peroxidase and interacts with heavy metals 
Known disease in humans is cardiomyopathy (Keshan disease) in China, conditioned by 
selenium deficiency, completely cured by selenium administration 
Toxic effects well recognized in animals 
Believed to activate insulin
Deficiency associated with impaired glucose tolerance and elevated serum lipids, and 
suspected link with heart disease; deficiency proven in malnourished conditions, in aging, 
in patients under TPN, and in subjects consuming highly refined foods; also known for 
occupational hazards, chromium allergy, eczema, and cancer 
Believed to be essential for growth in animals 
Metabolic interactions largely unknown 
Believed to be essential for growth in animals 
Metabolic interactions largely unknown 
At high concentrations, interferes with iron absorption 
Essential for the structure of teeth, possibly of bones, possibly growth effects 
Deficiency in humans observed through increased incidence of caries; possibly risk factor 
for osteoporosis
Toxic at high concentrations; fluorosis demonstrated in some populations
Connected with calcification and possibly in connective tissue formation
Deficiency aspects largely unknown and probably unlikely
Interferes with iron absorption; other metabolic interactions largely unknown
Excess exposure causes eczema and cancer
Believed to be essential for growth in animals
Metabolic interactions largely unknown
Note: Figures in parentheses indicate year that essentiality of respective element was discovered.
impaired (2). The body can utilise protective mechanisms which delay 
or minimise the effects of changes brought about by deficient, 
imbalanced or toxic quantities of elements in the diet or the 
environment. Ultimately, however, changes will be seen in the health 
of the animal; the extent and form of these will depend on a number of 
factors, including age, sex, animal species and degree of dietary 
imbalance.
1.1.4. Needs for elemental analysis
There is a need for elemental analysis of biological systems in many 
branches of the biological, environmental and medical sciences. In 
the first of these, there is very little current knowledge on the 
exact role(s) that various elements play in biochemical processes. 
Precise identification and quantification is necessary so that 
metabolic investigations can produce meaningful results. Among 
environmental scientists, and even the general public, there is an 
increasing awareness of the dangers to public health from pollution. 
It is therefore important to carry out monitoring and surveillance 
activities; plant-life, soils and dusts can be important sources of 
information. In medicine and related areas of work, elemental analysis 
is necessary for a number of situations. Examples of this are 
documentation of clinical problems from deficiency or toxicity states, 
preparations of diets and total parenteral nutrition, and
identification of inherited disorders of human trace metal metabolism. 
It is of vital importance to have a reliable set of reference values 
for essential and toxic elements in various tissues and fluids, 
particularly the readily accessible clinical specimens so that valid 
comparisons can be made and therapeutic action begun. Other areas of 
study involve clinical monitoring of patients undergoing dialysis, or 
those with replacement or restorative surgery.
In addition, information is required about the daily elemental 
requirements of humans, availability from the diet, and so on, 
particularly since trace element supplements are now readily available 
for purchase (1,36). The present literature is sparse for many 
elements, for example, boron and germanium, and for "new" analytical 
techniques, such as ICP-MS. As analytical methodology improves, it is 
importEint that reference information and data-bases be continually 
updated.
1.2. Analytical Methodology
1.2.1. Analysis techniques
Some of the principal methods by which the elemental contents of 
biological tissues and fluids can be measured are described in this
section. Table 2 compares the detection limits of a number of these 
techniques.
1.2.1.1. Atomic absorption spectrometry (AAS)
AAS allows measurement of the concentration of a species in an atomic 
vapour which absorbs radiation at characteristic, element-specific, 
optical wavelengths. The energy is provided for vapourisation and 
atomisation by a flame or by an electrothermal method, where 
structures such as carbon rods or graphite furnaces are subjected to 
resistive heating. It is essentially a single elemental technique, 
although in recent years, some attempts have been made to adapt this 
method so it can be used in a simultaneous, multi-element mode 
(37,38).
Flame AAS requires sample introduction via a nebuliser and spray 
chamber, which is a relatively inefficient method; it is a simple 
technique to use, however, and interferences or systematic errors are 
relatively low (39). Flameless AAS, of which graphite furnace (GF) 
AAS is most frequently used, utilises considerably smaller sample 
volumes, in the range of 5-50jjL, This method is particularly suited to 
the requirements of biological trace metal analyses, since it provides 
an in-built dry ashing procedure which can free the determination from 
the influence of the organic matrix (40). The details of this three-
Table 2: Comparison of detection limits for differentanalytical techniques (41): ng/^L
XRT FAA5 GFAA9 1CP-AE9 ICP-MS NAA
LI - - - 2 0.01 -
B# - - 0.003 0.001 0.01 -
Mg . - - 0.0002 0.003 0.01 50
Ai - 30 0.1 0.8 0.01 30
P - - - 15 0.1 -
K 3.5 - 0.004 200 10 20
Ca 4.5 - 0.05 0.01 ' 10 500
V 5 40 0.1 0.06 0.01 0.5
Cr 5 2 0.004 0.8 0.01 0.5
Hn 6 1 0.0005 0.02 0.01 0.1
Fa 5 3 0.01 0.09 0.1 10
Co 3 6 0.08 3 0.001 0.5
Ni 3 4 0.05 0.1 0.01 0.6
Cu - 1 0.005 0.6 0.01 3
Zn 4.5 0.8 0.001 0.01 0.01 5
A# 5 - 0.08 2 0.01 1
Ho - 30 - 0.1 0.01 0.2
Sn - - 0.03 3 0.01 30
Cd - 0.5 0.0002 0.2 0.01 5
Ba 12 6 0.04 0.01 0.01 10
Au - 6 - 40 0.001 0.3
Hg - - 0.2 10 0.01 1
Pb 3 10 0.07 1 0.01 -
Bi - 20 50 0.001 -
U 6 - - 30 0.001 2
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stage heating program of drying, ashing and atomisation must be 
carefully chosen, however, requiring highly skilled operation. Serious 
matrix effects have been troublesome in this technique, but
significant progress has been made in the reduction of these
systematic errors by the introduction of the Zeeman background
correction, treatment of graphite furnace surfaces and adaptation of 
tube geometry.
Both flame and flameless techniques are well established, and 
equipment is relatively inexpensive to purchase and run. Detection 
limits for GFAAS are about 100 times smaller than those of FAAS. The 
main disadvantage is the fact that neither technique is routinely
capable of multielemental analysis.
1.2.1.2. X-ray fluorescence (XRF)
This method is based on the observation that when a specimen is 
irradiated with a beam of sufficiently short-wavelength X-radiation, 
characteristic X-ray spectra are generated (41). Other excitation 
sources include electrons, gamma-rays, and more recently, charged 
particles. Simultaneous multielement detection is possible; detection 
limits range from several jjg/g in favourable cases (particularly 
around atomic number 30) to approximately 100% by weight (39,41).
11
Accuracy and precision is good, although matrix effects in biological 
or environmental samples may cause difficulties.
Recent developments in this area include PIXE (particle induced X-ray 
emission). The absolute detection limit of PIXE can be below the 
picogram level, if special procedures are used; more importantly,
however, the proton beam can be focussed to about 1pm in diameter
(1,39).
1.2.1.3. Atomic emission spectroscopy (AES)
The principle of this technique involves the coupling of enough energy 
to a small sample, to result in vapourisation and emission of light, 
as excited atoms return to lower energy states. The characteristic 
spectra of individual elements may be identified and their
concentration related to the intensity of the lines.
Various excitation sources have been used, including a high voltage, 
electric arc, high-temperature flame, direct current plasma (DCP) , 
microwave-induced plasma (MIP) or inductively coupled plasma (ICP). Of 
these, the ICP has been the most successful for multielement trace 
analysis, with detection limits of 0.01-50ng/mL. The method is 
relatively free from matrix effects although spectra can be very
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complex. Stray light and background recombination may cause some 
difficulties, when using ICP-AES (1,41).
1.2.1.4. Neutron activation analysis (NAA)
This technique involves inducing radioactivity in the sample material, 
followed by measurement of the radiation emitted by these radioactive 
nuclides. Neutrons are generally chosen as the irradiation source; 
gamma-rays are the usual choice for quantification of induced 
activity, as they exhibit discrete energies and are not subject to 
significant absorption within the sample (1,41). NAA has good 
detection limits of l-50ng/g, depending on the irradiation conditions 
used, and allows simultaneous determination of many elements (42,43). 
It is a non-destructive technique; in addition, solid samples require 
little or no sample preparation which reduces contamination problems. 
However, liquids must not be irradiated directly because of the 
leakage of radioactive material. Disadvantages of this technique also 
include expense, since access is required to a suitably equipped 
nuclear reactor. In addition, several elements cannot be routinely 
determined, such as boron and lithium, while others demand excessive 
counting times, including cobalt, zinc and iron.
Radiochemical NAA may be used in the determination of the shorter- 
lived isotopes (Ti/2<1 week) or to isolate low radioactivities of
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long-lived low-energetic isotopes which are otherwise
indistinguishable from the compton background. Elements such as 
vanadium, chromium, manganese and others, found at and below the ng/mL 
level in serum, have been successfully measured using this technique 
(77). The main advantage about this technique is that the risk of 
contamination to the sample is minute, provided sample collection 
techniques are good. The manipulation required of a sample, before 
irradiation, is minimal e.g. separation of serum from whole blood and 
freeze-drying. After irradiation, any contamination introduced in 
digestion and separation procedures is not important, since the 
elements added are not radioactive (77).
1.2.1.5. Mass spectrometry (MS)
This method of analysis involves the ionisation of sample material 
with subsequent ion separation on the basis of charge/mass ratio. The 
numerous designs of mass spectrometer include spark source, isotope 
dilution and secondary ion MS. Of these, until recently, only spark 
source has been of major importance for simultaneous multielement 
trace analysis (44-52). For this technique, excellent detection limits 
in the range 1-lOng/g are achieved. Sample preparation is difficult; 
extreme care must be teiken to ensure homogeneity of the sample 
material since only a fraction of the total sample is utilised in
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sparking. Spectra are difficult to interpret and sample throughput is 
small at low levels of concentration.
1.2.2. ICP-MS and biological systems
In the last decade, the technique of ICP-MS has been developed; this 
combines an inductively coupled plasma source with a quadrupole mass 
spectrometer to give a rapid, sensitive, multielement technique. The 
high sensitivity of the mass spectrometer and low background levels 
give detection limits in the order of 0.01-1 ng/mL in aqueous 
solution. Only a few elements cannot be measured by this technique, 
while spectral interferences result in a small number of problems. 
Other advantages include simple spectra and a wide dynamic range. The 
equipment is, unfortunately, quite expensive to purchase and run, when 
compared with techniques such as AAS; high sample turnover is 
possible, with more than 90% of the elements in the Periodic Table 
being covered. A thorough assessment of the analytical capabilities of 
ICP-MS has recently been completed (53).
It is still a relatively new technique, but the number of papers being 
published on various applications of its use is rapidly growing. Some 
of the more recent developments and reports will be described here.
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Because of its low detection limits and multielemental capability,
ICP-MS is ideal in obtaining information on elemental composition of
various samples. These include more "unusual" samples such as human 
oviduct fluid and cerebrospinal fluid as well as the more usual serum
(54,55). Some studies investigate various health problems, such as the
composition of seminal fluid in male infertility (56), brain tissue of 
human stillbirths (57) and zinc supplementation to anorexics (58). 
Analysis has also been carried out on both human milk and commercial 
inf ant f ormulas (59,60).
Determination of isotope ratios is also possible with ICP-MS. Isotopes 
of zinc in faeces and whole blood (61), and of iron in faeces and 
erythrocytes (62,63) have been considered in bioavailability and 
tracer studies. Selenium isotope ratios have also been measured, using 
human urine after a dose of isotopically enriched selenium had been 
taken orally (64,65). Tracer studies have been reported for strontium 
(66) and blood lead isotope ratios have been measured following 
environmental exposure (67). In addition, iron isotope ratios, in 
small samples of blood, have been carried out using electrothermal 
volatilisation as an alternative to solution nébulisation (68). This 
method of sample introduction could be of significant importance in 
medical studies where a limited quantity of sample material is 
available. The other major alternative to solution nébulisation is 
laser ablation of solids. This method is still in the development
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stage but has proved to be successful in the analysis of several 
biological reference materials (41). Suitable standardisation can 
present some difficulties with this technique.
Finally, ICP-MS has been used to good advantage when coupled with 
other analytical techniques. For example, it has been used as an on­
line detector for the analysis of the metalloproteins ferritin and 
metallothionein in liquid chromatography eluates (69). Moreover, the 
spéciation of cadmium in pig kidney has been investigated using size 
exclusion chromatography interfaced directly with ICP-MS (70).
1.2.3. Choice of analytical methodology
The development of such a wide range of analytical techniques, as 
described in the previous sections, indicates that no single technique 
can meet the needs of all the elements in the periodic table, for all 
types of sample under investigation. Two main factors which must be 
considered when pleinning a trace element study are the extent of 
elemental coverage and the order of magnitude of the instrument’s 
detection limits for the range of elements.
It is clear that within any given multielement technique, there are 
some elements which are capable of being measured to a high degree of 
accuracy and precision, while others are less suitable, thus requiring
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some degree of compromise when making a choice. For example, aluminium 
is readily measured by ICP-MS, and by the single elemental GFAAS. If 
NAA is used, however, there is a danger of interference from the 
reaction of fast neutrons with the phosphorus in the sample. Another 
example is calcium, which can be evaluated using NAA and FAAS. In ICP- 
MS, use of the main isotope of calcium ^®Ca is impossible because of 
the presence of the *°Ar plasma gas peak i.e. other isotopes must be 
used instead e.g. "Ca with an abundance of 2%. Fortunately, the 
levels of calcium in most biological tissues and fluids are 
sufficiently high to allow determination using ICP-MS.
1.2.4. Aims of this study
The main objectives of this work involve ' the further application of 
solution ICP-MS to the measurement of trace elements within biological 
specimens which are readily available within a clinical setting. In 
particular, the suitability of this technique is assessed with 
reference to the element boron. Since a certain amount of interest has 
been shown in whether or not it is essential for animal life, its 
levels and associations with other elements within certain tissues and 
fluids are investigated.
The multielement capabilities of ICP-MS are utilised in order to 
obtain information about a wide range of elements, such as lithium.
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germanium and lanthanum, in human tissues and fluids and in standard 
reference materials. In order to investigate patterns of elemental 
behaviour in various biological samples, the observed elemental 
levels, and correlations between elements and matrices are assessed.
Finally, ICP-MS is used as a technique for evaluating how elemental 
levels may become altered in cases of human disease; in this instance, 
the disorder of rheumatoid arthritis is investigated.
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2. METHODS OF ANALYSIS
2.1. Instrumentation
2.1.1. Inductively coupled plasma source mass spectrometry
Inductively coupled plasma source mass spectrometry (ICP-MS), is a 
comparatively new analytical technique: some of its applications to
the measurement of biological samples have already been summarised. In 
this section, the principles of operation will be described.
The design of the VG Elemental Ltd (Winsford, Cheshire) Plasmaquad 
used in this project is shown schematically in Figure 1. Basically, 
samples are introduced by means of a pneumatic nebuliser and ionised 
in the argon plasma. A portion of this ionised gas is introduced to 
the quadrupole mass analyser, which scans the entire mass/charge 
range. Beyond this, the ion detector is connected to the multi-channel 
analyser (MCA) and computer. In this chapter, each important step in 
this process will be outlined in detail.
2.1.1.1. Inductively coupled plasma
The ion source consists of an electrodeless argon plasma operated at 
atmospheric pressure, sustained by inductive coupling. Figure 2 shows
20
Figure 1: Schematic of complete ICP-MS system (41)
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the inductively coupled plasma (ICP) torch schematically. Two to 
three turns of a water-cooled copper "load" coil surround the tip of 
the quartz torch, and are coupled to a radio-frequency power supply 
(operating frequency 27.12 MHz, power output 1-2.5 kW).Argon is 
introduced tangentially to both the inner tube (1 L/min) and the 
annular region (10-15 L/min), thus producing a spiral flow. Since 
argon gas is initially neutral, a spark is required to produce an 
stream of electrons, which pick up energy from the load coil. A plasma 
fireball is formed in the mouth of the torch, and kept off the walls 
by the coolant flow of gas.
Samples are introduced into the torch via a jet of cold argon (0.5-1 
L/min) which flows through the central injector tube, narrowing to a 
capillary at its end. The resulting high velocity jet forms a central 
cooler channel through the fire-ball, surrounded by an annulus of hot 
gas at approximately 10,000K. The plasma is self-sustaining because 
the annulus of hot gas couples to the load coil. The central channel 
in this region reaches a temperature of almost 8000K, but this falls 
rapidly as the carrier gas leaves the torch mouth induction region, 
and enters the tail flame area. Figure 3 demonstrates the temperature 
profile of the ICP. Samples require sufficient time in the hottest 
part of the plasma to ensure that complete vapourisation and 
dissociation may take place i.e. complete release of elements from 
within the matrix microparticulates. Considering an optimised carrier
22
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gas flow, and the length of the fireball, the sample may be said to 
reside within the plasma for approximately 2ms (53).
A pneumatic nebuliser is used to introduce the sample to the plasma, 
using a peristaltic pump at a typical rate of ImL/min. Much of the 
sample taken up this way is wasted, because the gas stream is only 
able to support droplets below about 4pm diameter. These particles are 
rapidlj’ vapour ised on entry into the plasma; particles up to 
approximately Ijjm can be vapourised by the plasma described here.
The usefulness of the plasma as an ion source depends on the 
efficiency of ionisation of analyte atoms in the ion plume. The Seiha 
equation can be used to measure the degree of ionisation, a, of a 
species :-
Equation 1. a = m  where ni is the ion population
nt nt is the total population
= for singly charged ions
M++ M
The Saha equation is as follows
Equation 2. logSn = ^log Ti - 5040Ei + log Zi + 15.684
2 Ti ^
where Sn = a n*
1 - 0
Ti is the ionisation temperature, Ei is the ionisation energy for the
species, Zi, Z« are partition coefficients for ions and atoms, and n*
is the electron population (71).
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Figure 4 shows values calculated from this equation with an 
ionisation temperature of 7500K. Many elements have an efficiency of 
more than 90% for formation of singly charged ions, and even metalloid 
or non-metallic elements can be ionised. Doubly charged ions should be 
negligible - the highest proportion are found with barium, lanthanum 
and several other rare earths.
2.1.1.2. Source/analyser interface
In this stage, ions must be extracted from the plasma, which is at 
atmospheric pressure, and transferred to the mass analyser, in high 
vacuum, without altering the ionic composition of the sample. Figure 5 
is a schematic of a typical ion extraction interface, showing two of 
the three stages of vacuum used.
25
£O
Coüoc
aE«(0
O
oo
w oo 4"£  (0 
CL
0)CJtoiwM
(U•MC•HLi
OJen
njC(00)
CJDOoco
ir,
(UM300•Hk
26
Both the skimmer and sampling cone are typically made of nickel, which 
has a good thermal conductivity and chemical resistance. A 0.5-1.0 mm 
aperture is drilled in the tip of the cone; the minimum would be 
approximately 150jjm, or 100 times the mean free path of atoms in the
plasma. In practice, larger sizes are used, to minimise the problem of
clogging due to sample condensation around the aperture. This also
results in a very large volume of gas being admitted; hence the 
intermediate expansion stage, maintained at a pressure of 1-3 mbar by 
a simple rotating pump. The steep pressure gradient thus formed in the 
aperture drives a jet of gas from the centre of the plasma into the 
first stage of vacuum, with a rapid drop in temperature of 
approximately 6000K to 200K in a few microseconds. Thus the
composition of the sample is effectively "frozen" i.e. only reactions 
which occur in <l-5ps can take place, for example, the formation of 
some polyatomic ions from argon gas and sample matrix ions. Behind the 
extraction cone, the sharply-angled skimmer ( external angle 57° ),
extracts ions from the centre of the expanding jet of gas in stage 1, 
and passes then to the second stage. The mean free path is now in the 
same order as the skimmer aperture, at about 1mm, with the result that 
many of the species collide with the walls of the skimmer. In stage 2, 
the pressure is maintained at about 10“®-10“^mbar by a diffusion pump; 
at this level of vaccuum, the gas flow becomes fully molecular. 
Several electrostatic lenses are used to separate the neutral species 
and the ions. The latter are then focussed into the mass analyser in
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the third stage of vaccuum, past a metal baffle which is used to 
reduce noise due to detected light photons (53,71).
2.1.1.3. Mass analysis and ion detection
The quadrupole mass analyser is situated in the third stage of vaccuum 
where the pressure is approximately 2 x 10”® mbar. Figure 6 shows 
this part of the system schematically. A quadrupole analyser consists 
of four electrically conducting, parallel rods, typically manufactured 
from stainless steel or molybdenum and mounted in ceramics. The VG 
Plasmaquad, in addition to the normal analysing rods shown in Figure 
7, has a set of short rods (25mm long), mounted before and after them. 
These are supplied by a.c. potentials only and act to ensure that low- 
energy ions may enter. Opposite rods are connected together; a d.c. 
voltage and a radio-frequency (BF) alternating voltage (U + Vcos&mft) 
is applied to one pair while an equal and opposite voltage (-U -
Vcos2mft) is applied to the other pair. For a given RF potential and 
frequency, only one mass/charge (m/z) ratio can pass through the 
analyser and be detected. Lighter elements will oscillate with 
increasing amplitudes, while heavier ions will drift slowly towards 
the electrodes; both groups strike the rods and are neutralised. The
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quadrupole parameters determining which will have a stable path are 
shown in equation 3
Equation 3 JL “ C .V where C = constant
z f®ro* ro= radius of the inner
surface of the rods 
f,V = frequency, magnitude 
of a.c. voltage
By scanning d.c. and RF voltages through their ranges, multi-element
measurements can be carried out. Ions will then be transmitted and
detected in an order which depends on their m/z ratio (53,72).
The resolution of the analyser, or its ability to separate ions of
different masses, is controlled by the U/V ratio, which can be varied
electrically. A useful definition of resolution uses any given peak in
the mass spectrum (71):-
M where M is the mass of the peak
AM AM is the peak width at a peak height of 5%
The peaks produced by the quadrupole mass analyser are approximately 
triangular; imperfections in peak shape ("tailing") occur due to lack 
of symmetry in rod geometry, a reduced number of RF cycles during ion 
flight, and energy spread among the ions which enter the quadrupole, 
for example.
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2.1.1.4. Ion detection and data handling
Ion detection is carried out by a channel electron multiplier (CEM) in 
a pulse counting mode. This is able to detect individual ionà, and 
thus a high level of sensitivity is achieved. Within the CEM, a gain 
of about 10® takes place; the resulting pulse passes via an amplifier 
and discriminator to a ratemeter and a multichannel analyser (MCA), in 
which any given channel corresponds to a unique m/z ratio. This is 
done by synchronously sweeping the mass scan of the analyser and the 
channel addresses of the MCA. A spectrum over a specified mass range 
can thus be built up with successive sweeps; it is then downloaded to 
a storage medium, such as a floppy disk, via a computer.
2.1.1.5. Practical considerations
Theoretically, ICP-MS has detection limits superior to many other 
analytical techniques (see Table 2, section 1.2.1.). In practice, 
however, these levels are rarely obtained when working with "real" 
samples, especially those with high levels of matrix, or small sample 
volumes and high dilutions. A number of factors are involved in this 
degradation, both physical and spectroscopic (53,71).
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One factor which was mentioned earlier was extraction-cone blockage. 
This is caused by the condensation of solid during the rapid cooling 
of the gas, and usually occurs at high levels of dissolved solids, 
particularly refractory matrices. To avoid this, it is important to 
consider the total dissolved solids levels of samples during 
preparation, although care must be teiken not to "over-dilute" samples 
to beneath the detection limits. There is also the possibility of 
general analyte signal suppression in the presence of matrix elements.
The main reason for degradation in detection limit levels, however, 
are spectroscopic interferences with the isotope(s) of interest. 
Polyatomic interferences are a result of ion-molecule reactions 
between major species in the plasma. These occur during the extraction 
process at the cone, or the expansion stage immediately after this. 
The major elements present in solvent acids, or occasionally in the 
sample matrix, such as nitrogen, chlorine, phosphorus or sulphur, give 
rise to awkward interfering species when combined with argon, oxygen 
and hydrogen, for example. Most of these interferences take place 
below mass 80 (53); see Figure 8 .
The number of polyatomic interferences created is a very large factor
in the choice of mineral acid used in sample digestion and
dissolution, and in multi-element standard preparation. Table 3
+Ke.compares nitric, hydrochloric and sulphuric acids at^l% level (53). An
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Figure 8: Blank spectrum of 1% HN03 showing "water" and "gas"peaks and associated polyatomic ions (53)
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important consideration in this is that nitrogen has a higher 
ionisation potential than chlorine and sulphur, and thus nitrogen- 
containing peaks will tend to he smaller than those containing 
chlorine or sulphur (71).
These factors lead to the decision to use nitric acid alone in sample 
preparations (see section 2.2.3). It is important that acid 
concentrations are kept below approximately 5%, to avoid corrosion of 
the nickel cone and skimmer, and contamination of the first stage 
pump. Despite the careful choice of acid, interferences may still 
occur if elements such as phosphorus, chlorine and sulphur are found 
at high concentrations in the analyte matrix. One such interference is 
3GQ216Q+ Qjj but a correction technique has been devised to deal
with this, utilising various isotopes of chlorine and chromium (53).
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Table 3: Relative concentrations of some mineral acidpolyatomic ions (53)
1% Nitric Acid
Polyatomic Mass C o n e .
ion (u)
ArN 54 23.1ArO 56 232ArAr 80 2580
1% Hydrochloric Acid
Polyatomic
ion
Mass(u) C o n e .
CIO 51 1500CIO or ClOH 52 24.5
CIO 53 497
ArN 54 52.5ArO 56 365
ArCl 75 58.5ArAr 80 4840
1% Sulphuric Acid
Polyatomic
ion
Mass
(u)
C o n e .
SO 48 4750
SO or SOH 49 65.1SO or SOH 50 258
SO or SOH 52 3.38
ArN 54 23.8ArO 56 265
S2 or SO2 64 1130Ss or SO2 65 59.4
S2 or SO2 66 56.4ArAr 80 2800
Equivalent concentrations, ng.mL"^ Extraction cone 0.7mm, Skimmer 1mm. {ref. Ipg.mL-i s*Co)
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Another form of interference is due to the formation of analyte oxide 
ions, from incomplete dissociation in the plasma, recombination in the 
cooler boundary layer which forms over the sample cone, or from ion- 
molecule reactions at the cone aperture. The plasma operating 
parameters are of importance in determining their levels (53). The 
rare earth elements, thorium eind uranium are particularly susceptible 
to oxide formation; the size of these peaks are normally less than 1% 
of the element peak. Another example of an oxide interference is 
48Yii8Q Qyj ®'*Zn; in this case, there are other isotopes of Zn which 
are available for use (masses 66 and 68).
Finally, doubly charged ions of analyte or matrix species may cause 
some interferences. Figure 4 shows the degree of double ionisation 
predicted by the Saha equation. This indicates that barium and some 
rare earth metals will exhibit some degree of double ionisation. Only 
elements with a second ionisation potential below the first ionisation 
energy of argon can form these species and this number is limited to 
about thirty. Thus, doubly charged ions tend to. be a minor cause of 
interference, at levels of <1% of the total response (53).
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2.2. Pre-analysis Treatment of Samples
2.2.1. Sample population
In this study, the elemental content of a wide range of human tissues 
and fluids are analysed. These samples are taken from a number of 
subgroups within the British population; details of sex, age, number 
of population and tissue-type are summarised in Table 4.
2.2.2. Sample collection
2.2.2.1. Blood and blood fractions
Whole blood was collected by insertion of a stainless steel needle, 
pre-washed by alcohol to remove surface contaminants, into the vein of 
the right arm. Approximately 4-5mL of blood was withdrawn through a 
’’butterfly" connection into a plastic collection tube, coated with 
lithium heparin Einticoagulant. The tube was slowly turned, but not 
shaken, to ensure thorough mixing of the anti-coagulant without 
causing sample clot disruption. A further 4~5mL of blood was then 
withdrawn into a non-coagulated blood serum tube, allowed to stand for 
10-15 minutes at room temperature until the clot had formed, and spun 
at 2500 rpm for 10 minutes. The two fractions were separated into 
blood serum and clot, and stored in polypropylene containers. A third
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Table 4-. Sections of British population used in this study 
a) Adults (n=215)
Geographical
areas
Number of
subjects
M»
Subject 
age 
M“ pb
Sample
type
Health
status
S. W. England 24 12 38+18 29±18 whole blood,saliva healthy 
urine,hair,nails
Aylesbury 8 54 63±13 54±10 whole blood,urine 
hair,nails
various
cancers
Sheffield 4 9 59±6 59±10 whole blood,serum 
clot,packed cells
healthy
Manchester 34 29 47±19 54+22 synovial
fluid
various
arthritic
disorders
London 18 18 67±6 68+8 brain rheumatoid
arthritis/
controls
4 1 76±4 48 bone as above
b) Children {n=70)
Geographical
areas
Number of 
subjects 
M“ F^
Subject
age
M»
Sample
type
Health
status
Midlands - 14 - 17±1 saliva,urine,hair healthy
Sussex/
Hampshire
9 6 6±4 5+3 urine,hair healthy
Bucks/
Berkshire
34 7 9q6 6±4 saliva,urine 
hair,nails
healthy
a: male b: female
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aliquot of blood was drawn into a coagulated tube and spun in order to 
collect plasma and packed cell samples. However, due to some 
contamination in the separation of these two fractions, the blood 
plasma samples were discarded. All blood fractions were stored at 
-20°C within 30 minutes of blood collection or subsequent separation.
2.2.2.2. Saliva
Samples were collected between 8 and 9 a.m., after overnight fasting, 
to reduce variations due to dietary intake or diurnal changes. Saliva 
was collected directly from the subject into a sterile 5mL capacity 
polystyrene tube. Samples were labelled and stored at -20“C in 2-4 
hours.
2.2.2.3. Urine
Urine samples were collected between 8-9 a.m. for the same reasons as 
saliva. Specimens were taken in mid-flow, directly into sterile 25mL 
polystyrene bottles. Storage, prior to analysis, was at -20“C and was 
achieved within 2-4 hours of sample collection.
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2.2.2.4. Hair and nails
Samples were taken using standard stainless steel scissors and 
clippers. Hair was removed from a specifically designated region (for 
reproducibility reasons), namely the nape of the neck (midway between 
the shoulders), and cut as close to the scalp as possible. The 
"bundle" of hair was placed in a small plastic bag and sealed firmly. 
Nail clippings were taken from each finger and toe; finger-nails and 
toe-nails were stored in separate, sealable, plastic bags.
2.2.2.5, Synovial fluid
Synovial fluid samples were collected from the knees of patients. 
Before this, skin was disinfected with either 70% isopropyl alcohol, 
15% chlorohexidane or an aqueous solution of iodine. A sterile 
polypropylene hyperdermic syringe, lubricated with a silicone gel, was 
inserted into the knee joint. Then, liquid was drawn through this by 
a conventional stainless steel needle and ejected into a sterile 20mL 
polystyrene bottle. Prior to storage, the samples were divided into 
cellular and acellular subgroups. Half of the original sample was 
poured into a smaller capacity bottle; this was the cellular synovial 
fluid. The remaining sample was spun down in the original bottle (1000 
rpm for 20 minutes) and a sterile glass pipette was used to remove the
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supernatant i.e. the acellular synovial fluid. All synovial fluid,
with or without cells, was stored within three hours of collection.
2.2.2.6 . Brain and bone samples
Brain and bone tissue was collected from autopsy cases using a 
tantalum knife and a titanium saw respectively. All bone samples were 
well rinsed with doubly distilled deionised water (DDW) to remove 
blood or soft tissue particles which may have adhered during 
collection. Brain and bone samples were preserved, prior to sample 
digestion and analysis, at -20°C in plastic containers.
2.2.3. Sample preparation
The ICP-MS instrument used in this study, with its pneumatic 
nebuliser, requires samples to be introduced in a liquid form. Various 
types of digestion techniques were used, depending on the nature of 
the sample. These can be divided into the main groups of dry- and wet- 
digestions, which will be described in turn. At the time of sample 
preparation, "reagent" blanks and standard reference materials of a 
similar matrix were also prepared. Reagent blanks are samples made by 
carrying out all steps in any given sample digestion, for example, 
volume of reagent, length and manner of heating, further dilution and 
storage conditions, but without the addition of any biological sample
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material. The same digestion techniques were also used to prepare 
standard reference materials which were as close as possible to the 
actual sample matrix. By definition, reference materials are 
substances of which one or more properties are sufficiently well 
established to be used for the calibration of an apparatus or for the 
verification of a measurement (73). Standard reference materials 
(SRMs; sometimes also known as certified reference materials or ŒMs) 
are reference materials accompanied by a certificate stating the 
property value(s) concerned. Agencies such as the National Institute 
of Standards and Technology (NIST) or International Atomic Energy 
Agency (IAEA) provide the reference materials and the certification; 
in some cases, additional "information" values are provided. These are 
probable levels that are not sufficiently qualified for certification 
or recommendation (1). Utilisation of such materials provides a check 
on all stages of sample digestion and analysis.
2.2.3.1. Wet digestion
These were carried out on blood fractions, saliva, urine, synovial 
fluid, brain and bone samples; the procedure is summarised in 
Figure 9.
Brain (0.2-0.6g) and bone (0.5-l.lg) samples were digested using 5mL 
concentrated nitric acid (BDH Chemicals Analar Grade Reagent'*'”) and
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Figure 9: Flow diagram of wet digestion preparativetechniques used in this study
<0
Brain, bone samples 
weighed into 
boiling tubes
Synovial fluid, urine, 
saliva, serum pipetted 
into polypropylene 
tubes
Whole blood, clot, 
packed cells weighed 
or pi pot ted into 
teflon containers
: ■■ Y
Concent ra ted HNO. Conceit ti'atod HNOa . Concentrated HNOi
and 30% HtO* added added added
Pin en
©
Tubes placed in heating 
block. Heated on 
hotplate for several 
hours
Sunipic tubes covered. 
Houted in water bath 
on hotplate for 
several hours
Samples covered with teflon 
disc; placed in stainless 
steel "bombs". Heated in 
oven overnight
Y
Samples allowed to cool Samples allowed to cool Samples allowed to coole
\y
Q
V
Storage at 4 "C
Samples made up to final 
volume in the same 
polypropylene tube
Samples transferred to 
polypropy lene tube; 
made up to final volume
Samples made up to final 
volume in volumetric flask; 
transferred to polypropylene 
container for storage
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5mL of 30% hydrogen peroxide (BDH Chemicals Analar Grade Reagent 
in quartz boiling tubes. These were heated on a hot plate at 
approximately 90°C for 1-2 hours. The "clear" solutions obtained were 
transferred to volumetric flasks with copious rinsings and made up to 
50mL with DDW. Final storage was in polypropylene containers at 4°C.
Whole blood, clots and packed cells (ImL or equivalent) were placed in 
teflon containers with SmL concentrated nitric acid (BDH Chemicals 
Aristar Grade R e a g e n t co v er ed  with teflon discs, and then enclosed 
in stainless steel digestion "bombs". These were placed in an oven at 
approximately 80“C and then allowed to digest for approximately 20 
hours. Samples were allowed to cool, transferred to polypropylene 
containers and made up to lOiiiL.
Serum, synovial fluid, saliva and urine samples were digested in 
closed polypropylene tubes in a water bath. Wherever possible, ImL of 
sample was pipetted into the digestion vessel (samples with volumes 
<0.4mL were discarded).Then, 0.5mL (for saliva and urine) or O.BmL 
(for serum and synovial fluid) of concentrated nitric acid (BDH 
Chemicals Aristar Grade Reagent?") was added. Samples were allowed to 
digest for 3-4 hours; after cooling, synovial fluids were diluted to 
3mL and the remaining sample groups to 5mL.
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Wherever possible, samples were diluted to final volume and stored 
without being transferred from the digestion vessel. This was in order 
to reduce the possible areas of contamination or errors due to sample 
loss during transfer. If this was impossible, because digestion 
vessels were to be re-used, the vessels were repeatedly rinsed with 
DDW to minimise such losses. All reusable containers were washed in 
15% Decon (FSA Laboratory) made up in boiling distilled water, rinsed 
and boiled in 50% HNOa for at least four hours and finally, rinsed
thoroughly with DDW. All samples were stored at 4®G until analysis was
carried out.
2.2.3.2. Dry digestion
This type of digestion was used for scalp hair and finger- and toe­
nails; the procedure is summarised in Figure 10.
Unlike the tissues and fluids in the previous section, scalp hair and 
nails were washed before analysis. The decision of whether or not to 
wash such tissues is utterly dependent on the ts^ pe of analysis being 
undertaken. If it is important to discover the effect of the external 
environment e.g. the workplace on the elemental levels of hair, 
washing may not be necessary. In this study, however, the intrinsic 
trace element content of hair and nails was of interest, and so it was 
necessary to remove external contaminants by washing (74). In
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Figure 10: Flow diagram of dry digestion preparativetechniques used in this study
Hair samples were weighed 
into lOmL beakers
Nails samples were 
rinsed and dried
t
Hair samples were Nails samples were weighed
washed and dried ' into 5mL tubes
a
Samples were loosely covered and 
ashed overnight in a Gallenkanp 
muffle furnace, at 450*C
Samples were allowed to cool
Ashed samples were taken up into 
solution with 15» HNQ» and transferred 
into plastic tubes
ICP-MS
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addition, a single washing technique applied to all samples is 
important in an attempt at standardisation. This is particularly 
important for hair, since there are a wide range of shampoos and other 
hair products available on the market, each with a different 
composition and a different effect on the hair (75).
Hair samples were weighed into beakers; typical weights were 50-300mg. 
Each individual sample was sonicated for 20 minutes with 1% Triton-X- 
100 detergent (BDH Chemicals) ; this procedure was repeated twice with 
fresh aliquots of detergent, and followed by thorough rinsing with 
DDW. The samples were dried before placing in a Gallenkamp muffle 
furnace. Nail samples were individually rinsed in acetone before being 
weighed into 4mL glass sample tubes, and were then placed in the 
muffle furnace. All samples were loosely covered in the furnace to 
prevent any contamination from dust or degradation of the furnace 
walls. The temperature used was 450°C; this was chosen to ensure 
thorough ashing but to minimise volatilisation of certain elements. 
Samples were allowed to ash for at least 8 hours; generally this took 
place overnight. Following digestion, ashed samples were transferred 
from the digestion beakers or tubes into plastic containers for 
storage ; this was achieved by dissolving the ash in 1% HNO3. 
Successive rinsings were carried out to ensure efficient transfer, and 
samples were made up to a final volume of 3-5mL.
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All digestion vessels were cleaned before reuse by first soaking, and 
then boiling in 50% HNOa. These were dried and then stored in sealed 
plastic bags until required again.
2.3. Analysis of Samples by ICP-MS
2.3.1. Stetndard preparation
One multi-element standard was used for all analysis by ICP-MS. This
was used for calibration of the instrument, and also to monitor any
drift in the instrumental performance during the period of analysis.
The latter was carried out by measuring the standard solution at
various stages throughout the analytical period. The various elemental
concentrations within the standard were chosen for a number of
purposes, requiring a certain degree of compromise. The concentrations
needed to be sufficiently high to ensure reasonable counting
statistics, but low enough to minimise the possibility of memory
effects within the system. In addition, a spread of concentrations was
required which would approximately conform to the concentrations
expected within the biological specimens. The following levels were
used in the stock multielement standard solution:-
4pg/mL: Li,B,A1,Sc,V,Cr,Mn,Co,Ge,As,
Mo,Cd,Sn,Sb,Cs,Ba,La,Ce,Hg,Pb
lOjuig/mL: Fe,Ni ,Cu,Zn,Rb,Sr
50.ug/mL: Mg,P,Ca
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Solutions were made up in plastic volumetric flasks. The flasks were
cleaned prior to use by thorough rinsing, followed by standing for at
least 12 hours while containing 10% HNOa. After further rinsing, the 
flasks were filled with 1% HNOa and allowed to stand for at least five 
days before thorough rinsing and use.
Standards were made using proprietary single element lOOOjjg/mL stock 
solutions (BDH Chemicals) and 1% HNOa. Nitric acid was used for
improved stability and also to match the samples which were always
digested in nitric acid. In addition, nitric acid is recommended for 
use in ICP-MS work because of the comparatively few polyatomic peaks 
it produces compared with other acids (see Section 2.I.I.5.). 
Wlienever standard solutions were prepared, a "standard blank" would 
also be made. This involved using an identical plastic volumetric 
flask and 1% HNOs. It was stored, with the multi-element stock 
solution, at 4®C.
For analysis, dilution of the above multi-element standard and 
accompanying blank solutions was required. A hundred-fold dilution, 
also in 1% HNOa, was carried out, giving final elemental 
concentrations of 40-500ng/mL.
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2.3.2. Instrumental operating conditions and procedures
The SEune operating conditions were used for all the separate analyses 
carried out in this study, and are summarised in Table 5.
The VG Plasmaquad was completely under ccmiputer control during 
analysis. Therefore, in order that the analyses should be carried out 
according to specifications, an "element menu" and "run procedure" was 
written by the analyst and stored on the hard disk of the computer. 
The element menu defines the elements and their isotopes which are to 
be measured in a given scan, passing over areas in the Periodic Table 
where extremely large "gas" or "water" peaks are found. The run 
procedure defines the order in which samples are to measured; a 
critical factor in good analysis. At the start of any given "run", 
several readings of the blank were taken, followed by measurement of 
the standard solution in order to calibrate the instrument. Next, the 
reagent blank solution was measured, and finally, the "real" samples 
were introduced to the system. At various times during the run 
procedure and after the last biological sample, measurement of the 
multi-element standard was repeated so that instrumental drift could 
be monitored. Between each sample (blank, standard or "real"), the 
system was washed out for a period of 2-3 minutes using 1-2% HNO3.
49
Table 5. ICP-MS operating conditions
Plasma power-reflected 1300/<10W
Nebuliser pressure 40 psi
Coolant flow 14 L/min
Sample pump rate 1.5 mL/min
Skimmer type, aperture diameter Ni, 0.7 mm
Cone type, aperture diameter Ni, 1.0 mm
Distance torch/cone 10 mm
Expansion pressure 2.7x100 mbar
Intermediate pressure <1x10-4
Analyser pressure 2x10-°
Mass range 5-206 amu
Number of channels 1024
Number of scan sweeps 120
Dwell time 500 us
Skipped mass regions 12.5-21.5
39.6-41.5
All data acquired was stored automatically on a floppy disk, and a 
hard copy printed out while the run continued. This enabled any 
anomalies to be seen and dealt with immediately.
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2.3.3. Data calculation
The data accumulated during the course of a run is in the form of 
"raw" counts; before statistical analysis of such data can take place, 
it must be transformed from counts to concentrations i.e. ng or jog of 
a given element per g or mL of sample. A computer program, entitled 
NEWPQ (76), was written to facilitate this manipulation of data.
The principle of this calculation involves comparing the counts 
obtained by measuring a sample with those from the multielement 
standard, where each element is at a specified concentration. 
"Standard" and "reagent" blanks are subtracted; in addition, changes 
in sensitivity are taken into account by using a corrected standard 
value for each sample (assuming a linear variation between consecutive 
sensitivity standards). Mass and dilution factors must also be 
considered.
Other systematic errors can be introduced by interferences from 
polyatomic ions, or other spectral sources. Included in the NEWPQ 
programme is a correction for the chlorine interference on vanadium 
(51) using chromium (52 and 53). This method is only accurate, 
however, in the absence of significant carbon content, which would 
otherwise lead to interefence with °^Cr from “OAr^^C.
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2,4. Accuracy and Precision Measurements
2.4.1, Standard reference materials
Whenever biological samples were prepared for analysis by ICP-MS,
standard reference materials were digested alongside these tissues and
fluids. The reference materials used were as follows
IAEA A13 Animal blood: n=7; 0.16-0.29g dry weight
IAEA H4 Animal muscle: n=4; 0.13-0.29g dry weight
NIST SRM909 Human serum: n=12; 0.5-1.0mL wet
NIST 1577A Bovine liver: n=15; 0.19-0.35g dry weight
SINR 0920 Chinese hair: n=12; 0.04-0.12g dry weight
The Chinese reference hair, SINR 0920, was used whenever hair euid 
nails samples were digested. Therefore samples, in the mass range 
described, were ashed at 450“C in a Gallenkamp muffle furnace and made 
up to 5mL with l%v/v HNOa. NIST SRM909 was used with blood serum, 
synovial fluid, urine and saliva, while NIST 1577A bovine liver, IAEA 
A13 animal blood and H4 animal muscle were used in conjunction with 
brain, bone, whole blood, clot and packed cell samples. Thus, wet 
digestions were carried out using concentrated nitric acid; heating 
took place on a hotplate or in an oven. Duplicate analyses of each 
sample were carried out; the number of separate preparations is listed 
above.
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The results obtained for these analyses are listed in Tables 6 to 10, 
with certified or information values where available. The reference 
materials, therefore, acted as a monitor of the digestion and 
analytical procedures used in this study.
For most elements, in each reference material, there appears to be 
good agreement between measured and certified or information values. 
It is unfortunate that, for a number of elements, no such comparison 
was possible due to the lack of reference data. On the whole, however, 
good accuracy was achieved. For some elements in certain reference 
materials, however, the precision was slightly less good in the 
measured data than in the certified or information values quoted i.e. 
there was a larger spread around the mean value than expected. This 
was most noticeable in AIEA H4 animal muscle; the precision is very 
much better in AIEA A13, for example. There have been some 
difficulties involved in the certification of AIEA H4, possibly due to 
lack of homogeneity of the material; recently, the certificate has 
been revised, with several certified and information values being 
altered (77). In the main, however, accuracy and precision, as 
demonstrated by the measurement of these five standard reference 
materials, were maintained at a satisfactory standard throughout this 
study.
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Table 6: Analysis of biological reference material IAEA A13
animal blood: ng/g (dry weight) unless stated
Element This
Mean
study
s.d.*
Certified^/ 
Information® 
Mean s.d.*
Li 100 54 _
B 1815 1531 — —
Mg“ 96 7 99® 29
A1 511 93 — —
P“ 843 704 940 = 216
Ca“ 257 44 286» 54
Sc 108 19 — —
Fe" 2142 334 2400» 151
Mn 636 494 --
Ni 1260 157 1000 = 400
Co 84 74 — —
Cu“ 4.2 0.4 4.3» 0,6
Zn“ 12.5 0.2 13 = 1
Ge 196 60 — ..
Rb 2.0 0.3 2.3» 0.7
Sr 317 123 — ——
Mo 1256 917 — —
Cd 54 4 — —
Sn 33 27 — —
Sb 48 38 — —
Cs 28 19 — —
Ba 91 18 — —
La 20 15 -- —
Ce 16 13 — —
Hg 32 27 —— —
Pb 163 35 180= 79
a: jjg/g (dry weight) 
d: standard deviation
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Table 7 : Analysis of biological reference material IAEA H4
muscle: ng/g (dry weight) unless stated
animal
This
Mean
study
s.d.*
Certified»/ 
Information* 
Mean s. d. *
Li 639 456 _
B 852 285 - -
Mg= 1019 167 1050*’ 59
A1 343 235 10000= -pa 10446 1206 *“ -
Ca“ 213 27 188^ 24
Sc 240 321 - -
Fe“ 47 9 49^ 2
Mn 520 147 466^ 42
Ni 35 25 64= . 37
Co <6 - 2.7= 1.0
Cu“ 3.7 0.2 3.65** 0.35
Zn“ 85 2 86^ 3
Ge 26 16 - -
Rb“ 18 2 19*’ 1
Sr 1127 750 - -
Mo 148 110 40.9= 2.8
Cd 2 1 4,9= 1.0
Sn 77 55 - -
Sb 17 13 - -
Cs 111 24 120f 14
Ba <3 - - -
La <0.4 - - -
Ce <0.3 - 2.3 = -
Hg 18 16 6.8*’ 0.4
Pb <0.1
a: jig/g (dry weight) 
d: standard deviation
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Table 8: Analysis of biological reference material NIST
SRM 909 human serum: ng/mL (wet) unless stated
Element This
Meem
study
s.d.»
Certified 
Mean s. d. »
Li“ 9.0 1.3 11.4 0.3
B 1111 738 — —
Mg“ 25.5 2.7 29.4 0.7
A1 118 114 — -
P 128 25 —
Ca“ 115 19 121 4
Sc 14 14 —— —
Fe" 1.8 0.3 1.98 0 . 2 7
Mn 65 7 — —
Ni 39 15 — —
Co 1.0 0.8 — —
Cu= 1.0 0.3 1.1 0.1
Zn= 1.4 0.4 - -
Ge 1.0 0.9 - —
Rb 5.5 4.2 — -
Sr 39 5 - —
Mo 6.4 4.2 — —
Cd 1.1 0.8 1.24 0.10
Sn 1.5 1.3 — -
Sb 12 6 - -
Cs 0.5 0.4 — —
Ba 308 170 - -
La 3.2 2.9 — -
Ce 0.1 0.1 — -
Hg 1.3 1.1 — -
Pb 15.5 2.9 20 2.5
a: ^/mL (wet) 
b: standard deviation
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Table 9: Analysis of biological reference material NIST 1577a
bovine liver; ng/g (dry weight) unless stated
Element This study Certified»/
Information*
Mean s.d.4 Mean s.d.d
Li 157 49 176 = 5
B 571 257 590 = 80
Mg“ 592 74 600» 15
A1 2733 521 2000 =pa 11597 647 11000» 396
Ca“ 126 38 120» 7
Sc 61 43 - -
Fe® 184 78 194» 20
Mn® 8.4 1.0 9.9» 0.8
Ni 232 129 - -
Co 163 49 210» 50
Cu® 153 18 158» 7
Zn® 122 9 123» 8
Ge 28 17 — -
Rb® 13,1 3.1 12.5» 0.1
Sr 111 38 138» 3
Mo® 3,1 0.9 3.5» 0.5
Cd 290 85 444» 62
Sn 130 102 - -
Sb 25 19 3 = -
Cs 19 11 — -
Ba 374 249 - -
La 29 21 - _
Ce 24 19 - -
Hg 10 8 4» 2
Pb 155 80 135» 15
a: ug/g (dry weight) 
d: standard deviation
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Table 10; Analysis of biological reference material SINR 0920
Chinese hair: ng/g (dry weight) unless stated
Element This
Mean
study 
s.d. »
Certified
Mean
Li 184 256
B 1441 504 -
Mg“ 85.5 7.3 75
Al“ 9.4 1.8 13.3pa 154 30 184
Ca“ 875 49 790
Sc 6.2 9.2 -
V 106 94 —
Cr“ 3.7 1.8 4.8
Fe® 45 11 —
Mn® 2.2 0.2 2.9
Ni® 2.6 0.8 3.2
Co 122 112 -
Cu® 20.1 1.6 23
Zn® 165 13 189
Ge 15 10
Rb 4.1 5.0
Sr® 4.0 0.3 4.19
Mo 2039 714 _
Cd 71 40
Sn 540 622 —
Sb 279 153 -
Cs 4.8 7.4 —
Ba® 4.5 0.5 5.4
La 16 9 -
Ce 29 8 —
Pb® 6.0 1.0 7.2
a; ^/g (dry weight) 
b; standard deviation
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2.4.2. Detection Limits
The term "detection limit" describes the "least value which can be 
distinguished from zero" (2 for a given element being measured by a 
particular analytical technique. It is calculated using the standard 
deviation (tr) of the blank sample multiplied by a specific factor, 
usually three. For each run procedure (i.e. group of seunples) carried 
out by ICP-MS, detection limits were calculated for the entire range 
of elements, using 3e of the reagent blank. The mean value of 
detection limit was calculated, and is shown in Table 11.
To investigate this theme further, a standard solution was repeatedly
diluted so that a range of concentrations was obtained
0.16-16ng/mL; Li,B,Al,Sc,V,Cr,Mn,Co,Ge,As
Mo,Cd,Sn,Sb,Cs,Ba,La,Ce,Hg,Pb
0.4-4ng/mL: Fe,Ni,Cu,Zn,Rb,Sr
2-200ng/mL: Mg,P,Ca
These samples were analysed, by ICP-MS, in ascending and descending 
orders of concentration, separated by a sensitivity standard (40,100 
or 500ng/mL). The results obtained by this are shown in Figure 11 a) 
to f), where measured concentration is plotted against nominal 
concentration. The data obtained is also displayed in Table 11, 
alongside the calculated detection limits. For some elements, 
including aluminium, phosphorus and molybdenum, only a part of the
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Table 11: Detection limits for ICP-MS (ng/mL 3<j blank and
standard dilution comparison)
Element Detection limit ng/mL
3ff blank" Standard dilution**
Li 0.12 <0.2
B 2.6 <4
Mg 0.1 -
A1 0.12 <0.3
P 30 <30
Ca 15 <15
Sc 0.03 <0.2
V 0.29 <0.3
Cr 0.98 <1.5
Fe 0.03 -
Mn 0.03 -
Ni 0.32 —
Co 0.6 -
Cu 0.3 -
Zn 0.96 <1.0
Ge 0.22 <0.3
As 0.7 <0.5
Rb 0.13 -
Sr 0.11 -
Mo 0.3 <2.0
Cd 0.29 <0.3
Sn 0.18 <0.2
Sb 0.08 <0.4
Cs 0.09 -
Ba 0.3 <0.2
La 0.04 <0.2
Ce 0.03 <0.2
Hg 0.23 <1.0
Pb 0.01 -
a: cr is the average standard deviation of the reagent blanks 
b: value below which subsequent standard dilutions could not 
be measured
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Figure 11; Measurement of standard solutions by ICP-MS
a) B, Li, Al, Sc, V.
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Figure 11 (con.): Measurement of standard solutions by ICP-MS
c) Mo, Cd, Sb, Cs, Sn
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Figure 11 (con.): Measurement of standard solutions by ICP-MS
e) Fe, Ni, Cu, Zn, Rb, Sr
STANDARD DILUTION EXPERIM
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full reinge of concentrations cein be distinguished from the blank. For 
others, notably boron and iron, erroneous values of concentration were 
obtained in the decreasing sample sequence, reflecting a slight 
increase in the background level of the element. This is probably due 
to memory effects caused by adhesion of elements to the plastic tubing 
and glassware of the spray chamber etc. Therefore, in Table 11, a 
figure is given for those elements, below which, if values are 
obtained, data must be treated with caution. In most cases, this 
figure is very close to the detection limit calculated using 3cr of 
the reagent blank.
2.4.3, Standard addition experiments
The suitability of the two main types of sample digestion used i.e. 
wet and dry ashing, was investigated. This was done by the method of 
matrix addition; that is, by adding various aliquots of multi-element 
solutions to a number of hair and synovial fluids before digestion. A 
large sample of scalp hair was chopped finely and well mixed, while a 
large-volume sample of synovial fluid was repeatedly inverted, in 
order to attain homogeneity as far as possible. Hiese samples were 
then ashed, diluted and analysed by ICP-MS, along with other, more 
routine samples.
64
Figures 12 and 13 show the results obtained for lead, copper and 
phosphorus for both matrices, scandium in synovial fluid and tin in 
hair; in addition, the data for boron, magnesium and manganese are 
displayed in Section 3.2.1.4. Error bars are drawn on the graphs ; 
these are based on the variations in elemental concentration between 
three, separately digested aliquots of hair or synovial fluid, without 
sample addition.
The elements shown in Figures 12 and 13 are representative of the 
remaining elements. In general, there is little deviation from the 
expected values of concentration, induced during the sample digestion 
procedures; for example, there seem to be no major systematic 
elemental losses or gains. It can be seen that the largest variations 
in data occur when the "addition" of standard solution is relatively 
close to the intrinsic concentration of that element. This is 
demonstrated by phosphorus, with additions of approximately 40% and 
10% to synovial fluid and hair respectively, compared with additions 
of 1000% to scandium in synovial fluid and 100% to lead in hair. 
Therefore, the inter-sample variations of phosphorus are clearly 
evident but those of scandium and lead are completely hidden by the 
comparatively large standard addition.
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Figure 12: Standard addition to synovial fluid
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Figure 12 (con.); Standard addition to synovial fluid
c) Copper
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Figure i3: Standard addition to hair
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Figure 13 (con.); Standard addition to hair
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3. BORON
3.1. Introduction to Boron
3.1.1. Physical and chemical properties
Boron is in the second period of group lllA in the Periodic Table, and 
can best be classified as a metalloid element. Natural boron consists 
of two isotopes; one of atomic mass 10, with an abundance of 18.9% and 
the other of atomic mass 11, with 79.1%. It is quite a rare element, 
being found at approximately 0.001% of the earth's crust (78). Much of 
it is localised in evaporated lake beds in south western parts of the 
USA in the form of borax {Na2B40?.lOHzO) and kernite (NagBaOv.&HaO), 
hydrated sodium salts of tetraboric acid (79). Other naturally 
occuring minerals containing boron are colemanite (CazBeOii.5HsO) and 
boracite (MgvClaBieOao) (80). These commercial deposits are thought to 
have resulted originally fron spring water in volcanic areas. As 
borates are soluble in water, no deposits now remain in regions which 
have rainfall and adequate drainage to the sea (81).
Boron is often found in soils as boric acid or as a borate. Boric acid 
is a Lewis acid i.e. an electron acceptor. It is a very weak acid, and 
also acts as a mildly acidic antiseptic.
Equation 3. HsBOs + HzO ' H4BO4- + H+
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The solid acid melts and loses water at very high temperatures, and 
gives a melt of boric oxide, which becomes a glass-like solid. Boric 
acid is used in fabrication of borosilicate glass, which shows 
considerable resistance to heat.
It is difficult to obtain elemental boron to any degree of purity. 
When boric acid is heated with magnesium, boron is seen as a dark 
brown or black powder. Purer samples can be obtained by passing a 
mixture of hydrogen and purified boron trichloride over a tungsten or 
tantalum wire at 1300-1400°C, when semi-crystalline boron is deposited 
on a wire (81). The structure of elemental boron seems to have certain 
unique characteristics among the elements. Its three valence electrons 
are too localised for it to be metallic, but insufficient in number to 
form a simple covalent structure. The three allotropie modifications, 
whose structures are known, contain groups of twelve boron atcxns in an 
icosahedral array as the major structural unit, as shown in Figure 14. 
These units are strongly linked to each other to form very stable 
three-dimensional networks, of which the «-rhombohedral 
is the simplest (78).
Boron forms an interesting range of compounds; these include boranes 
(BnHn+4 or BnHn+e; n>l), and carboranes (BmCaHm+g), along with all 
four trihalides which are also Lewis acids. Boron and nitrogen form
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some compounds that closely resemble the carbon analogues, because the 
B-N bond is isoelectronic with C-C; see Figure 15. If borazine is 
heated, it forms boron nitride which can exist in two modifications, 
somewhat similar to carbon i.e. a hexagonal form like graphite, and a 
cubic form, borazon, like diamond. Elemental boron, and boron carbide 
(B12C3) also approach diamond in their hardness (81).
Like aluminium and germanium, boron forms complexes with organic 
groups containing hydroxyl (OH) groups. This is the case, particularly 
when the hydroxyl groups are on adjacent carbon atoms and on the same 
side of the molecule (cis). Reactions increase in intensity as the 
number of adjacent hydroxyl groups increases. For example, the 
strength of reaction with the following alcohols is as follows: 
glyceroKerythritoKadonitoKarabitoKmannitol (82) .Complexes may also 
be formed with compounds containing certain treins 1,2-diol groups, 
provided that the single of the adjacent hydroxyl group relative to the 
carbon-carbon axis is suitable, for example, in several ring 
configurations (83). The ability of boric acid and the borate ion to 
react with the hydroxyl groups meeuns that complexing may take place 
with a whole range of biologically important compounds, for example, 
polysaccharides and sugars, adenosine-5-phosphate, pyridoxme, 
riboflavin and others (82,84). These complexes are thought to be of 
the form I to III, as shown in Figure 16. Phenylboric acid (IV) also 
complexes with diols, and has been known to substitute for boric acid
72
Figure 14: Icosahedral array of boron
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Figure 16; Complexes of boron
in a plant (the diatom Cylindrothea fusformis), whereas derivatives 
such as tetraphenyl borate (V) do not substitute (85). The structure 
of the only biologically synthesized metabolites known to contain 
boron show the use of the structure III. These are aplasmomycin and 
boromycin, both antibiotics, isolated from Streptomyces griseus and 
Streptomyces antibioticus respectively (86,87).
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3.1.2. Distribution and availability of boron
Apart from a number of commercial deposits, boron is found at low
levels in most plant and animal life, soils, rocks and water.It has 
been known that boron is essential for higher plants for the last 
seventy years (88), although there has been much debate over the 
precise role of the element. The question of boron essentiality in 
animals and humans is still open. In this light, it is important to 
know the distribution of boron in soil and plant-life and its 
availability in food and from other sources.
The range of boron concentrations in plants required for "normal" 
growth (between deficiency and toxicity) is quite narrow. Levels of 
boron within plants or crops are highly dependent on soil type ; 
deficiency is more common in low acid igneous rocks, as shown in Table
12. Here, borate is easily lost in leaching, and lime can induce a
deficiency, which is normally seen as abnormal or retarded growth
with brittle leaves or stem (89). There is also some seasonal 
behaviour; this is probably an impairment in boron mobility in the 
soil medium during dry weather. Crops particularly sensitive to boron 
deficiencies are sugar beet and celery, whereas apples, pears and 
grapes are comparatively insensitive. Boron toxicity is more usually 
associated with marine sediments, arid or semi-arid regions. It is 
shown by yellowing of the leaf tip and progressive necrosis, until
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Table 12: Boron concentrations in rock, soil and plant-life (89)
Substance Concentration jug/g
Igneous rock (granite) 15
Sedimentary rock (shale) 200
Soil 7-80
Plant ash 30-300
Trees/shrubs ash 50-500
finally the plant takes on a scorched appearance and dies. Grapes and 
peaches are very sensitive to high boron levels, while barley, maize, 
potato and tobacco are slightly more resistant.
Figure 17 shows how plants and animals can obtain boron. Its levels in 
natural water are normally very low (90). The soil quality, therefore, 
is the major consideration here. Enthusiastic use of NPK fertilisers 
has resulted in low availability from the soil (91). While attempting 
to rectify this deficiency, farmers have encountered some toxicity 
problems (92).
In the main, animals and humans obtain borqn from foodstuffs, although 
it may be taken in other forms, for example, eyewash containing boric
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acid, borax in shampoo and bathsalts, and also in soaps and detergents 
(81). In general, plant foods such as vegetables and fruit are good 
sources of the element in the diet, while animal and fish products 
have a lower boron level. Boron is particularly high in nuts, dried 
fruit and honey (93). There is considerable variation between produce 
from tropical and sub-tropical regions (94). Recent studies of Finnish 
food and some English foodstuffs are shown in Tables 13 and 14. Boron 
concentrations are quoted in different units (dry compared to fresh 
weight) and so direct comparison is difficult. It is thought, however, 
that cooking or processing of vegetables and fruits leads to a
considerable loss of mineral content (95). The Finnish study gave a
high dietary intake of boron as 1.7mg/day (96). This compares quite 
well with 3.1 mg/day in US diets (97), and 2.8±1.5 mg/day for British 
diets (98).
The boron in food and any supplementation in the form of sodium borate
or boric acid is quickly and almost completely absorbed and excreted,
this latter process takes place mainly in the urine (99-101). There 
have been some cases of toxicity from boron; symptoms of poisoning 
include anorexia, nausea and vomiting, cardiac weeikness, convulsions, 
diarrhoea and a skin eruption (80). Most examples of toxic effects 
have been after treatment of large burns with boric acid (102,103), 
and it seems that boron has a low order of toxicity when given orally.
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Table 13: Average boron content (jig/g dry weight) in Finnish
food groups (96)
Food group Boron jjg/g (d.w. )
Cereals 0.92
Meats 0.16
Fish 0.36
Dairy products 1.1
Vegetable foods 13
Other 2.6
Table 14: Boron concentration in English foodstuffs (104)
(jL!g/g solids, jjg/mL liquids fresh weights)
Foodstuffs Boron jjg/g or mL (f.w.)
Breakfast cereals 1.65
Bread 0.55
Cereals 1.55
Whole milk 0.03
Cheese, cheddar 0.27
Eggs, raw 0.07
Beef, roast 0.17
Chicken 1.06
Vegetables, cooked 1.44
Fruit, fresh 2.61
Fruit, tinned 0.42
Cof fee, powdered 10.6
Sugar, white 0.04
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3.1.3. Role of boron in plants
One of the reasons for the confusion about the exact role of boron in 
plants is that even within a particular "family" of plants, a wide 
range of symptoms are shown when they are deficient in boron. These 
signs include inhibition of root growth, breakdown of root and shoot 
apical meristems and malfunction of the reproductive systems. Over a 
longer time period, uncontrolled cell expansion takes place, producing 
giant, thin-walled cells which collapse. These regions become 
necrotic, with a resulting black or brown slime (105). These symptoms 
are probably secondary effects of a boron deficiency, rather than the 
primary action, which explains their divergence, along with the long 
time-scale over which these symptoms can arise.
Researchers in this field, therefore, have attempted to assess boron’s 
role during the onset of deficiency, to try to identify the mecheinism 
of the primary action (106). In the last thirty years, experimentation 
has been carried out into a number of pleuit biochemical systems, 
considering the propensity of boron to form compounds containing cis- 
hydroxyl groups. In attempting to connect these disparate areas of 
work, Parr and Loughman (106) have suggested that impaired membrane 
function, caused by lack of boron, may be that link.
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Some electrochemical experiments have given credence to the view that 
boron is involved in membrane transport; the presence of borate caused 
an alteration in the selective permeability of the plasmalemma 
(membrane at junction of cell wall and cytoplasm) to sodium and 
potassium ions relative to chlorine ions, without changing the cation 
distribution (107). Tanada found that the boron of mung bean seedlings 
was localised in the membranes (108). A reduction in capacity for ion 
transport (for example, phosphate uptake) of 25% has been seen just 
five hours after boron was removed from the culture solution; a 
similar 20% drop in rubidium uptake was also shown, while the anion 
uptake seemed unaffected (109). These results, so soon after the onset 
of deficiency, are important because they imply that the primary role 
of boron may be involved in the maintenance of membrane integrity 
(106).
Other important findings involve interactions with auxins (growth 
hormones) and phenols, both of which are known to affect membrane 
transport, usually by inhibition of absorption at the root (110). 
There is, however, no evidence that the phenol levels, for example, 
alter sufficiently during boron deficency to initiate the changes in 
membrane function. It has been suggested that the central role for 
boron is to act as a control on the levels of these two types of 
compound (111), but it is possible that boron has a more direct part 
to play in membrane function than this (106). Some recent NMR work
81
(105) measured in control roots and boron deficient roots and 
showed that the distribution of inorganic phosphate between cytoplasm 
and vacuole had been altered. This suggested that a deficiency of 
boron had in some way affected the transport capacity of the tonoplast 
(the membrane at the junction of vacuole and cytoplasm). It was also 
clear that the growth of boron deficient roots was impaired.
To summarise, it appears that the early effects of removal of 
boron from the root environment of many species are found to be 
directed at a membrane site. The physical symptoms which arise later 
are probably as a result of interference with processes which depend 
on the close control of metabolites moving between and within cells
(106).
3.1.4. Boron in animals and humans
Following the early discovery of the essentiality of boron to plants 
in 1923 (88), several attempts were made during 1939-44 to induce a 
boron deficiency in rats. These were unsuccessful, despite low dietary 
levels of 155-163 ng/g. In 1945, one study reported that potassium 
deficient rats, fed a boron supplement, showed enhanced survival, 
maintenance of body fat and elevated liver glycogen levels. A further 
report was unable to confirm these findings, when rats were given a 
different diet containing an unknown amount of boron, and various
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levels of boron as supplements (112). After these disappointing 
results, the assumption was made that boron had no role to play in
animal metabolism, and no further experimentation was carried out I
!
until the early 1980’s. In 1981, Hunt and Nielsen (113) reported that
Iboron might be essential for chicks; deprivation of this element 
depressed growth and elevated plasma alkaline phosphatase activity in 
chicks fed adequate cholecalciferol (a component of vitamin D, 
necessary for calcium and phosphorus activity and linked with the 
parathyroid). Further experiments confirmed that cholecalciferol 
deficiency indirectly enhanced the body’s need for boron; hence the 
possibility of an involvement of boron in the action of the 
parathyroid hormone, and thus in the metabolism of calcium, potassium 
and magnesium (114). More work in this field (115-8) has indicated 
that rats respond to changes in dietary boron in a way that is 
dependent on levels of dietary methionine (an essential amino acid), 
potassium, magnesium, cholecalciferol, aluminium and calcium.
Other workers have independently carried out animal studies linking 
boron and parathyroid activity. Elsair et al. (119,120) found that
high levels of boron in the diet partially alleviated the secondary 
hyperparathyroidism symptoms of hypercalcemia, hsqjophosphatemia and 
depressed renal absorption of phosphorus, induced by fluoride given to 
rabbits. Seffner and co-workers (121,122) noted a reduction in the
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fluoride-induced thickening of the cortices of the long bones, and an 
alteration in the histology of the parathyroid gland when borate was 
administered to pigs. Moreover, Baer et al. (123) reported findings in 
which boron corrected radiographic and histologic changes caused by 
fluoride toxicity in bone.
Neilsen considered that the animal studies carried out by himself and 
co-workers indicated that when diet was manipulated in some way, 
leading, in particular, to a possible alteration in cellular membrane 
integrity (potassium or magnesium deficiencies) or in • hormone 
responsiveness (magnesium or cholecalciferol deficiencies, aluminium 
toxicity), many responses were shown by the animals to a 
change in dietary boron (124). This was not seen to the same extent 
when animals were fed an apparently "optimal" diet i.e. no known 
nutritional déficiences. This suggested that the need for boron was 
not crucial under normal conditions, but became enhanced under 
metabolic or nutritional stress (83).
These findings have led to a number of human studies, again by Nielsen 
and co-workers, directed at groups of people in situations of the 
previously described stress. Research was carried out, for example, 
under conditions of low magnesium intake or when hormonal changes were 
occuring, for example, during the menopausal period with the resultant 
increased loss of calcium from bone. In one such study (125), twelve
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post-menopausal women consumed a conventional diet (with boron of 2.5 
mg/day) for 119 days, and were given a supplement of 3 mg boron/day 
for the following 48 days. Boron supplementation reduced calcium
excretion in urine, and increased the serum concentration of ionised
calcium and estradiol-170; all these changes were most noticeable when 
the dietary magnesium was low.
Another recent project by the same group involved four men (aged 45 
years and above), nine postmenopausal women, of which five were on 
estrogen therapy and four were not, and one premenopausal woman (93).
Again, a period of boron supplementation followed one of a
"conventional" diet; the latter contained 0.23 mg boron/2000kcal and 
was also low in magnesium. Several indicators of calcium status showed 
a variation between depletion and repletion regimes; in particular, 
plasma ionised calcium euid serum 2,5-hydroxycholecalciferol were 
higher, while serum osteocalcin, calcitonin and glucose were lower 
during boron supplementation. Moreover, after this supplementation, 
the values in the groups not receiving estrogen therapy moved closer 
to those that were. This suggested that boron has a role in calcium 
metabolism, and thus in the maintenance of healthy bones; also, this 
role became more evident when calcium loss from the bone was likely. 
Other experiments have shown that dietary boron also affects copper 
metabolism in humans (126), and that under conditions of low dietary
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magnesium, boron can influence the brain function of healthy adult men 
and women, measured by elecroencephalogram (EEG) (127).
How boron is acting in the body is still unknown. However, the
knowledge that it has the ability to complex with organic compounds
containing hydroxyl groups is significant. Boron deficiency has been 
shown to exacerbate symptoms of cholecalciferol deprivation, 
including abnormal bone function and poor growth, and it has been 
suggested that boron may be required for a hydroxylation step to
create the active species of cholecalciferol. Moreover, the formation 
of estradiol-170 from precursors involves the creation of hydroxyl 
groups on the steroid structure. If boron is involved in the 
hydroxylation of biological substances in the body, it may have a role 
to play in numerous other disorders, for example, rheumatoid arthritis 
(RA). Corticosteroids, which are frequently used to alleviate symptoms 
of RA, involve the formation of hydroxyl groups during synthesis 
(124). This is particularly interesting since claims have been made 
that boron supplementation can play an important therapeutic role in 
the treatment of RA (91).
In addition to the investigations of the role of boron in animals and 
humans, a limited number of studies have been carried out to identify 
the levels of boron within various tissues and fluids. A recent
example is the analysis of bone and teeth in rheumatoid arthritic and
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control subjects using prompt gamma ray activation analysis (128), in 
which there appeared to be a reduced level of bone boron in arthritic 
subjects. Table 15 gives a summary of the work carried out on boron in 
animals and humans.
3.1.5. Analysis of boron
Analysis of boron in the past has involved the use of various 
techniques, including spectrochemistry (235*), colorimetry (236) and 
atomic absorption spectrometry (2.?f-4o) . The relative difficulty in 
these analytical processes, in both sample preparation and 
measurement, has resulted in very few attempts to investigate boron 
and a possible role in animal and human health (128).
In recent years a new neutron irradiation/gamma-ray spectroscopic 
procedure has been devised which is a significant advance on the 
previously available methods (128). In addition to this, ICP-MS, with 
both solution and solid sample introduction, seems to provide an 
opportunity to extend still further the knowledge of boron in 
biological systems. The postulated detection limit of boron in 
solution ICP-MS, calculated from "ideal" solutions indicates that this 
technique would be suitable for the elemental levels expected in most 
biological samples. This value, and those from some other techniques, 
are given in Table 16. Of course, measurement of "real" samples
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Table 15: Summary of research on boron in animals and humans
Year Research work
1923
1939-44
1945
1953
1963
1980
1981 
1981
1983
1985
1986
1987 
1989
Essentiality in plants (88)
Unsuccessful attempts to induce B-deficiency 
in rats (112)
Unconfirmed reports of enhanced survival of 
K-deficient rats when given B-supplementat ion 
(112)
Values of B in hair and nails of 5 and 
33jjg/g, measured by AES' (129)
Values of B in blood and urine measured by 
AES/FES®: 104 and 919 ng/mL respectively 
(130)
Boron reported as an antidote to acute 
fluoride intoxication in rabbits: reference 
to F and Ca/P metabolism (119)
B first suggested as a cure for arthritis
(91)
Suggested interaction between B and 
cholecalciferol in chicks; possible role in 
Ca and P metabolism (113)
B as an antidote in experimental fluorosis 
in pigs (121)
Interactions suggested among dietary A1, B, 
Mg, and methionine in the rat (115)
Effects of B, A1 and Mg on major mineral 
metabolism were studied in post-menopausal 
women were studied; reduction in urine 
excretion of Ca and Mg (124)
B in bone of RA subjects found to be low 
(128)
Dietary B found to affect Cu metabolism 
(126)
a: AES/FES arc/flame emission spectrometry
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Table 16. Detection limits of boron ng/mL (3a blank)
Technique ICP-MS® FAAS» LA-ICP-MS” PG-NAA**
(24t) (244) (41) (128)
Detection limit 0.1 700 3000 50
a: solution inductively coupled plasma source 
mass spectrometry 
b: flame atomic absorption spectroscopy 
c; laser ablation ICP-MS
d: prompt gamma ray neutron activation analysis
generally results in a less than "ideal" analytical situation, with an 
accompanying increase in detection limits.
3.2. Results and Discussion
Standard reference materials and a range of human tissues and fluids 
were prepared and analysed by ICP-MS (as outlined in Chapter 2) to 
provide information on their elemental levels of boron, and the 
accuracy and precision with which they can be measured. The results 
are presented in the following section.
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3.2.1. Analytical quality control 
3,2.1.1.Standard reference materials
A range of standard reference materials was analysed for the element 
boron; details of sample preparation are given in Chapter 2. The 
results are presented, in Table 17, as the mean boron concentration 
(ng/mL or ng/g), with its associated standard deviation. Certified or 
literature values are presented for comparison, where available. NIST 
1577A bovine liver shows quite good agreement with the literature 
data, although the precision of the data is less good. The boron 
levels of the remaining standard reference materials are presented for 
future comparison and confirmation.
3.2.1.2. Detection limits
The detection limit for boron was calculated from 3cr (where or denotes 
standard deviation) of the blank value. After each run procedure, 
detection limits were evaluated using the reagent blank. From this 
data, a mean value of 2.6 ± 0.8 ng/mL was calculated. This, however, 
does not take into account the varying dilution factors of the 
different biological samples under analysis. Therefore, when samples 
are found to fall below this level they are quoted in tables or
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Table 17; Concentration of boron in standard reference
materials
Standard Reference 
Material
Boron concentration 
Mean ± s.d.
Certified'/ 
Information** data
IAEA SRM909® 
Human serum
1110 ± 738
NIST SRM 1577A4 
Bovine liver
571 ± 257 590 ± 80"
IAEA AI34 
Animal blood
1650 ± 1450
IAEA H4*^  
Animal muscle
500 ± 170
SINR 09204 
Chinese hair
1370 ± 530
c; ng/mL
d: ng/g dry weight
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figures as being "<X ng/mL or ng/g", where X is the product of the 
dilution factor and the detection limit of 2.6ng/mL.
3.2.1.3. Standard dilution experiment
A standard solution containing boron was repeatedly diluted until the 
boron was at levels close to the calculated detection limit i.e. at 
concentrations of 0.16, 0,4, 1.6, 4 and 16 ng/mL (see section 2.4.2.). 
These samples were then analysed, by ICP-MS, in both ascending and 
descending order of concentration, separated by a sensitivity standard 
at 40 ng/mL; the results are shown in Figure 18. It is interesting to 
note that while the increasing steps of concentration are well- 
defined, the downward trend is rather less clear. This is probably due 
to a slight increase in the background levels of boron following the 
measurement of the higher concentration samples. Boron seems to cling 
to the plastic of the nebuliser tubing and to linger in the spray 
chamber even after extensive washing. At levels of below approximately 
4 ng/mL, according to this experiment, it becomes difficult to 
distinguish between samples. This tallies quite closely with the 
detection limit calculated from 3or of the blank, given in section 
3.2.1.2..
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Figure 18: Measurement of boron standard solutionby ICP-MS
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3.2.1.4. Standard addition experiment
The detection limit is basically an instrumental factor; it is also 
important to consider whether boron levels will be affected in any way 
by pre-analytical sample preparation. To study this in more detail, 
matrix addition was carried out; various aliquots of multielement 
standard solution (including boron) were added to hair and synovial 
fluid before digestion, as described in section 2.4.3.. Scalp hair was 
a representative of the dry-ashing technique, and synovial fluid of 
the wet-ashing method. The samples were then digested, along with 
other more routine samples, and measured by ICP-MS.
The results for boron are shown in Figures 19 and 20, with those for 
magnesium and manganese presented as comparisons. Error bars shown on 
the graphs are based on variations in elemental concentration between 
three, separately digested aliquots of hair or synovial fluid, without 
additions. At first glance, it appears from these graphs that analysis 
of boron is subject to larger experimental errors than the other 
elements. However, the "additions" of boron to synovial fluid were 
approximately 20% of the intrinsic boron concentration, compared to 
200% for magnesium and 4000% for manganese. It is easy to see, 
therefore, that small inter-sample variations are masked by the large 
"additions" for both magnesium and manganese, while they remain 
visible for boron. Similarly, "additions" of boron to hair were
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Figure 19: Standard addition of boron to synovial fluid, with comparisonsa) Boron
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approximately 3% of the intrinsic levels, with 11% for manganese and 
63% for magnesium, so the wider spread of the boron values was not 
surprising.
In summary, the detection limits for boron measurement by ICP-MS were 
determined, and adequate quality control was ensured by use of 
standard reference materials and checks on the digestion techniques. A 
wide range of biological tissues and fluids were then analysed in 
order to characterise their boron content. The results of these 
analyses will be presented in the next section.
3.2.2. Boron in tissues and fluids
3.2.2.1. Elemental levels
The levels of boron found in a range of blood fractions, in synovial 
fluid, urine, hair, nails, bone and brain are presented in Table
18. As the terms "mean" and "standard deviation" are usually used to 
describe a normal distribution of data, it was felt that the median, 
interquartile range and the full sample range would provide a better 
description of the data.
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Table 18: Concentration of boron (ng/mL or ng/g fresh weight)
in various tissues and fluids
Tissue/fluid Median Lower
Quartile
Upper
Quartile
Minimum Maximum
Whole blood" 156.6 131.3 259.2 50.1 730.5
Blood serum* 161.6 140.2 428.6 45.5 795.6
Packed cell volume* 196.0 155.8 215.2 122,7 237.8
Clot» 288.5 244.6 335.0 159.3 375.8
Synovial fluid* 30.3 7.9 105.2 <7.8 529.5
Saliva" 41.4 21.4 120.9 <13.0 588.2
Urine* 1079 637.4 2021 163.8 8374
Hair‘d 2573 677 6580 <13 32710
Nails'* 12269 6312 19991 <13 82738
Bone** 2130 1123 4648 150 9380
Brain'* 4263 811 8015 <60 19756
a: ng/mL
b; ng/g (fresh weight)
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In general, fluids such as blood, synovial fluid or saliva have 
relatively low levels of boron. The values for blood and urine are 
quite close to the values quoted in Table 15. Urine is known to be the 
route by which most ingested boron is excreted, and thus has quite a 
high boron content, as expected. Nails and hair can also be described 
as "excretory pathways"; because of their slow growth, boron can 
accumulate there over a long period of time. In addition, the low 
water content of these matrices makes high levels of boron quite 
likely. Similar concentrations of the element in the epidermal (and
dermal) layers have been noted in the literature (131), for example, 
hair and hoof of mammal, feathers of birds. The results also show 
considerable accumulation of boron in the bone and brain tissues; this 
tendency has been reported by other authors for both bone and tooth 
enamel (80). The range of values quoted for brain tissue is somewhat
higher than the rather limited data in the literature. If a high dose 
of boron is ingested, however, the brain may show a particularly high 
increase in its boron level, compared to other tissues (103).
3.2.2.2. Distribution of boron data
It has been suggested that essentiality can be defined by 
investigating the shape of the distribution curve, in tissue, of any
given trace element. That is, essential elements should have a
symmetrical or normal distribution, whereas environmental
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contaminants should result in a skewed pattern (4,5). Samples of hair, 
nail, saliva, urine and blood from the different groups ("control" or 
"normal" subjects only) within the British population were brought 
together, giving the values in Table 18. The distribution of these 
data have also been demonstrated in Figure 21, showing the number of 
samples within certain concentration ranges. Boron in blood is closest 
to a normal distribution; the remaining graphs all have similar 
shapes, approximately log-normal. For some of matrices, part of the 
upward slope of the distribution is masked by the closeness of the 
data to the detection limits.
It is interesting to compare the results of hair and nails analysed 
from one individual with the population as a whole. Samples were 
collected from a man who had been taking a boron supplement of 5mg/day 
over a period of years; boron concentrations were 5.8 jjg/g in hair and 
42.5 jug/g in nails. If these values are compared with Table 18 and
Figure 21d and e, it is clear that the levels of boron are quite high
in this individual. The value for hair is near the upper quartile in 
that distribution, while that for nails is between the upper quartile
and the maximum. This again suggests that boron may accumulate in
these tissues; attempts to minimise the possibility of external 
contamination, by washing prior to digestion, were carried out, as 
described in section 2.2.3.2..
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Figure 21: Frequency distributions of boron in clinical specimens
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Figure 21 (con.)** Frequency distributions of boron in clinical specimens 
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Figure 21 (con.)z Frequency distributions of boron in clinical specimens
d) Hair
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3.2.2.3. Boron in blood
After considering the approximately normal distribution of boron in 
whole blood, it was interesting to investigate various components of 
the blood. Within the large sample population, a group from Sheffield 
gave blood. This was collected in anticoagulated tubes, giving whole 
blood and the packed cell volume (plasma was discarded because of 
contamination problems), and in untreated tubes, giving serum and its 
associated clot. The data obtained from analysis of these samples are 
presented in Table 18, and graphically in Figure 22.
The clot has the highest median value, followed by the packed cell 
volume, serum and whole blood; all values are quite close in 
magnitude, however. It is thought that contamination to plasma may 
have taken place when the "spun" plasma was being removed from the 
packed cell volume since the use of anti-coagulant does not seem to 
have affected concentrations in whole blood or packed cells. If this 
is the case, this may also explain why the serum samples have a 
comparatively large range, unlike the remaining blood fractions. 
Similar contamination, but to a lesser extent, may have taken place to 
serum when being separated from the clot.
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Figure 22: Boron in various blood fractions
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3.2.2.4. Boron in synovial fluid
The synovial fluid samples analysed in this study were obtained from 
subjects suffering from a number of different arthritic disorders, and 
could therefore not be designated a "normal" population. This fluid 
was measured in order to investigate if boron showed any significant 
patterns of behaviour between the different disorders; boron has been 
linked with rheumatoid arthritis (91,128). The difficulties inherent 
in trying to obtain synovial fluid from healthy individuals are 
obvious; in addition, after death, the composition of the fluid is 
known to change (132) with the result that postmortem samples are not 
particularly useful.
The distribution of boron concentrations in synovial fluid samples are 
shown in Figure 23. The pattern of the distribution is unclear because 
a sizeable proportion of the samples fell below the detection limit of 
7.8 ng/mL. It is interesting to note that the median boron level in 
synovial fluid is somewhat lower than those reported for both serum 
and plasma, in this study and in the literature (80,133). Synovial 
fluid is similar in composition to both these, fluids; it is a 
dialysate of plasma. In general, the protein content of synovial fluid 
is rather lower, consisting mainly of smaller molecules e.g. albumin. 
This changes in the case of most inflammatory disorders; for example, 
fibrinogen (a large molecule involved in clotting processes) is absent
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Figiire 23: Boron in. synovial fluid
60C
ao•MCO>-i
4-1gOCou
§OP3
600
500.
400
300
200-
lOCL
7.8
• U.Q.
Â M.
® 29 samples
U.Q.M,L.Q.
Upper quartile
Median •
Lower quartile
107
in "healthy" or "non-infleunmatory" synovial fluid but may be present 
in fluid taken from sufferers of rheumatoid arthritis.
Such possible variations in protein content may account for the wide 
range of boron levels, as may the possible presence of small fragments 
of cartilage, ligament and bone. Moreover, some arthritic disorders 
result in the formation of crystals within the fluid; these may be 
bone-derived, monosodium urate or calcium pyrophoshate, for example. 
All these factors will have a bearing on the general trace element 
composition of the synovial fluid, as well as the boron content, and 
will be discussed in more detail in Chapter 5.
3,2.2.5. Boron in brain and bone.
Figure 24 shows the sample distribution obtained by the analysis of 
boron in brain and bone samples. In the case of both tissues, the data 
seem to be clustered, rather than being evenly spread. The reasons for 
this are unclear, but neither brain or bone are particularly 
homogenous materials. In the brain, the regions from which samples are 
taken may be important in trace element analsis (1). On this basis, 
the student’s t-test was used to distinguish between data from the 
hippocampus and the basal ganglia regions; no significant variations 
in boron content were found. In the case of bone, it is felt that the 
difference between the rheumatoid arthritic and control samples
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Figuré 24: Boron in bone and brain
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(significant at the 0.1% level) does not completely explain the 
observed "clustering". It is likely that the effect would probably
have been alleviated if a larger number of samples had been available 
for analysis, thus reducing the effects of tissue inhomogeneity.
3.2.3. Consideration of age/sex parameters
The sample groups of urine, hair, nails, saliva, whole blood, brain
and synovial fluid were analysed statistically to investigate the
importance of an individual’s age and sex on the boron concentration
within their tissues. It was felt that the size of the bone and
remaining blood fractions sample groups were too small to permit such
statistical manipulation. The student’s t-test (two-tailed) was used
to compare the elemental status of males and females. The influence of
age on boron levels was investigated by using regression analysis. The
values of the correlation coefficient, r, thus obtained, were
substituted in the following equation (134) to produce a "t-value":-
Equation 4. tn-2 = |r| T(n-2) where n is the number
T(l-r^) of samples
In the above case, the null hypothesis is that there is no correlation
between age and boron concentration. If the calculated value of t is
greater than the tabulated critical value, this hypothesis is rejected
i.e. a significant correlation does exist. The data obtained were also
used to plot graphs, with a regression line superimposed on the
measured boron levels.
1 1 0
3.2.3.1. Differences due to sex
Most of the matrices analysed, that is, hair, whole blood, synovial 
fluid, brain, nails and saliva showed no relationship between the sex 
of the individual from which samples were taken and the boron content 
of these seimples. Urine was the only matrix in which such a dependence 
was seen; the concentration of boron in the urine of males was
"significantly" greater than in females (i.e. at the 5% level). This 
is shown graphically in Figure 25. It has been found that most
ingested boron is excreted in the urine (80); it follows from this
that the amount of boron excreted is proportional to the quantity 
ingested. On average, males have a slightly greater calorific intake 
than females; if more food is being eaten, a marginally greater amount 
of boron may be ingested, with the resultant slight increase in
urinary boron.
3.2.3.2. Differences due to age
For hair, synovial fluid and brain samples there appeared to be no 
relation of the boron levels to the age of the individual involved. 
Nails showed a significant relationship, S (at the 5% level), urine a 
highly significant relationship, S* (at the 1% level), while saliva 
and whole blood both demonstrated a very highly significant 
relationship, S** (at the 0.1% level). Figures 26 to 29 show these
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Figure 25: Boron in urine: variation due to sex
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results graphically. In Figure 26, a simple dependence of boron in 
nails on age can be seen. There appears to be a slight accumulation in 
nails as the individual increases in age. Figure 27 shows the slightly 
more complicated regression curve obtained when investigating how 
boron in urine varies in age. It suggests that the levels are slightly 
lower at the youngest ages, reaching a maximum in the late teens and 
early twenties, with a gradual decline as the individual reaches the 
middle years and old age. As with the variation between males and 
females, this may be related to average food consumption at various 
stages in life, with a resulting alteration in excretion. It should be 
noted that there are a number of exceptionally high values at just
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Figure 26: Boron in nails: variation with age
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Figure 27: Boron in urine; variation with age
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Figure 28: Boron in saliva; variation with age
BORON IN SALIVA
Boron Concentration vs. Acs
BDD
500 —
+00
300 -
200 -
100
+0 BO
Figure 29: Boron in whole blood: variation with age
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below ten years of age; these tally closely with several high values 
obtained for saliva shown in Figure 28. In fact, children and 
adolescents seem to have the highest levels of boron in saliva, with a 
general decrease through the middle and senior years. The values of 
boron in whole blood also show a tendency to decline as the 
individual’s age increases, as demonstrated in Figure 29.
3.2.4. Associations of boron with other elements
Linear regression analyses were carried out on the different tissues 
and fluids, comparing the boron content with the levels of the other 
trace elements within each matrix. Values of regression coefficient, 
r, were calculated and substituted into equation 4 as in the previous 
section. The results obtained from these processes are presented in 
Table 19.
3.2.4.1. Blood and blood fractions
Blood serum, plasma, packed cell volume, clot eind whole blood data all 
underwent regression einalysis. The first four of these groupings were 
rather limited in sample number; the small number of associations 
recorded for serum, plasma and packed cell volume was therefore 
unsurprising. A number of associations significant at the 5% level (S) 
were seen for the clot. Prominent among these was the element calcium;
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Table 19: The statistical significance of associations between 
boron and other elements
0.0Kp<0.05 0.00Kp<0.01 p<0,001
Tissue/fluid (S) (8*) (S**)
Blood serum - Sr
Packed cell volume -
Clot Ca,Ge, La -
8b
Whole blood — 8c,Rb,Hg,Pb Mg,P,Ca,Fe
Cu,Zn,8r,Cs
Hair Al,Or,As,Mo Li,Rb Zn
Nails As,Mn,Zn Ca,Cr,Rb Li,Mg,P,8c
8aliva Al,Pb - Ba,Ce
Urine Al,Cr,Mn,Ni Ca,8r Li,Mg,P,Zn
Cd Rb,Mo,Cs
8ynovial fluid Cr Mo P
Bone Li,Sr,8b Co,La Sc,Ni,Cs,Ce
Brain — Ca, Li, Al, Sc, Ni
Sr
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a very highly significant (S**:0.1%) association was also shown
between boron and this element in whole blood, shown in Figure 30c.
Among other very highly significant relationships are boron with
magnesium, phosphorus and copper (see Figure 30 a,b,d). These are all
essential elements named by Nielsen in his work on dietary boron and
mineral metabolism. He has suggested that boron may affect the action
of the parathyroid hormone, and therefore be involved in the
metabolism of calcium and magnesium (114). Along with Neilsen, other
authors have linked boron with calcium and phoghorus, and with the
maintenance of healthy bones (83,93). Other experiments have shown
that dietary boron affects copper metabolism in humans (126). Other
essential elements with which boron was seen to be strongly
associated, in blood, were zinc and iron; to date, no dietary studies
have been carried out investigating boron and the metabolism of these
elements. However, these elements are known to interact within the
body. Boron levels also appeared to be related to scandium, strontium,
caesium, rubidium, mercury and lead. None of these elements are
irvessential, although they are found most tissues and fluids.’ CalciumA
and strontium have showed a certain amount of interactive behaviour, 
as have rubidium and caesium (with the essential element potassium) 
(2). Mercury and lead are known to be toxic, even at very low levels.
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Figure 30: Boron associations in whole blood
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Figure 30 (con.); Boron associations in whole blood
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3.2.4.2. Hair eind nails
Hair and nails show a reasonable number of associations between boron 
and other elements, although rather less are at the very highly 
significant level. Those of boron with magnesium and lithium in nails 
are shown in Figure 31. The number of associations in these tissues is 
not surprising, considering their role as excretory pathways. Lithium 
and rubidium, both non-essential elements, are common to the two
tissues. Arsenic and chromium , again in both hair and nails, are 
essential, but are found at very low levels within the body. By
contrast, zinc is a major trace element constituent of hair and nails
and its observed association with boron is therefore interesting.
3.2.4.3. Urine and saliva
Saliva shows a small number of elemental associations with boron, all
of which are with non-essential elements; barium, cerium, aluminium
and lead. These can probably best be explained by elevation through
recently eaten food or similar substances. Urine, however, shows a
large number of elemental associations; those of boron with lithium
and phosphorus are shown in Figure 32. This is probably due to the
un-fact that ingestion of a food rich in one mineral is^likely to be rich 
in that mineral alone. Such a diet would probably result in the 
excretion of quite high levels of a wide range of minerals, if in
1 20
Figure 31: Boron associations in nails
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Figure 32: Boron associations in urine
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excess to the body’s requirements. In addition, all three elements are 
examples of those which are preferentially excreted by the urinary 
route.
3.2.4.4. Bone and brain
A large number of relationships between boron and other elements are 
seen in both these tissues. Most of these are non-essential; among 
these, lithium and scandium are again present. Strontium is known to 
accumulate in bone (l), and aluminium in brain (135,136), which may, 
in part, explain the observed statistical association with boron.
3.2.4.5. Synovial fluid
Only molybdenum and phosphorus show any degree of association with 
boron in this matrix. The sparcity of such relationships is similar to 
blood serum; all three fluids are similar in composition. The presence 
of the element phosphorus as one of the associated elements is 
possibly due to the presence of freigments of bone within the synovial 
fluid itself.
To summarise, many of the elements involved in associations with boron 
are non-essential, for example, lithium, scandium, rubidium and 
caesium. However, some interesting findings have been made; namely the
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close relationship of boron with calcium, phosphorus, magnesium, 
copper and other essential elements in blood. These may be significant 
in the light of work carried out by Neilsen, suggesting that boron may 
play a role in the metabolism of several minerals within the body.
3.3. Summary
Finally, the findings of this part of the study can be summarised
i) Detection limits were evaluated for the comparatively new 
analytical technique of ICP-MS; namely 2.6ng/mL.
ii) Values are given for boron in a range of standard reference 
materials, for future comparison; IAEA A13 animal blood, IAEA H4 
animal muscle, NIST SRM909 human serum, NIST 1577A bovine liver and 
SINR 0920 Chinese hair.
iii) Boron levels are, for saliva and synovial fluid, in the order of 
30-40ng/mL, blood 150 ng/mL, urine Ijjg/mL, hair, bone and brain 2-4 
pg/g and nails lOjug/g, fresh weight or volume.
iv) Blood appears to follow an approximately normal frequency
distribution, while remaining sample distributions are more skewed in 
shape. Synovial fluid, bone and brain samples show wide ranges of
boron concentration.
v) There are slight variations in boron levels with sex in urine, and
age in nails, saliva, urine and whole blood.
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vi) Boron seems to have some degree of association with nonessential 
elements such as lithium, particularly in urine, hair and nails 
seimples. Moreover, in whole blood, this was also found for boron with 
calcium, phosphorus, magnesium and copper, the elements with which 
Neilsen has suggested interactions, following alterations of dietary 
boron (114,126).
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4. TRACE ELEMENTS IN HUMAN TISSUES AND FLUIDS
4.1. Introduction
4.1.1. Biological systems
4.1.1.1. Blood and blood fractions
Blood is a connective medium with a complex liquid intercellular 
matrix, plasma, in which various components, for example, red blood 
cells, leukocytes and platelets, are suspended (1). The two primary 
functions of blood are transport and regulation of homeostasis.
Blood can dissolve or suspend many different substances and transport 
them to and from cells as it circulates around the body. For exMiple, 
the nutrients absorbed by the body - amino acids, lipids, vitamins and 
minerals - are transported from the gastrointestinal tract and carried 
to cells. In addition, red blood cells, utilising haemoglobin, bind 
oxygen in the lungs and then distribute it, while hormones are carried 
from various adrenal glands to target organs. Blood also transports 
the body’s waste products, for example, carbon dioxide to the lungs 
for expiration, and other substances for excretion via the kidneys or 
intestine. Blood is involved in the maintenance of homeostasis within 
the body by regulating fluid volume, pH, body temperature; components
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of blood play a role in protection against infection and blood loss 
from the body.
Blood plasma is 90% water, 1% inorganic substances, 6-8% protein, 
while the remaining fraction consists of substances such as glucose, 
oxygen, carbon dioxide, lipids, enzymes and hormones. The proteins 
have a number of roles, including immunological reactions, 
inflammatory responses, binding of specific elements, vitamins and 
some lipids, a buffering action, and the exertion of osmotic pressure. 
The main groups of plasma proteins are albumin, prealbumin and 
globulins. Among the last group, fibrinogen is important - this 
protein takes part in the clotting process and disintegrates along 
with the platelets. Serum is formed when whole blood is allowed to 
clot. Thus serum differs from plasma in that the protein fibrinogen is 
no longer present.
Erythrocytes, or red blood cells, are involved with the operation of 
active transport systems in the membrane. They contain a 33% solution 
of haemoglobin, and enzymes of glucose metabolism. Leukocytes, or 
white blood cells, are major components of the body’s defence 
mechanisms, and contain enzymes such as alkaline pho^hatase and 
collagenase. Platelets are tiny cells whose main role is the 
coagulation of blood.
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4.1.1.2. Saliva
This fluid has a mainly mechanical role i.e. assisting in mastication, 
swallowing and in speech. It contains two types of secretions; mucous 
for lubrication, and serous. The latter contains ptyalin, an enzyme 
for digestion of starches. Saliva contains potassium and bicarbonate 
concentrations above those in plasma, but lower sodium and chloride 
levels (1).
4.1.1.3. Urine
The composition of the urine depends on the nutritional status, the 
state of metabolic processes, and the ability of the kidney to cope 
with the material presented to it (1). Blood passes continually 
through the kidney; various substances in the plasma are able to move 
through the semi-permeable membrane of the kidney glomeruli. This 
filtrate is modified within the kidney tubules and nephron collecting 
duct to form the urine which is excreted. Urine is largely made up of 
urea and sodium chloride, with additions of ammonia and various salts. 
There are also smaller amounts of sugar, and oxalic, citric and free 
fatty acids. Trace quantities of cholesterol and metals are also 
excreted in the urine, as are various hormones and vitamins. Normal 
urine will contain red and white blood cells, and other aged 
epithelial cellular material.
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4.1.1.4. Hair and nails
Hair is a down growth of epidermal (outer layer) cells into the 
dermis, forming a hair follicle set at an angle to the skin; the hair 
is produced by mitosis in the follicle base (1), The main component of 
hair is the cortex, containing the most resistant keratin; coarse 
hairs contain a central medulla. The cortex is surrounded by the 
cuticle, on which overlapping cuticular scales are arranged, to 
provide a protective covering. At its lower end, hair has an expanded 
bulb, embedded in the skin; blood vessels flow through these folded 
dermal layers and supply nutrients which ensure hair growth. This 
growth is cyclic; the length of cycle depends on the hair location. 
The period of growth is known as the anagen phase, after which the 
follicles shrink down and the matrix cells degenerate, in the catagen 
phase. During the resting period, or telogen phase, part of the 
follicle is lost, the hair develops a club-shaped proximal swelling 
and is dislodged (1,74). -
Nail is a hardened corneal layer eind is comprised of a main "body", 
with a root and a free edge (1). The nail rests on the nail bed 
(derived from the epidermal layer) and has a cuticle above its root. 
The active growing area lies under the root and is shown by a white 
"half-moon".
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4.1.2. Trace elements in the human body
4.1.2.1. Ingestion, absorption and excretion
Most nutrients and toxic substances are taken into the body via the 
gastrointestinal tract, although the inhalation and accumulation of 
dust can result in high levels of elements within the lungs (1). 
Information about the elemental composition of the diet, however, is 
only a rough guide to the nutritional value of the diet. The ultimate 
measurement of mineral availability from a particular dietary source 
must be its contribution to the maintenance of body function (137). 
Factors affecting mineral availability tend to fall into two main 
groupings, dietary or physiological.
Dietary factors include the impact of soil and geochemistry on content 
e.g. selenium in China (138). In addition, the chemical form of an 
element within the diet must be considered e.g. selenate and selenite, 
haem-Fe and non-haem-Fe (139). Interrelations between nutients in the
diet can be critical, for instance, protein and zinb upteike,
carbohydrate and copper uptake (138,139). The effect of food refining
is also important: processing of food can result in considerable loss
of trace elements, but the availability of some elements after
extrusion cooking has shown an increase (137,138). This latter fact is 
probably due to the reduction of phytate; the outer layers of grains
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and seeds contain the major part of many trace elements but also many 
substances that could influence trace element uptake, such as fibre, 
phytic acid and tannins. Mineral-mineral interactions may also take 
place. Iron and manganese have shown behaviour of this tsrpe in animal 
and man (140), while high levels of tin have been found to impair zinc 
absorption (141,142). Fortification of products, such as infeint 
formulas, with trace elements can also precipitate imbalances. In all 
these cases, interactions may occur at the level of intestinal uptake 
and transfer, or may cause an alteration in the systemic metabolism of 
nutrients (138).
Several physiological factors affect the mineral solubility and rate 
and efficiency of upteike from the intestines of the different 
nutrients in thier various chemical forms, Because of the body’s 
control mechanisms, wide variations in rates of excretion, as well as 
intestinal absorpton, may occur with the essential elements. The stage 
of development, nutritional status, state of health, pregnancy and 
lactation, and the ability of individuals to adapt to variations in 
nutrient supply can all influence the availability of' elements for 
absorption and metabolism. For example, iron-deficiency amaemia 
results in an increased ability to absorb iron (142); in addition, 
iron absorption is also influenced by the level of iron in the diet 
consumed over the previous 1-3 days (143). Deviations in elemental 
absorption may be long or short term; reasons for prolonged variations
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include disease. Tissue levels of essential elements may be altered 
due to metabolic diseases; concentrations of potentially toxic 
elements may be raised after abnormally high exposure (1).
In the gastrointestinal tract, only a part of the ingested quantity is 
absorbed and distributed around the body by the bloodstream. The 
unabsorbed part is excreted in the faeces which is added to by bile, 
pancreatic juice and intestinal secretions. This process is quite 
slow; with zinc, for example, faecal samples can contain quantities of 
the element from 12-30 days before collection (139). The absorbed 
portion is transferred to the different organs and tissues. Most is 
then excreted in the urine, with some endogenous intestinal losses (as 
described above), and minor quantities via hair, nail, sebum and sweat
(l). The amount of element excreted by each route varies; for example, 
high percentages of boron, molybdenum and arsenic, amongst others, are 
absorbed by the gut, and thus their urinary excretion is high. For 
elements such as iron, copper and zinc, the amount eliminated in the 
urine is 1, 2 or 3%, respectively, of the amount ingested. For other
elements, such as cadmium, manganese and tin, there is very poor 
absorption in the gastrointestinal tract, with the result that the 
waste is passed via the faeces (1,144).
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4.1.2.2. Blood
Due to homeostatic control, the level of essential elements in blood 
is not always a good indicator of adequate or deficient supply (1). 
Abnormal levels of copper, iron, selenium or zinc have been seen in 
certain populations, such as high blood copper in some native 
Australian or New Zealand settlements or low zinc in sections of 
Middle East populations. For elements such as arsenic, chromium, 
mercury, nickel and lead, blood concentrations become elevated under 
conditions of exposure. Lead, mercury and cadmium bind very readily 
with red cells, indicating that serum is not a preferred specimen for 
analysis of these elements (145). The level of lead in blood is a good 
indicator of current exposure, and reflects a dynamic equilibrium 
between exposure, absorption, distribution and elimination of lead in 
situations of relatively high exposure. It has been shown that the 
cadmium level in the blood of smokers is noticeably greater than 
nonsmokers, and that blood mercury levels are increased in those that 
freqently eat fish (146,147).
For many diagnostic purposes, it is considered useful to analyse blood 
samples in conjunction with analyses of other specimens, such as urine 
or hair.
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4.1.2.3. Urine
A specimen of urine is a good indication of the nutritional condition, 
and the state of metabolic processes within an individual. For a 
number of elements, including copper and zinc, below average levels 
are seen in urine under deficient input; this data should, however, 
always be supplemented by information from blood (and its fractions) 
and hair to aid in interpretation of results. If the complete range of 
specimens display lowered values, some kind of deficiency is likely. 
Some paradoxical situations occur, however, such as increased levels 
of zinc in the urine of alcoholics (148). Urine can also be useful as 
a specimen in the cases of occupational exposure, by elements such as 
arsenic, chromium, mercury, nickel and lead (149-152). For mercury, 
urine concentrations are useful if an individual is exposed to 
metallic mercury or to inorganic salts, but not to alkyl mercury 
salts. In the latter case, urinary excretion does not reflect any 
increases of mercury concentration in the blood (1).
4.1.2.4. Hair
Hair may be used as an indicator of the general level of exposure to 
potentially toxic elements, or the supply of essential elements. Since 
growth of hair is slow, this is a more long-term indicator than those
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previously described. In addition to deposition during matrix 
formation or by sweat or sebum, external contamination is a trace 
elemental source.
For most elements, no quantitative physiological relations have been 
shown between hair eind elemental intake, resorption, blood or tissue 
concentration. Mercury, particularly as methyl mercury, is an 
exception to this (153). Elements are transferred to the hair, at 
various rates; mercury and zinc, for example, have a high turnover 
unlike cadmium (154). Moreover, the biological meaning of levels of 
essential elements in hair often remains doubtful, because 
fluctuations of these elements, due to the homeostatic control 
mechanisms in the pool which supplies hair, may obscure the direct 
reflection of a nutritional deficiency (1). Therefore, elevated zinc 
concentrations have been found in hair despite acute zinc deficiency 
(155).
4.1.2.5. Other samples
Very little work has been carried out on either nails or saliva. One 
recent study used toenails in an attempt to monitor selenium status in 
various populations from high and low selenium status areas (156). 
Another group have attempted to correlate hair and nails samples from 
a rural U.S. population since the two matrices are chemically related
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(157), and show variations in Alzheimer’s patients (158). Saliva has 
had some use as a biological monitor of fluorine in the body and 
lithium in patients undergoing lithium therapy (159,160).
4.1.3. Concentration of chemical elements
4.1.3.1. Distribution in the body
Biological samples are made up of the basic structural elements 
carbon, hydrogen, nitrogen, oxygen, phosphorus, sulphur and calcium 
(in hard tissues). Calcium, chlorine, potassium, magnesium and sodium 
make up a group of elements which are required for electrolyte 
balance, with HCOa”, SO4 ^ "and HP04^“. The remaining essential 
elements, along with environmental contaminants, occur in minute 
quantities. These minor and trace groups of elements are not 
necessarily distributed evenly around the body; a number of tissues 
act as major storage depots.
Bone is a target tissue of many elements; in particular, calcium and 
phosphorus, but strontium, lead, barium, fluorine and uranium also 
accumulate here preferentially. According to the ICRP Reference Man, 
composed by Snyder et al. (161), over 90% of each of these elements 
are found in the skeleton. Other elements, including magnesium, 
rubidium, aluminium and manganese are at higher concentrations than in
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soft tissues. Teeth are also high in elements such as strontium and 
calcium. Levels in muscle are generally much lower; in this matrix, 
however, zinc is a particularly important trace metal. Liver and 
kidney tend to accumulate large quantities of trace elements. For 
example, 21% of manganese is stored in the mitochondria-rich liver
(2), along with sizeable quantities of copper and iron, while 20% of 
the body’s cadmium is sequestered in the protein metallothionein in 
the kidney (2). Other target body components are erythrocytes and 
spleen for iron, thyroid for iodine, and semen, prostrate gland, hair 
and nails for zinc. Lung tissues may have considerable levels of a 
number of elements, for example aluminium, fron inhaled dust. Solid 
tissue, including hair and nails, tend to concentrate trace elements 
to a higher degree than body fluids.
4.1.3.2. Trends in literature data
Before trace element researchers cam make clinical judgements about 
possible elemental roles in disease states, well-founded reference 
values or ’’base-line” data are required for comparison. As analytical 
techniques are improved, however, it is important that the literature 
data be re-evaluated, and reference values revised, where necessary.
Figure 33 shows a comparison of two compilations of literature data 
for serum concentrations of selected elements (145). This reflects the
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Figure 33: Comparison of literature data for serum
COMPARISON OF e l e m e n t a l  LEVELS IN SERUM
Twc Compilations from Literature
B -4
G - f
2 -I#
VO
/ / //XH
C c  C r Hg
cleiviorit...I-y I 1353 i^s?
Mn
# Ia\
Ma
fact that many reference values in human tissues and fluids are 
generally thought to be at lower levels now, than a few years ago. 
Particularly striking, in Figure 33, is the example of chromium. Even 
quite recently, values of 6-40 ng Cr/mL have been published in the 
literature (162-6) which are probably seriously affected by 
contamination and other methodological errors. Other authors, 
reporting values of approximately 1-6 ng/mL, and 0.56 ng/mL (166,167) 
are still above the range of values which is becoming a general 
consensus. This suggests that the "true” value of chromium in serum is 
in the order of 0.1-0.2 ng/mL (168-170).
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Progress will be aided in the refinement of reference values by the 
development of new biological reference materials with elements at 
ultra-trace levels (145), and the improved certification of existing 
materials (77).
4.1.3.3. Summary of literature values
Figure 34 shows some of the most recently available literature data on 
the elemental content of whole blood, blood serum, hair and urine. The 
data displayed are values frequently obtained for the elements in 
question (1), that is, populations with abnormally deviating levels 
are not included. The reasonably small number of different elements 
quoted is an indication that reference values of several other 
elements in the tissues or fluids selected have not yet been 
established satisfactorily.
In general, elemental levels in hair are higher than in the fluid 
samples of blood and urine, as expected. For most elements, the range 
of frequent values is wider in both urine and hair than in serum and 
whole blood, since the former matrices are both excretory pathways. 
Several elements are at higher levels in whole blood than in serum, 
including zinc, lead, msinganese and cobalt; many of these can be found 
at still higher concentrations in the red blood cells fraction of
139
Figure 34: Literature trace element values in human specimens
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Figure 34 (con.): Literature trace element values in human specimens
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blood (145). Copper is one exception to this; most of this element is
complexed to ceruloplasmin, a plasma protein (1).
4.2. Results and Discussion
Human tissue and fluid samples were prepared and analysed, using ICP- 
MS, as described in Chapter 2., parts 2 and 3. The results of this
analysis are described in the following sections.
4.2.1. Distribution of data
Graphs were plotted to show the frequency distributions of the 
elements within the main sample groupings of saliva, urine, whole 
blood, hair and nails. Figures 35 to 41 show these distributions for a 
number of representative elements i.e. calcium and phosphorus 
(essential micronutrients), copper, zinc and molybdenum (essential 
trace and ultra-trace elements), strontium and lead (non­
essential/toxic trace elements). For both essential and non-essential 
elements, the same basic results are seen. In whole blood, all samples 
seem to be approximately normally distributed, while most elements in 
the remaining tissues and fluids follow a log-normal distribution.
It has been suggested that the shape of the distribution curve for a 
trace element in tissue can be used as a method of determining whether
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Figure 35: Frequency distributions of calcium data
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Figure 35 (con.): Frequency distributions of calcium data
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Figure 36; Frequency distributions of phosphorus data 
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Figure 36 (con.): Frequency distributions of phosphorus data
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Figure
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37: Frequency distributions of copper data
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Figure 37 (con.); Frequency distributions of copper data
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Figure 38:
a) Saliva
Frequency distributions of zinc data
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Figure 38 (con,): Frequency distributions of zinc data
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Figure 39: Frequency distributions of molybdenum data 
a) Saliva ELEMENTAL DISTRIBUTION
I
Uahrbdenum In Saüve
%
I
XX.
#
IQ
:Ti c a re t
b) Urine
ELEMENTAL DtSTR!BUTION
J03 <102 602
c) Whole blood
e le m e n t a l  DISTRIBUTION
h fa h rb d s n u m  In B i s s d17 1i■1
1
Moli^Ktenurp. caKsntr'Stün ng/mL
151
Figure 39 (con.): Frequency distributions of molybdenum data
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Figure 40; Frequency distributions of strontium data
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Figure 40 (con.): Frequency distributions of strontium data 
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Figure 41: Frequency distributions of lead data 
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Figure 41 (con.): Frequency distributions of lead data 
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the element is essential (4). For the essential elements, an internal 
control mechanism has been postulated with a resulting symmetrical 
distribution, whereas the level of non-essential elements is 
completely dependant on the degree of contamination from the 
environment (4,5,145). Moreover, the type of tissue or fluid, and the 
role it plays within the body is obviously of critical importance. All 
elements in this study, essential, non-essential and toxic, 
demonstrate an approximately normal distribution in whole blood. The 
number of samples in this tissue was comparatively small, which gave 
rise to the lack of "smoothness" in some of the curves obtained. 
Moreover, in the case of molybdenum, a fraction of the samples were at 
or below the detection limit of ICP-MS for this element (under the 
conditions of sample volume and dilution used); thus the complete 
upward slope of the distribution was ill defined. As the body is 
thought to exert homeostatic control over essential elements, such as 
calcium and copper, the curves obtained followed the expected shape. 
The fact that similar distribution graphs should have resulted from 
the measured strontium and lead data is more surprising, since 
strontium has no known role within the body and lead is known to be 
toxic. This suggests that blood, in its role as a transport 
mechanism, carries the environmental contaminants to various organs, 
where they are stored. It is likely that the elemental levels in these 
tissues increase to produce a distribution which reflects the degree 
of environmental exposure (5). Moreover, a number of elements are
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known to be associated with cells within the blood; for example, lead, 
mercury and cadmium with erythrocytes (145). These cells have a 
limited life; it is possible that the continuous formation and 
breakdown of cells would preclude any build-up within the blood of the 
elements attached.
Most elements in the remaining sample matrices of saliva, urine, hair 
and nails demonstrate log-normal distributions. Figure 42 shows a few 
examples; they differ from Figures 35-41 in that the number of samples 
is plotted against the logarithm of the elemental concentrations 
(divided into ranges, as before). The exceptions to this are 
phosphorus and zinc in hair, and calcium in saliva. Little is known of 
the role of trace elements in saliva; previous published research has 
been confined mainly to specialised studies where fluoride or lithium 
levels required monitoring (159,160). Saliva is made up of mucous and 
enzymatic components (1,160); how elements are distributed between 
these two components is not known. The shape of the calcium 
distribution suggests that this element, unlike the others, is under 
homeostatic regulation in this fluid or that calcium has some specific 
role to play within saliva. The fact that the remaining elements 
display log-normal curves is not surprising; this matrix could be 
easily affected by a number of factors, including dental hygiene, 
dietary intake and environmental conditions such as dust.
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Figure 42; Logarithnof frequency distributions
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The dietary intake of an individual also has a direct bearing on the 
elemental content of urine samples. The similarly skewed distributions 
obtained for all the elements is an indication of the variability of 
intake, absorption and excretion of nutrients and environmental 
contaminants. As the water content of urine is variable, it would be 
interesting to see if a 24-hour collection of urine would produce 
different results, particularly for the essential elements (171); 
unfortunately, this option was not available in this study.
Urine has a use in identifying some elemental deficiency states, for 
example, copper, selenium and zinc, where this depletion is reflected 
in a reduced urinary output (1). Similarly, high occupational exposure 
of elements such as arsenic, chromium, mercury, nickel, lead and 
thallium (149-152) can be revealed by ein increased output. Urine is an 
excretory pathway, not a tissue where homeostatic regulation results 
in a well-defined, narrow concentration range.
Hair and nails also act as excretory pathways; as with urine samples, 
most elements display a log-normal pattern of distribution. Exceptions 
to this are the normal distributions of phosphorus and zinc in hair, 
this suggests an importeint part in the production and structure of 
hair. Interestingly, these findings were not replicated in nail 
tissue, despite the similarities in chemical structure. There is some 
conflict in the literature over the expected elemental data
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distribution in hair (there is little published data on nails); some 
authors have reported that the homeostatic control of copper eind iron 
within the body results in symmetrically shaped frequency
distributions (145) while others have described log-normal curves for
all trace elements except zinc (157). In this study, essential 
elements, such as copper, calcium and manganese were found to mirror 
the behaviour of non-essential elements in producing log-normal
distributions. It can be assumed, therefore, that for most essential 
elements, hair and nails act only to a very small extent as storage 
tissues.
4.2.2. Elemental levels
In this section, the data obtained for saliva, urine, hair, nails, 
blood serum, whole blood, clot and packed cells are summarised in a
series of tables (Tables 20 to 27). Ranges of values found in the 
literature are presented along with the measured concentrations, where 
available. In the previous section, most elements were found to follow 
log-normal frequency distributions in all samples except blood. 
Therefore, median values were quoted for elements in saliva, urine, 
hair and nails, while mean values with associated standard deviations 
were reported for whole blood and the blood fractions.
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4.2.2.1. Saliva
Median elemental levels in this matrix tend to be rather low, with 
many values falling close to or below detection limits , as shown in 
Table 20. Despite the generally low levels, several samples were seen 
to have high elemental concentrations ; this wide range of values is 
demonstrated by many elements, including boron, aluminium, zinc and 
tin, i.e. aluminium ranging from <0.6-2225 ng/mL . Saliva samples 
follow a log-normal frequency distribution of concentration; the 
exception being calcium, as described in Section 4.2.1.
It is interesting to compare saliva data with the measured values for 
serum. While most elements are found at considerably lower levels in 
saliva, phosphorus has approximately the same median concentration, 
170ug/mL, in both fluids. The range of values is markedly different, 
however; in saliva, the range :mean ratio is seven times larger them in 
serum. Even in calcium, normally distributed in both fluids, the 
range :mean value is a factor of three greater in saliva. The levels of 
rubidium in saliva are five times higher than in serum (500 c.f. 
lOOng/mL), while caesium levels are twice as great (1.6 c.f.0.7ng/mL). 
This may be linked with the observation that the concentration of 
potassium in saliva also exceeds that in plasma (1); both rubidium and 
caesium have been shown to resemble potassium in its pattern of 
distribution and excretion (172,173). A relationship between these
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Table 20: Elemental composition of saliva:
stated
ng/mL unless
Median
This Study 
Minimum — Maximum
Li 0.7 <0.6 422.5
B ■ 44.5 <13 — 4383
Mg'* 4.48 1.23 — 18.35
Al 89.2 <0.6 — 2225pa 169.8 30.46 — 719.7
Ca** 49.06 14.54 — 115.7
Sc <0.2 <0.2 — 2.4
Fe 113 <1.5 • — 2712
Mn 15.4 <0.2 — 160.6
Ni 10.3 <1.6 — 128.7
Co <3.0 <3.0 — 29.7
Cu 39.78 2.44 — 659.7
Zn 189.0 <1.0 — 999.8
Ge <1.1 <1.1 — 5.08
Rb 527.1 124.8 — 1210
Sr 17.3 1.6 — 1737
Mo 2.9 <1.5 — 37.9
Cd 0.8 <1.5 — 18.8
Sn 1.2 <0.9 — 183.9
8b <1.0 <1.0 — 11.4
Cs 1.6 <0.5 — 14.6
Ba 3.6 <1.5 — 788.5
La <0.7 <0.7 — 78.6
Ce <0.6 <0.6 — 5.1
Hg <1.2 <1.2 — 20.6
Pb 3.2 <0.07 115.2
a: ug/mL
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elements has been shown to exist for a variety of physiological 
processes (174,175). They can also act as nutritional substitutes in 
yeasts and bacteria (176,177) and to a lesser extent, and over a short 
term, in higher animals (178,179). Elements such as iron, copper and 
zinc display similar median values in saliva and urine; 40 and 20ng 
Cu/mL, 189 and 391ng Zn/mL respectively (comparing Tables 20 and 21). 
These elements are relatively poorly absorbed by the body, with 1,2 
and 3% respectively being excreted in the urine (1).
4.2.2.2. Urine
The elemental levels in urine reflect, to a large extent, the dietary 
intake of various elements and the percentage of this intake which is 
absorbed: the data is displayed in Table 21. Reference values are
given as comparisons; deviations have been described in the 
literature due to dietary déficiences, metabolic disorders or 
environmental exposure (1). Elements in urine tend to follow a log­
normal frequency distribution, thus indicating a strong dependence on 
intake rather than stringent homeostatic control.
Median values of boron, molybdenum and rubidium are high in urine 
(1079, 108 and 811 ng/mL respectively) ; all these elements are well
absorbed in the gut with only a small fraction of the amount ingested 
being excreted via the faeces. Cobalt, copper, iron, mercury,
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Table 21 : Elemental content of urine
comparison: ng/mL unless stated
with literature
This Study Literature’
Median Minimum-- Maximum Minimum— Maximum
Li 15.2 <0.6 88.4
B 1079 163.8 — 5943 709 — 919
Mg“ 60.43 0.16 — 376.1 48 — 200
A1 19.8 <0.6 — 1675 60 -
P“ 488.1 30.3 - 2045 24 - 621
Ca“ 65.88 2.01 — 422.4 55 — 164
Sc 1.5 <0.2 7.5 - -
Fe 130 30 — 3840 180
Mn 1.7 <0.1 — 132.8 3 — 300
Ni 9.1 <1.6 — 736.9 2300 — 8.5
Co 0.4 <0.4 — 20.6 98 -
Cu 20.3 <2.0 — 144.2 17 — 300
Zn 391.0 <5.0 — 1938 193 - 2040
Ge 1.0 <1.1 — 4.9 - -
Rb 810.7 <0.6 — 2375 941 - 1520
Sr 108.6 5.04 — 464.7 100 -
Mo 107.6 3.36 — 803.4 10 — 10
Cd 0.5 <1.6 — 17.9 0.64 — 8.9
Sn 2.0 <1.0 — 21.8 13 -
Sb 0.3 <0.8 — 6.6 - -
Cs 5.4 0.5 — 16.4 80 -
Ba 1.8 <1.5 — 731.5 89 -
La <0.1 <0.1 — 6.4 - -
Ce <0.1 <0.1 — 1.4 - -
Hg 1.2 <1.6 — 15.2 4.3 — 114
Pb 2.7 <0.5 — 29.4 6.3 — 110
a: ng/mL
b: Iyengar 1978 (133)
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strontium and zinc fall into the category of "medium” absorption.
These elements are found at lower levels in the urine than those
mentioned above, taking into account their relative concentrations 
within the body, and also compared with their levels in some other 
biological fluids. For example, copper has a median urine level of 
20ng/mL which is two orders of magnitude lower than in serum. Other 
elements, such as cadmium, aluminium, manganese, nickel and tin, are
very poorly absorbed by the gut ( median levels of 0.5, 19.8, 1.7,
9.1, and 2ng/mL respectively) - the large unabsorbed portion appears 
in the faeces (1). The rare earth elements of lanthanum and cerium 
also have low urine concentrations{both <0.Ing/mL), suggesting that 
the same pattern of poor absorption eind faecal excretion is followed. 
Wide ranges are seen, as in saliva, with a few examples of 
unexpectedly high values e.g. aluminium, 1.7ug/mL, and nickel, 
2.3ug/mL. Such sample values probably give some indication of 
environmental exposure.
4.2.2.3. Hair and nails
As is usual with solid biological matrices, trace elements are found 
at higher levels here than in most fluids; see Tables 22 and 23. 
Concentrations in hair and nails may reflect the level of intestinal 
absorption in some situations or the accumulation within the body 
(145). Trace elements may leave the body via nails and hair along with
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Table 22: Elemental content of scalp hair
comparison: ng/g unless stated
with literature
This Study Literature
Median Minimum— Maximum Minimum — Maximum
Li 95.1 <0.6 — 3192 - -
B 827 <13 — 23621 5000 -
Mg“ 31.7 5.2 - 775 19 — 163
Al“ 7.2 0.6 — 50.1 4.2 — 29.3pa 121 5 — 512 83 - 165
Ca“ 431 46.6 — 7206 146 — 3190
Sc 1.3 <0,2 “ 129 - -
V 33.5 <1.5 — 429 5 — 70
Cr 228 <1.4 — 3676 130 — 3650
Fe“ 10.2 4.2 — 153.5 5 — 44.7
Mn 323 52.4 - 3066 250 5700
Co 16.2 <3.0 - 407 30 — 1050
Ni 441 <1.6 - 8763 600 - 6500
Cu“ 13.4 1.4 - 203 11 — 34
Zn“ 130 22.1 - 319 99 - 450
Ge 3.2 <1.1 — 108 2300 -
Rb 4.7 <0.6 — 236 210 — 500
Sr 1048 20.7 — 9079 46 — 920
Mo 88.7 <1.0 — 1110 • 64 — 205
Cd 185 . <1.6 — 5918 240 — 2700
Sn 301 <1.0 — 8180 1000 -
Sb 79.1 <0.8 — 460 90 — 3000
Cs 1.2 <0.5 - 103 370 — 1100
Ba 399 <1.5 — 8740 550 — 4200
La 13.9 <0.1 — 3155 150 — 650
Ce 15.1 0.3 1823 — -
Pb 1969 50 — — 18780 3000 - 25400
a; ue/s
b: Iyengar 1978 (133)
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Table 23: Elemental content of nails with
comparison; ng/g unless stated
literature
This Study- 
Median Minimum Maximum
Literature’* 
Minimum Maximum
Li 753 <0.6 — 8299 -
B“ 12.27 <0.01 — 82.74 33 — 0
Mg'* 137 20.8 — 467 16.2 — 125
Al“ 36.6 <0.6 — 244 132 — 927po 340 45.8 — 3784 180 990
Ca“ 1044 31.6 - 3459 368 — 3400
Sc 9.7 <0.2 — 969 - -
V 86.6 <1.5 — 1422 <150 — -
Cr 708 <1.3 — 7002 6200 — -
Fe“ 36.9 6.2 — .287 27 — 347
Mn 993 138 — 8383 40 — 2100
Ni 591 <2 — 10000 33 — 11900
Co 38 <3 — 1586 <200 -
Cu** 4.7 0.3 — 130 11.2 — 53
Zn“ 97 2,5 — 922 73 — 304
Ge 6.7 <1.1 — 251 - -
Rb 70.8 <0.7 — 1750 3100 -
Sr 1408 88.4 — 28060 17 — 650
Mo 121 <1.5 5794 <150 — 5600
Cd 131 <1.5 — 4802 80 — 3400
Sn 486 <1.0 — 7340 12000 -
Sb 146 <0.8 — 6133 <30 — 750
Cs 5.2 <0.5 - 14710 6600 -
Ba 1518 139 — 35089 7500 -
La 64.7 4.1 — 683 310 -
Ce 111 4.3 - 1319 600 -
Pb 1557 <1.0 — 116 13800 — 39000
a: ug/g
b: Iyengar 1978 (133)
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other routes, such as sweat and sebum. Wide concentration ranges of 
elements are seen, including many detection limit values, with log­
normal frequency distributions seen for most trace metals (exceptions 
being zinc and phosphorus).
Zinc, phosphorus, calcium and magnesium are found at substantial 
levels in both nails and hair. Zinc is higher in hair, whereas the 
latter three elements are at greater concentrations in nails. Several 
other elements are generally found at microgram per gram levels or 
above, for example copper, aluminium and iron, followed by boron and 
lead. Several of these are elevated in the nails compared to the hair. 
This is probably because nail has a greater density than hair. Nails 
were also more difficult to clean than hair; acetone was used to 
ensure that all traces of lacquer were removed, as well as residual 
grease, but some impurities may have been engrained. Rubidium is 
unusual in that it is found at lower levels (medians of 4.7 and 71ng/g
for hair and nails) within these two solid tissues than in most
biological fluids, such as blood and saliva (1.2 and 0.5jjg/mL 
respectively). Despite being within the literature range quoted, 
manganese levels are possibly slightly elevated due to extraneous
additions from the scissors or clippers used, although it is hoped
that the washing regime removed such effects.
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4.2.2.4. Blood and blood fractions
Whole blood and its fractions of serum, clot and packed cells were 
analysed; the data is presented in Tables 24 to 27. As most elements 
follow an approximately normal distribution, the results of analysis 
by ICP-MS in this study are presented as the arithmetic mean, with the 
standard deviation in parentheses. Most elemental concentrations are 
in good agreement with the literature (no values for packed cells or 
clots were readily available).
For manganese, however, a value of 3.8 ng/mL in serum was found. Some 
recent studies suggest that the "true" value for this element is in 
the order of 0.6 ng/mL. This variation may be due to contamination of 
the blood by the manganese content of the stainless steel needle. It 
is possible that whole blood and the remaining products show similarly 
elevated values, although as the reference data are poorly defined, 
the measurements fall within the expected range. Another possibility 
is the rupturing of red blood cells during sample collection with 
"leakage" from the red cells into the serum, since most literature 
sources report a higher level of manganese in red blood cells than in 
serum (145,180-2). The element is almost totally linked with a Di- 
globulin in plasma, and forms a firmly bound porphyrin compound in 
red cells (183-5). Other elements which show some variation 
in their values are aluminium and barium. In
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Table 24: Mean elemental content of blood serum with
literature comparison: ng/mL unless stated
This Study Literature*=
Mean(s.d.“) Minimum— Maximum Minimum — Maximum
B 201(127) 45.5 — 460 0.12 -
Mg’* 19.7(2.9) 14.73 — 25.80 19.9 — 27.5
A1 37(21) 5.8 — 82.9 2.1 — 10pb 168(25) 124 — 222 115 — 163
Ca” 119(20) 91.5 — 169 92 — 109
Sc 33(16) 7.3 — 68.6 <1 -
Fe’* 2.1(0.6) 0.88 — 3.1 0.8 — 1.87
Mn 3.8(1.6) 1.2 6.5 0.5 — 1
Ni 13.3(3.9) 6.4 — 21.1 0.4 — 2
Co 0.4(0.3) <0.4 — 1.2 0.11 — 8
C u ’* 1.3(0.4) 0.65 — 2,2 0.815 — 1.64
Zn** 0.95(0.23) 0.52 — 1.45 0.67 — 1.83
Ge 1.2(0.7) <1.1 — 2.6 <4 — 290
Rb 113(21) 81.5 — 152 40 — 580
Sr 38(17) 14.8 — 67.6 20 — 46
Mo 5(3) <2 — 11.5 0.6 — 27
Cd 0.3(0.3) <0.2 — 0.8 0.1 — 12
Sn 7(8) <1 — 19.9 1 — 30
Sb 0.1(0.1) <0.1 — 0.5 <0.3 — 3.2
Cs 0.7(0.3) 0.2 — 1.2 0.74 — 1.3
Ba 207(60) 91.4 — 296 25 — 80
La 2.3(1.3) 0.9 — 4.0 5.5 — -
Ce 44(18) 15.4 — 66.5 -
Hg 0.3(0.5) <0.3 — 1.5 1.3 — 3
Pb 2.3(1.2) 0.3 — 4.0 <1 — 5.4
a: standard deviation 
b: Mg/mL
c: Iyengar 1978 (133)
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Table 25 : Mean elemental content of whole blood with
literature comparison: ng/mL unless stated
Thi 
Mean(s.d.“)
s Study 
Minimum — Maximum
Literature* 
Minimum — Maximum
B 133(106) <26 511 40 740
Mg’* 29.5(9.7) 16.1 — 57.7 27.1 - 45.5
A1 348(600) <2 — 3987 2 - 720pb 335(127) 160 — 707 311 - 510
Ca” 61(17) 39 — 105 57.5 — 78
Sc 26(16) 0.5 - 81.2 7.6 -
Fe’* 315(72) 200 417 301 — 530
Mn 41(39) <0.5 — 198 1.6 — 75
Ni 295(254) <3 — 864 4.8 — 106
Co 8(34) <6 — 68 0.3 — 9.9
Cu 663(300) 220 — 1390 640 — 1280
Zn’* 4.4(2.7) 0.6 — 10.5 4.8 — 9.3
Ge 20(22) 1.4 — 77 440 - 5000
Rb” 1.2(0.3) 0.6 - 1.9 1.2 - 6.0
Sr 19(10) 4.9 — 49 16 — 95
Mo 50(80) <3 - 418 1 - 75
Cd 7(6) <3 — 24 1 — 7.4
Sn 13(18) <2 — 74 8.5 — 290
Sb 16(30) <2 — 129 1.2 — 4.7
Cs 3(2) 0.2 — 9 3 — 4.7
Ba 30(32) <3 — 96 41 — 95
La 2(4) <0.5 — 17 - -
Ce 7(6) <0.4 — 18 <2
Hg 15(17) <2 — 78 5 — 20
Pb 43(33) 0.6 — 150 50 — 400
a: standard deviation 
b: ne/mL
c: Iyengar 1978 (133)
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Table 26: Mean elemental content of clot; ng/g (fresh weight)
unless stated
Mean(s.d .“) Minimum — Maximum
B 283(71) 159 — 376
Mg” 48.8(4.5) 39.3 — 54.0
A1 88(46) <1.2 — 147pb 511(47) 427 — 588
Ca” 66(15) 39.5 — 85.8
Sc 54(32) 3.5 — 107
Fe” 614(42) 549 — 662
Mn 20(12) <0.3 — 42
Ni 11(18) <3 - 49
Co 0.9(1.3) <0.9 - 3.4
Cu” 0.73(0.11) 0.55 — 0.94
Zn” 10.6(0.8) 8.5 - 11.7
Ge 102(18) 74 - 133
Rb” 2.5(0.3) 2.2 - 3.3
Sr 16.9(3.6) 11.7 - 24.5
Mo 7(8) <3 - 18,3
Cd 1.8(2.0) <1.6 - 5.2
Sn 7(11) <2 - 28.2
Sb 2.6(4.3) <1.5 - 10.5
Cs 4.5(1.4) 1.5 — 7.1
Ba 205(29) 170 - 252
La 7.4(4.3) 1.5 — 13.6
Ce 71(18) 40 — 99
Pb 167(46) 96.4 — 246
a: standard deviation 
b: jjg/g
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Table 27: Mean elemental content of packed cells: ng/g (fresh
weight) unless stated
Mean(s.d .“) Minimum — Maximum
B 186(37) 122 238
Mg“ 41.3(9.3) 24.1 — 54.1
P“ 475(107) 283 — 581
Ca“ 48.4(6.8) 36.8 — 58.1
Sc 12(8) 4 — 29
Fe" 458(87) 289 - 535
Mn 20(30) <0.3 — 75
Ni 115(183) <3 — 454
Co 1.3(2.0) <0.9 - 5.2
Cu" 0.36(0.08) 0.26 — 0.48
Zn" 6.6(1.9) 3.4 - 8.5
Ge 11(4) 6 - 18
Rb" 1.3(0.3) 0.7 — 1.7
Sr 14(10) 0.6 — 31
Mo 74(104) <3 — 296
Cd 0.7(1.7) <0.5 - 5.0
Sn 0.7(1.3) <0.6 3.8
Sb 11(10) <0.9 — 30
Cs 3.0(0.5) 2.4 — 3.7
Ba 62(18) 35 — 95
La 1.8(0.9) <0.5 — 3.1
Ce 28(6) 21 — 43
Hg 2(2) <1.7 — 5
Pb 67(39) 13 — 128
a: standard deviation 
b: ng/g
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packed cells, the levels of aluminium could not be detected in any 
samples, while in whole blood, in particular, there are some extremely 
high values i.e. a maximum of 4jLig/mL. Barium appears to be at high 
mean levels in serum and in the clot, compared to the other fluids 
(207 and 205ng/mL or g, in serum eind clot, with whole blood and packed 
cells of 30 and 62ng/mL or g). As the clot and serum were from the 
same aliquot of blood, this is probably due to some sample mis­
handling during separation stages i.e. the possible use of a glass 
pipette or container by clinical staff (see section S.2.3.2.).
Copper is unusual among trace elements at being found at greater 
quantities in serum than in erythrocytes, and thus in 
whole blood (2,145). These results are confirmed by the data shown in 
Tables 24 to 27 (1.3pg/ml in serum compared to an average value of 
0.6ug/mL for the remainder). A large proportion of copper is bound to 
the globulin protein ceruloplasmin, which is critical in the 
mobilisation of iron, particularly from reticuloendithelial systems 
and/or the liver (186). Copper is also attached to the plasma protein 
albumin, by which it can readily pass to erythrocytes (187). The great 
difference in iron concentration between serum and whole blood, clot 
and packed cells is due to the occunfence of iron in haemoglobin in the 
red blood cells and as transferrin in plasma, in a ratio of nearly 
1000:1. A very small fraction of iron, as ferritin, is also found in 
red and white blood cells and plasma. Approximately 80% of blood zinc
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is bound to erythrocytes, with about 17% in plasma, and the remaining 
fraction in leukocytes and platelets (188). The measured values of 
zinc reported in Tables 24-7 reflect this fact; the clot and packed 
cells have the highest measured zinc (ll)Jg/g in the clot c.f. 0.9jag/mL 
in serum). In plasma, 30-40% of zinc is firmly bound to an «2- 
macroglobulin, with 60-70% loosely bound to the albumin (189).
Many other elements were found to be at higher levels in whole blood, 
clot or packed cells than in serum. These include cadmium, mercury, 
lead, cobalt and rubidium; literature findings describing a greater 
affinity for red blood cells were therefore confirmed (146,172-3,190). 
For example, lead and rubidium were found to have mean values of 0.3 
and 113ng/mL in serum and 43 and 2500ng/mL in whole blood, 
respectively. Some authors have suggested that plasma lead has a 
ceiling value, possibly related to the binding capacity of a low 
molecular weight protein or polypeptide of the serum, and that 
erythrocytes represent a large repository for lead, maintaining plasma 
lead concentrations between narrow limits (191,192). The comparatively 
high values of molybdenum in the whole blood and other cellular 
components, compared to serum, were rather unexpected. This element is 
thought to be evenly distributed between red blood cells and plasma 
(145,193). It has been suggested that it is transported in blood Eind 
urine as the molybdate ion (MoOa®") (194). Caesium is found at 
approximately 6.5 times higher levels in packed cells than in serum
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(77); these findings were confirmed in this study, with mean values of 
3 and 0.7ng/mL respectively.
4.2.3. Distribution of elements in human clinical specimens
4.2.3.1. Variations in tissues eind fluids
Figure 43 (a-g) demonstrates graphically how elemental levels differ 
from one biological tissue/fluid to another. Where possible, elements 
in the same group are listed together e.g. calcium, magnesium, barium 
and strontium, from Group IIA, and transition metals, for example, 
copper, zinc and iron.
It is possible to identify a few similarities in behaviour. For 
example, rubidium and caesium are quite alike in distribution among 
fluid samples, despite the difference of some orders of magnitude 
(1200ng Rb/mL c.f. 3.2ng Cs/mL in whole blood). They appear to behave 
differently in the nails and hair; rubidium is particularly low in 
hair, while caesium follows the more established pattern of moderately 
elevated levels in solid tissues. Strontium follows the pattern of 
calcium quite closely, particularly in being higher in serum than in 
the remaining blood samples. Strontium has demonstrated some degree of 
interaction with calcium; many research articles have concentrated on 
its retention in bone with particular reference to the abundant ®®Sr
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Figure 43: Range of elemental levels in various human specimens
a) Rb, Cs.
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Figure 43 (con.): Range of elemental levels in various human specimens
b) Ca, Mg, Ba, Sr.
LU
ÜW
iû_
c/1
X
of
1-;
Qlh-
LÜ
O
oo
wCO
QO
LL
Oo
TD■5
!ü3
ILU JO 5 / 5 n uo 1+0x4.U3 DUOo
179
Figure 43 (con.): Range of elemental levels in various human specimens
c) P, B, Sb.
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Figure 43 (con.): Range of elemental levels in various human specimens
d) Pb, Ge, Sn.
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Figure 43 (con.): Range of elemental levels in various human specimens
e) Mn, Co, Ni, Sc.
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Figure 43 (con.): Range of elemental levels in various human specimens
f) Fe, Zn, Cu.
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Figure 43 (con.): Range of elemental levels in various human specimens
g) Mo, La, Ce, Cd.
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by-product of nuclear fission (2,195). There is, however, a biological 
discrimination that occurs eigainst strontium compared with calcium
i.e. Sr:Ca ratios in bones and bodies of animals are lower than Sr:Ca 
ratios of diets (196). Hiis is mainly due to the fact that calcium is 
absorbed more readily than strontium, and strontium has a 
comparatively higher urinary excretion than calcium. Barium does not 
seem to follow a similar pattern of behaviour; this element is poorly 
absorbed, with little retention in tissues (except bone) or excretion 
by urine (a median level of 1.8ng/mL) . Magnesium also appears to 
behave differently from the other Group IIA metals; its urinary
excretion is particularly high (60us/mL), and its levels in saliva are
comparatively low (4ug/ml).
Lead and germanium seem to have approximately the same pattern of 
distribution; lead and tin also show a high degree of accumulation in 
hair and nails. The relativly low urine levels indicate that none of
these elements are well absorbed by the gut. Elemental accumulation by 
the hair and nails is not unusual - this is shown by many other 
elements, including cadmium, the rare earths, molybdenum, antimony and 
boron. Phosphorus, as an essential micronutrient, is found at 
substantial levels in most tissues and fluids. Its excretion in the 
urine is high (488;ig/mL median value) , which contrasts greatly with 
antimony (0.2ng/mL) , also a Group VA element. It is interesting to 
see that where absorption of dietary intake is high, such as boron and
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phosphorus, the urine levels are within an order of msignitude of the 
levels in hair. This is also demonstrated by cobalt and molybdenum.
Higher elemental levels in erythrocytes rather than in plasma are seen 
in many elements, for example, manganese, lead, antimony, zinc and 
iron. The latter two elements are shown in Figure 43f with copper, 
also a transition metal. Copper is higher in serum than in red blood 
cells; apart from this, these three elements show approximately 
similar patterns of distribution i.e. they are at high levels in hair 
and nails and low in saliva and urine.
4.2.3.2. Inter-element associations
Regression einalysis was carried out between various pairs of elements 
from the different sample tissues and fluids (the packed cell and clot 
sample groups were not included here because of their limited size), 
to investigate whether variations in the level of one element resulted 
in similar behaviour in the other. As before, the regression 
coefficient, r, was evaluated; from this, a t-value was calculated and 
used to identify significant correlations.
The essential micronutrients displayed numerous associations, both 
among themselves and with other trace elements, in a wide range of 
tissues and fluids. For example, magnesium, calcium and phosphorus
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were "very highly significantly" positively associated (+S**: 0.1%
level) in serum, whole blood, saliva and urine. This was seen to a 
lesser extent in hair or nails; however, more trace elements showed 
apparent relationships here, such as, calcium with phosphorus, zinc, 
copper or lead (+S**), phosphorus with zinc (+S**) and copper with 
zinc or lead (+S**). Some of these relationships are shown in Figures 
44 to 47. The data displayed, particularly for hair, indicates how 
important it is to examine data graphically, and not to rely "blindly" 
on statistical techniques (197). It seems likely that zinc and 
phosphorus interact in some way within hair; the same cannot be said 
for copper with zinc or lead, even though associations, significant to 
the 0.1% level, were found in all these examples. In the latter cases, 
the data appear to be distorted by a small number of high 
concentration samples while most of the remaining data seem to be 
clustered in a completely different pattern. This is due to a small 
number of individuals having elevated levels of a number of elements; 
this could be a reflection of a high exposure to, or a metabolic 
imbalance of these elements at the time when the hair was actively 
growing, or, perhaps, of some treatment carried out to the hair by 
that individual.
Surprisingly few associations between essential trace and toxic 
elements, such as mercury and lead, were seen in blood. Several 
essential trace elements and micronutrients, however, showed a close
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Figure 44; Associations between elements in hair
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Figure 46; Associations between elements in urine
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Figure 47: Associations between elements in whole blood
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degree of association with each other in both serum and whole blood; 
Figure 47 displays zinc with magnesium, phos^rus and copper, all in 
whole blood (+S**). Calcium showed a "highly significant" relationship 
(+S*; 1% level) with strontium in whole blood; these elements were
also linked in urine and nails (+S**). Reports have been made in the 
literature about interactions between calcium and strontium (195). In 
saliva and urine, however, more relationships were seen involving 
toxic elements (particularly lead; mercury was at low levels 
throughout), Moreover, in these two fluids, the elements rubidium and 
caesium showed a very high degree of positive association; see Figures 
45 and 46c. The similarities in behaviour of these two elements have 
already been described, particularly in their reported tendency to 
replace potassium (172,173). The concentration of potassium is 
comparatively high in saliva (1); rubidium and caesium also seem to 
have elevated levels. The association of these two elements in saliva 
suggests, therefore, that they behave in a similar way within this 
fluid. Their relationship in urine is indicative of the patterns of 
absorption and excretion within the body. Rubidium and caesium do not 
form any associations in blood, nor in hair and nails.
It is interesting that very few significant correlations were shown 
between pairs of elements in nails, particularly in comparison with 
hair. This suggests either a different way of accumulating trace 
elements into the matrix (even though hair and nails are thought to be
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similar in chemical structure), or perhaps that either nails or hair 
are affected by exogenous deposits of elements to a markedly different 
degree (157). External factors which might cause a change in elemental 
levels, and thus their interrelationships, might be dirt, dust and 
lacquer, for example, although washing procedures were used to try and 
reduce such effects.
4.2.3.3. Inter-matrix associations
Regression analysis was carried out on each element, in various types 
of tissue and fluid. For example, the variations of copper in hair 
were compared with copper in blood, and so on. This was to continue 
and expand on a study reported in the literature, where correlations 
between hair and nails samples were investigated using INAA (157).
Vance et al. found that the levels of nonessential elements were 
generally correlated in hair and nails, whereas those of essential 
trace elements were not (157). This study does not agree totally with 
these findings; aluminium, calcium, chromium, copper, lithium, 
magnesium, molybdenum and strontium showed some degree of positive 
correlation (at the 5% level; exceptions of molydenum and strontium at 
the 0.1% level). Vance at al. suggested that hair and nail may not 
incorporate internal trace elements in exactly the same way, despite 
their similarity in chemical composition. It is also realised that
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different methods of preanalysis treatment and basic population 
differences {influenced by factors such as diet and environment) may 
cause some variation between results. It is interesting to note that 
calcium and strontium, with their suspected interactive behaviour, are 
among the elements listed.
The levels of calcium and strontium also displayed some correlation in 
saliva and urine (+S*); in addition to these were caesium, nickel and 
molybdenum, also at the 1% level of significance. The importance of 
these associations is not known; saliva may simply have been altered 
by ingestion of nutrients and other elements in other forms (although 
a standardised collection protocol was used to try and prevent this), 
while urine is clearly dependent on the dietary intake and its 
absorption by the body.
Each element’s levels in blood and hair were also correlated against 
each other; the concentration in blood represents information about 
immediate, metabolic levels, while in hair, a record is provided over 
a time scale of weeks and months (75). Therefore, a correlation is not 
necessarily expected, although a chronic deficiency or exposure might 
be shown in both types of specimen. Here, positive correlations were 
seen for aluminium, molybdenum, lead and rubidium; of these elements, 
only molybdenum is essential - this element has been reported in the 
literature as having important interactions with copper and inorganic
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sulphate (2,194). Moreover, increasing dietary molybdenum has been 
shown to raise the elemental content of hair and wool, in cattle and 
sheep (198).
Few correlations were seen between blood and urine; the elements of 
interest here were boron, magnesium and zinc, all at the 5% level of 
significance (+S). By contrast, a number of elements showed 
correlation of their levels in hair eind urine. These elements were 
boron, aluminium, scandium, manganese, copper, barium, rubidium and 
caesium. Of these, only copper and manganese are essential, however; 
among the remaining elements were rubidium and caesium, which have 
demonstrated marked similarities in behaviour throughout the body, in 
this study and reports in the literature.
4.2.4. Variations due to age
The population was subdivided into two groups; children (below 18 
years) and adults (18 years and above). A comparison of the elemental 
levels in saliva, urine, whole blood, hair and nails was carried out, 
using the Student’s t-test; the results are summarised in Table 28.
No statistically significant differences were seen between the two 
groups in the data obtained for whole blood. In saliva, levels of 
boron, zinc and antimony were higher among the group of children, at
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Table 28: Comparison between the elemental levels in clinical
specimens collected from adults and children, male 
and female.
Saliva
Elemental
Urine
differences"
Hair Nails
Li C<A
B Ct>A= M4>F« C<A
Mg M>F
Al C<A M<F
P M<F C<A C<A
Ca M>F
Sc C<A M<F C<A
Mn C<A M<F
Ni C<A M<F
Go C<A
Cu M<F
Zn O A M>F C<A
Ge C<A M>F
Rb M>F
Sr F>M
Mo C<A
Cd C<A M<F
Sb C<A
Ba F>M
Hg C<A M<F
a: differences significant at the 1% level are shown 
b: children (<18) 
c: adults (+18) 
d; male 
e: female
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the 1% level of significance (S*). There may be some physiological 
reason for this - knowledge of the roles of various elements in saliva 
is extremely sparse because very few studies have been carried out 
(160,54). It is more likely, however, that environmental and/or 
dietary factors are involved in this observed disparity between 
children and adults.
In urine, the situation was reversed; several elements were lower in 
children than in adults. These elements were aluminium, scandium, 
manganese, nickel, cobalt, germanium, cadmium and mercury - the 
majority of these are nonessential or toxic elements. As urine 
concentrations are directly related to intake, the comparatively low 
elemental content of urine in children may be linked to the fact that 
they eat less, on average, than fully grown adults. It is also
interesting to note that all these elements are poorly absorbed from
the gut i.e. the fraction of daily intake excreted in the urine is 
low. This is reported in the literature (1,144); also, the
comparatively low levels of these elements in urine can be seen in
Table 21 and Figure 43 (a-g).
The levels of zinc, phosphorus and molybdenum are low in the hair of 
children compared to adults; see Figure 48 a-b. Zinc and phosphorus 
are strongly bound to the S-H groups in hair; moreover, these elements 
were the only ones to follow a normal frequency distribution in this
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Figure 48: Variations in elemental level with age
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tissue. Lithium, boron, phosphorus and scandium were low in the nails 
of children when compared to those of adults; the reasons for these 
diferences is not clear; adults may be more exposed to these elements 
from external, environmental sources,
4.2.5. Variations due to sex
Samples of saliva, urine, blood, nails and hair were divided into male 
and female groups, and a comparison was made between the two groups, 
using the Student’s t-test; see Table 28. No differences between the 
sexes were seen for either blood or saliva; in hair, strontium and 
barium were elevated in females, while in nails, germanium and 
rubidium were at increased levels in males. No reason is known for 
these findings - none of these elements are essential.
In urine, a large number of sex-related differences were shown. Boron, 
magnesium, phosphorus and zinc concentrations were elevated in urine 
from men, while the reverse was true for aluminium, scandium, 
manganese, nickel, copper, cadmium and mercury. A simple explanation 
might be that men, in general, consume larger quantities of food than 
females, and thus have a greater trace element (and other nutrient) 
intake. They would therefore excrete a larger quantity of trace 
elements than women. This rather simplistic argument suggests that men 
should excrete an elevated trace elemental content in the urine for
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all elements; this was not seen. It is interesting to note, therefore, 
that the elements in which male values in urine exceeded those of 
females, are those where a sizeable proportion of dietary intake is 
absorbed by the body and excreted in the urine, for example, boron and 
phosphorus. The remaining elements, where female urine levels are 
higher than males, are those with poor absorption, for example, 
aluminium, manganese and cadmium. The larger unabsorbed portion is 
passed via the faecal route.
4.3. Summary
Having completed this section of the study, the work can be summarised 
as follows
i) Most elements demonstrated approximately normal frequency
distribution curves for whole blood and log-normal distributions for 
the remaining sample groups; exceptions were calcium in saliva, 
phosphorus and zinc in hair. For some ultra-trace elements, the 
patterns of distribution became a little unclear, due to the proximity 
to the detection limit (the product of the "instrumental" detection 
limit and the dilution factor).
ii) Tables of elemental levels were presented for a range of readily 
accessible human tissues and fluids; the multielement capability of 
ICP-MS was used to provide a broad range of data. This included
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information on saliva and nails, which are not well documented in the 
literature.
iii) Graphs were plotted to demonstrate how the elemental levels in 
the various tissues and fluids varied, for example, across a group of 
the Periodic Table. Inter-element and inter-matrix associations 
evaluated using linear regression analysis were discussed. Several 
pairs of essential elements showed relationships in blood, for 
example, while the largest number of inter-matrix correlations were 
seen between hair and urine.
iv) Finally, variations in elemental content indicated in the 
different age and sex groupings, for all tissues and fluids, were 
summarised. Of these, urine levels showed the largest number of 
variations between males and females, children and adults.
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5. TRACE ELEMENTS AND RHEUMATOID ARTHRITIS
5.1. Introduction to Rheumatoid Arthritis
5.1.1. Epidemiology
Rheumatoid arthritis (RA), the most common arthritic disorder, is a 
chronic inflammatory disease which varies widely in severity and rate 
of onset (199). Diagnosis of the disease is based on the recognition 
of certain clinical and laboratory features specified by the American 
Rheumatism Association (ARA), which have recently been revised (132). 
These include morning sickness, joint swelling, symmetrical joint 
involvement and X-ray erosions of cartilege and bone (200). Despite 
the widespread use of the ARA diagnostic criteria, there is still some 
variation in the resulting values of disease frequency found in the 
literature. A consensus of opinion suggests that 1-3% of the world
population suffer from RA (199-2021), although one study gave a figure
of 20% for disease prevalence in the UK, USA, New Zealand and
similarly developed countries (203). It is well documented that women 
are more likely to suffer from RA than men, in a ratio of
approximately 2-3:1, It appears that climate, dampness and social 
status are unrelated to disease prevalence (199), despite the opinion 
held for years that a hot climate was beneficial. For example, it is 
refuted by the observations that Jamaica and Mauritius have high
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Table 29: % Population with definite rheumatoid arthritis 
(200,204)
Region Males % Females % Both %
Wens1eydale-Leigh 
(U.K.)
0.47 1.60 1.07
Rotterdam
(Holland)
0.5 1.2 -
Michigan 
(U.S.A.)
0.3 0.7 0.5
Puerto Rico 0.16 0.4 0.34
Japan 0.4 0.7 0.55
Finland 1.4 5.4 3.0
Czechoslovakia 0.30 0.76 0.51
incidence of arthritis within their poulations (203) and Eskimos have 
low incidence (201). Some South African evidence indicated an increase 
in disease prevalence from 0.87% to 3.3% when a section of its native 
population moved from a rural to an urban environment (205). In the 
UK, however, people from rural and urban environments suffer equally, 
as do white and black populations in the USA (202). Table 29 shows the 
levels of disease found in different parts of the world.
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5.1.2. Aetiology
The aetiology of RA is still uncertain; the two major hypotheses are 
the infective and autoimmune, although as knowledge grows in both 
fields, the distinction between the two becomes blurred (200). Other 
areas of research have been investigated; the findings can be 
summarised (132,199,201):-
5.1.2.1. Genetic factors
A weak influence of heredity has been shown by family and twin 
studies. More recent research has shown the importance of the major 
histocompatability complex (MHC) in immune response, although an 
individual MHC product may not of itself be necessary for initiation 
of disease (200).
5.1.2.1. Infection
No organism is consistently found in the joints or blood, although a 
number of agents have been investigated, such as mycoplasma, 
diphtheroids, and a variety of viruses (200). Work still continues, 
however, since several viral infections, for example, rubella and 
serum hepatitis, may produce a transient arthritis very similar to 
rheumatoid.
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5.1.2.3. Autoimmunity
There is much evidence of immunological involvement: for example, high 
proportions of mononuclear chronic inflammatory cells, especially 
lymphocytes, found within an affected joint, and the presence of a 
variety of autoantibodies, especially rheumatoid factor (RF) (200). 
Antigens, usually foreign to the host, can elicit an immunological 
response from the body by production of specific antibodies. 
Demonstration of antibodies to immunoglobulin G (IgG), nucleoproteins 
and collagen in serum and synovial fluids of patients with RA suggests 
an impairment discrimination between self and non-self (host and 
foreign cells) in this disease.
5.1.2.4. Endocrine factors
There are no known consistent factors, although some observations have 
been made and will be described. For example, several studies have 
shown that the prevalence of RA has declined while the oral 
contraceptive pill has been used (200). In addition, remissions in the 
severity of the disease are common in pregnæicy and exacerbations 
common during menopause. Adrenocortical steroids and corticotrophin 
(ACTH) produce a decrease in disease activity, while RA is uncommon in 
association with hypothyroidism.
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5.1.3. Pathogenesis and pathology
RA is a generalised disorder of connective tissue involving extra-
articular structures as well as joints (199-201). In particular, it 
attacks synovial joints - fingers, knees, toes - and this attack is 
typically symmetrical in form i.e. both knees. The onset of the 
disease may be sudden or gradual (over months and years) and is 
characterised by periods of exacerbation followed by remission, rather 
than a constant deterioration.
Figure 49 clearly shows the pathogenesis of RA. A "normal" synovial
joint is shown, and then the various stages of attack are detailed. 
The first stage (i) is early inflammation of the joint, leading to 
swelling of the synovial membrane and exudation of increased synovial 
fluid. This effusion adds to the swelling of the joint, with a very 
high protein and white blood cell content. In the second steige (ii), 
the swelling continues. A mass of granulation tissue or "pannus" is 
formed and starts to encroach on the bone and cartilage causing
destruction of joint surfaces and weakened ligaments. The loss' of 
tissue cein be detected radiologically as "erosion". As the disease
continues to grow in severity (iii), the granulation tissue, formed in 
continuity with the inflamed synovial membrane, continues to replace 
bone and cartilege throughout the joint. Adhesions between the joint 
surfaces may form. The fourth stage (iv) shows how the weakened
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Figure 49: A synovial joint; normal and rheumatoid (i - iv)
Normal joint
Bone
Jointcapsule
Synovial
fluid
Synovial
membrane
Cartilage
Rheumatoid joint; 
(i) (ii)
Synovial
swelling
Synovial
effusid
Pannus
^Bony
Erosion
(iv)(iii)
Thinning of 
cartilage by erosion  Subluxed joint
ligaments 6ind bone destruction may cause subluxation and complete 
dislocation. Fibrous or bony fusions may be produced with resulting 
stiffness, shortening or complete rigidity of the joint.
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5.1.4. Synovial fluid
Almost all types of articular disease tend to increase the volume of 
synovial fluid. Examination of this fluid in RA can play an important 
part in the diagnosis of complicating factors in the disorder such as 
bacterial infection (200). Only a film of synovial fluid separates the 
moving parts in normal, healthy joints. Generally, the free fluid, 
clear to pale yellow in colour, is so viscous that it cannot be 
recovered by needle aspiration . Moreover, the protein concentration 
in fluid obtained from postmortem cases is sufficiently altered, 
compared to normal cases, to preclude its use in studies as a 
substitute for normal fluid (132).
Synovial fluid is a dialysate of plasma with the addition of 
hyaluronate, an important aspect in lubrication mechanisms, 
synthesised by cells in the synovial tissue. Proteins are present at 
lower concentrations than in plasma (approximately 1.3%) and 60-75% of 
that protein is albumin. The larger molecules, such as fibrinogen, 
large globulins, and certain complement components are excluded, due 
to their molecular size. The above is true for "normal" and "non­
inflammatory" (for example, osteoarthritis) synovial fluids, although 
the latter group may have slightly raised protein levels. The absence 
of fibrinogen explains the absence of clot formation. By contrast, 
when the synovium becomes inflamed, the fluid clots after aspiration
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by needle, the concentration of each protein approaches that of 
plasma, and the complement activity increases (132,200). All factors 
present in plasma are then present in the synovial fluid.
A very limited number of trace element studies have been carried out 
on synovial fluid samples. One study (206) used synovial fluid from 33 
control subjects (post-mortem) and 13 RA patients; the findings were 
copper, iron, aluminium, rubidium, lithium and strontium in all 
fluids; barium, silver, manganese and caesium inconsistently in both 
groups; nickel not detected. It found increased levels of copper, 
iron, and aluminium in the RA group. Another, more recent study (207) 
also noted that copper was elevated in rheumatoid effusions compared 
with "controls" (osteoarthrosis). A similar observation was made for 
zinc, present in both normal and rheumatoid ssnnovial fluids (208).
5.1.5. Treatment
To date, no prevention or cure has been found for RA; treatment is 
carried out in order to alleviate symptoms wherever possible (199- 
201 , 212) .
The first group of drugs administered to an arthritic patient is that 
of nonsteroidal anti-inflammatory drugs (NSAIDs), for example, 
aspirin. These are agents that reduce the symptoms of established
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inflammation within a few days, without serious side-effects. Chronic 
inflammatory arthritis is often moderated, without being completely 
suppressed, by NSAIDs.
If this is unsuccessful, the next stage is treatment by slow-acting 
antirheumatic drugs (SAARDs). This large, diverse group includes the 
anti-malarial drugs, gold compounds and penicillamine. They are 
delayed in their effect, eventually producing reversal of symptoms in 
70-80% of cases. Side-effects may be more serious than with NSAIDs; 
the anti-malarials may cause damage to eyes. Gold and penicillamine, 
at worst, may cause suppression of cel1-production in the bone marrow. 
These drugs are given systemically.
The final groups of drugs, if NSAIDs and SAARDs prove unsuitable or 
inadequate, is the corticosteroids. These may have alarming side- 
effects if used at the dosage required to suppress disease completely, 
such as the hairy "moon-face", and perforated and bleeding gastric 
ulcers. The total dose can be reduced by local injections; this is a 
useful method of treatment if just one joint is swollen.
5.1.6. Trace elements and rheumatoid arthritis
Increasing interest has been shown in alterations of trace element 
levels and metabolism in chronic inflammatory diseases during recent
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years. Some recent findings seem to indicate that the redistribution 
of cellular metals is an extremely sensitive marker of ein inflammatory 
process not evident by clinical symptoms (209). A number of elements 
of particular concern to RA will be discussed in turn.
5.1.6.1. Gold
Injected gold salts have been used to treat RA since the 1920's (210); 
most of such drugs consist of gold and sulphur-containing-coraplexing 
agents e.g. gold thiomalate. After intramuscular injection and 
absorption of gold thiomalate, the gold becomes bound to plasma 
proteins and most of the thiomalate is liberated in the free form 
(211). Gold salts are microbial and anti-inflammatory and can alter 
immunological functions. A wide range of enzyme systems are influenced 
by gold; it is known to enter lysosomal enzymes which contain 
important compounds of RA. The phagocytic activity of synovial 
macrophages from RA patients is significantly reduced in the presence 
of gold (212). Other reported effects include a redistribution of 
trace elements within the body, including a reduction in serum 
concentration of several trace metals such as tin, molybdenum, 
manganese, barium and caesium but not copper, iron or zinc (213).
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5.1.6.2. Boron
The element boron, as described in Chapter 3, has been linked to 
arthritic disorders. Work carried out in New Zealand (91,203) 
suggested that areas with very low availability of soil boron (<0.5 
jjg/g) tended to have high proportions of arthritis, for example the 
populations of Mauritius and Jeunaica. The levels of 0.5-1.5 pg/g 
typical in the USA, UK, RSA, New Zealand and Australia were regarded 
as inadequate, particularly compared to Israel. In that country, and 
limited areas elsewhere, with >1.5 pg/g boron, there were very few 
cases of arthritis. The author also reported that a remarkable 
improvement in the severity of arthritic cases was seen when boron 
supplementation was given; however, no double-blind trials were 
carried out. In a more recent study, bone and tooth samples of sixteen 
rheumatoid arthritics and fourteen controls were analysed for boron 
(128). The results indicated that arthritic individuals had 
significantly lower levels of boron in their bone.
5.1.6.3. Copper
Serum and synovial fluid copper levels rise in patients with 
rheumatoid arthritis . Since almost all of the copper in both serum 
and sjTiovial fluid is complexed to ceruloplasmin, an acute phase 
reaction protein, these levels rise as well in the course of the
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disease (207,214). Direct correlations with disease activity,
articular index, erythrocyte sedimentation rate, and antioxidant 
activity of the serum were found with serum copper and ceruloplasmin.
Inverse correlations were found with serum iron and zinc (215-7).
Anti-rheumatic drugs associated with a lowering of copper level
include glucocorticosteroids, gold and penicillamine. The latter is 
also used in treatment of Wilson’s diseases (copper toxicity) because 
of its potent copper-chelating properties (132).
5.1.6.4. Zinc
Serum zinc levels have been shown to be low in patients with RA (211). 
They have also been shown to correlate inversely with osteoporosis 
associated with the disease (218). An original trial (219) was based 
on the hypothesis that zinc is essential for the normal synovium and 
is depleted in rheumatoid synovitis; zinc supplementation was 
attempted with promising results. Further trials were carried out 
based on whole-body amounts of zinc. Those with low levels were 
treated by supplementation while others were given penicillamine. 
Despite large differences in whole body zinc levels, no difference in 
disease severity was found. Since then, more negative evidence has 
been supplied (220,221). This suggests that variations in plasma zinc 
are due to the inflammation of RA, and no convincing aetiologic nor 
therapeutic roles should be attributed to zinc. Reports have also been
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made of reduced levels of zinc in the granulocytes of patients with 
inflammatory disorders (209), eind increased zinc concentrations in 
synovial fluid and urine of RA patients (208).
5.1.6.5. Selenium
Selenium is known to act as a component of the membrane protecting 
enzyme, glutathione peroxidase, which utilises glutathione for the 
breakdown of peroxides (222). Elevated levels of peroxides have been 
found in RA serum and synovial fluid; the activity of enzymes 
protecting against free radical damage have been suggested to be 
insufficient (223,224). Low selenium levels have been found in RA 
serum (222,225) and supplementation with this element has been 
attempted. Although serum selenium increased, there was no significant 
improvement in the condition of the RA patients, measured by a number 
of laboratory and clinical parameters.
5.1.6.6. Other elements
Anaemia is a frequent finding in patients with RA and its severity 
roughly parallels the activity of the disease (226). Iron supply to 
the marrow may be limited either by a reduction in whole body iron or 
by defective release of iron from the reticuloendothelial system into
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the plasma pool. In the latter case, simple iron therapy would not be 
useful.
Increased nickel concentrations in sweat, serum and urine have been 
found for RA subjects compared to controls. It was suggested that 
sweating is an important route of elimination for nickel; the high 
nickel levels in RA could be explained by reduced sweating due to 
impaired physical activity (227).
Other recent reports include abnormal cellular stores of calcium, 
magnesium and strontium in patients with rhuematoid arthritis; 
erythrocytes and granulocytes were measured (228,229). Granulocyte 
calcium is an important metal for the phagocytic eind secretory 
activities of inflammatory cells (230), while strontium stimulates 
degranulation of granulocytes (231).
5.2. Results and Discussion
Samples of brain and bone tissues, and synovial fluid (as listed in 
section 2.2.1.) were digested and analysed as described on Chapter 2, 
sections 2 and 3. The results of these analyses are presented in the 
following sections, along with a discussion of the findings.
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5.2.1. Analysis of brain tissue
5.2.1.1. Elemental levels
A group of brain samples was analysed by ICP-MS; the results 
are presented in Table 30, in ng/g or jug/g fresh ("thawed") weight. 
The median value, together with the range of values (minimum to 
maximum) is given for each element. The data were not necessarily 
expected to follow Gaussian curves; in addition, the use of the median 
minimised the effect of outlying values on the distribution as a 
whole. Some samples were found to have elemental levels below the 
limit of detection of ICP-MS (taking into account the mass and 
dilution factors involved), and are presented as such. The trace 
elemental content of brain is also shown graphically, in Figure 50, 
indicating clearly how elements vary in concentration within a tissue 
matrix. For example, magnesium is found at levels approximately three 
orders of magnitude greater than manganese.
Table 30 also shows how the data obtained in this study for brain 
tissue compare with the information available in the literature about 
this sample matrix. A number of elements, such as manganese, zinc, 
rubidium and strontium are at comparatively high levels within brain 
tissue, as compared to other matrices, such as blood. For example, 
manganese has an average value in brain of approximately 300ng/g,
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Table’ 30 ; Elemental content of brain with literature
ng/g fresh weight unless stated.
comparison
This study 
Median Range
Literature'
Range
Li 342 4 — 1888 -
B“ 4.65 0.13 —• 22.0 0.06»
Mg'* 214 66.1 — 598 114 — 690
Al" 7.18 0.47 — 28.4 0.5 — 3.6
Ca“ 73.1 28.7 — 169 130» -
Sc 150 7 — 948 210» -
Mn 312 58 — 7963 200 — 1930
Fe** 8.31 0.12 — 57.5 45.4 — 73.5
Co 8 <5 — 610 55 — 210
Ni <14 <14 — 3620 140 — 400
Cu“ 1.09 0.04 — 126 2 — 10.6
Zn- 17.8 5.81 - 111 12 — 84
Rb-* 3.82 0.53 - 14.1 1.5 — 12
Sr“ 2.75 1.09 - 8.13 0.08» -
Mo <16 <16 — 267 16.3 — 210
Cd <14 <14 — 558 500» -
Sn <9 <9 — 3611 60 - 550
Cs <6 <6 — 481 0.7» -
Ba 86 <13 — 1812 6» -
Ce 13 <2 — 251 - -
Hg 20 <3 - 430 5 - 280
Pb 123 <1 — 7224 130 500
a: concentration in jJg/g fresh weight 
b: only one value available 
c: Iyengar 1978 (133)
216
Figure 50; Elemental content of brain; ng/g (fresh weight)
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compared to measured levels of approximately 4 and 40ng/mL in serum 
and whole blood, respectively, while strontium is found at 
approximately 2jas/g in brain, and 40 and 20ng/ml in serum and whole 
blood. Within the group analysed in this study, several samples seemed 
to contain unexpectedly high elemental levels. This included metals 
such as copper, barium and tin. In most cases of these high levels, 
both hippocampus and basal ganglia samples (from a single individual) 
showed a similarly elevated content i.e. copper values of 119 and 
126t»s/s respectively, compared to a median of l.ljog/g. Therefore, the
altered trace metal composition is probably a naturally occuring
abnormally high level in the individual, from environmental exposure
or a metabolic disorder. An example of the latter is Wilson’s disease, 
where the brain is known to demonstrate high concentrations of copper 
(2,133).
The distribution of several elements within the brain tissue was
examined; Figure 51 shows the curves obtained for magnesium, 
aluminium, copper and lead. For aluminium and lead, in particular, 
there is considerable spread in the data shown on the graphs. Neither 
element is essential, so the variation is probably an indication of 
environmental exposure. Elevated levels of aluminium have been linked 
with Alzheimer's disease; these are thought to be localised in areas 
of neurofibrillary degeneration (232), and would probably not be seen 
in bulk tissue samples such as those used in this study. A gradual
218
Figure 51: Elemental frequency distribution in brain
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Figure 51 (con.): Elemental frequency distribution in brain
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accumulation of aluminium from the environment is thought to occur in 
the brain and other tissues (such as lung) (233). This also applies to 
a number of other non-essential elements and would account for some 
scatter in the distribution curve. For example, more than half of the 
brain samples analysed contained levels of cadmium which could not be 
detected using solution ICP-MS (bearing in mind the dilution factors 
involved) i.e. <14ng/g; despite this, a maximum value of 558ng/g was 
also seen.
5.2.1.2. Regional variation
In this study, samples were taken from the hippocampus and basal 
ganglia regions of the brain. The basal ganglia appear to be involved 
in the coordination of movement, while the hippocampus is thought to 
be linked with memory. A number of authors have reported variations in 
elemental composition in different regions of the brain (1). For this 
reason, the values for brain tissue obtained in this study were 
examined to see if there were any such significant differences for 
these two particular regions.
Statistical analysis was carried out using the "matched pair" t-test. 
This involved evaluating the elemental difference between each pair of 
samples, and calculating a t-value from the mean and standard 
deviation of these differences:-
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Equation 5 tn-i = xa J'n where n is number of sample pairs
sa xa is the mean difference
sa is the standard deviation
This method was used because the variation among samples is 
sufficiently large that smaller inter-regional differences might 
otherwise be obscured.
When the t-test was carried out, however, no variations in elemental 
content between basal ganglia and hippocampus regions were found to be 
significant (at the 5% level or above), for any of the elements 
measured in this study.
5.2.1.3. Variations due to age.
As the brain samples were taken from a relatively narrow agegroup of 
middle-aged and elderly people (matched in numbers of male and 
females), regression analysis was not carried out on the data. 
Instead, the samples were divided into two groups, of 51-69 years, and 
>70 years. The Student’s t-test was used to differentiate between the 
two groups; there were, however, no significant variations (at the 5% 
level or above) in elemental content for etny of the minor or trace 
elements measured in this study. This result was confirmed by
222
calculating and comparing median and quartile values; again, no 
significant differences were seen.
There have been some reported literature findings concerning variation 
of elemental content with age. For example, aluminium and caesium have 
been shown to increase, and phosphorus and rubidium to decrease, with 
increasing age (232,233). However, subjects or patients were generally 
of a wider range of ages i.e. an adult population of 20-99 years 
(233).
5.2.1.4. Variations due to sex
The brain samples were taken from an equal number of age-matched males 
and females (67 ± 8 and 68 ± 8 years respectively). The Student’s t- 
test was used to investigate if an^  ^gender-based variations in trace 
element composition might be observed. Again, the median and quartiles 
were employed to examine the data graphically. This statistical 
analysis revealed no sex-based distinctions in elemental content of 
brain samples taken from basal ganglia and hippocampus regions of the 
brain.
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5.2.1.5. Comparisons between rheumatoid athritics and controls
In this study, forty brain samples were from RA subjects, and thirty- 
two from controls. The elemental data obtained by ICP-MS for the two 
subdivisions were compared using the Student’s t-test. At the 5% level 
of significance (S), calcium and strontium both had depressed levels 
in RA subjects. At the 1% level (S*), RA individuals had significantly 
lower lithium levels.
These variations, calculated by t-test, can be seen clearly iri Figure 
52. For a number of elements, in addition to those mentioned above, 
the content of RA samples appeared to be slightly lower than in the 
control group. This is true, notably, for iron, copper and zinc. The 
reverse is true for manganese, barium and lead, amongst others. It is 
interesting that, graphically, for both copper and manganese, there 
appears to be an easily distinguishable separation between the data 
obtained from the two sample groups. This illustrates how a t-value 
(obtained from mean and standard deviation) can be distorted by 
outlying data points, and that it is important to study data by 
observation in addition to simple statistical manipulation.
The reasons for the elemental variations in brain tissue taken from RA 
and control subjects are unclear. Iron and copper are known to 
interact, with deficiencies leading to anaemia (1); a high percentage
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Figure 52: Comparison between rheumatoid arthritic
and control brain (I)
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Figure 52 (con.): Comparison between rheumatoid arthritic
and control brain (II)
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of RA subjects are found to be anaemic. Another observed finding 
concerning copper and RA is that serum copper levels are elevated in 
the disorder; this is thought to be concerned with the inflammation 
that characterises RA (214). Abnormal cellular distributions have 
been reported for calcium and strontium in blood taken from patients 
suffering from inflammatory disorders, such as RA (209,228-9). Calcium 
is, moreover, a major component of the bone and cartilage which 
undergoes erosion. It also forms crystals, with phosphorus, which are 
found in the joint tissues and fluids of other arthritis disorders.
Elevated manganese concentrations have been found in the red blood 
cells of RA patients (234); in addition, studies have shown that 
excess of this element leads to neurological disorders (1), Lithium is 
found in human systems at low levels i.e. 0.7 and 15ng/mL in saliva 
and urine, respectively. It does not have any specific function within 
the body (1), but is used as a drug in the treatment of manic 
depressives (2).
5.2.2. Analysis of bone tissue
5.2,2.1. Elemental levels
Table 31 shows the values obtained from analysis of bone material by 
ICP-MS. Results are presented in ng/g or pg/g fresh ("thawed") weight
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Table 31. Elemental content of bone with literature
comparison: ng/g fresh weight unless stated.
This study 
Median Range
Literature° 
Range
Li 310 240 — 400 - -
B“ 2.13 0.15 — 9.38 0.74 0.9
Mg“ 1272 467 -r 3627 700 1800
Al" 5.74 2.52 - 31.2 3 — 5
Sc 375 130 - 920 1 — 4600
Fe“ 104 40.8 — 445 3 — 2040
Mn 775 180 - 3840 190 — 3000
Ni" 4.89 3.15 — 6.33 110 -
Co 275 60 — 890 10 — 4600
Cu“ 4.04 0.46 - 96.9 1 — 25.70
Zn“ 49,9 30.8 — 212 50 — 170
Rb" 2.84 1.63 — 15.1 0.1 — 5.11
Sr“ 37.1 14.9 — 90.7 42.6 — 237
Cd <14 <14 — 80 1280% -
Sn <9 <9 - 40 800 — 3000
Sb 40 <10 — 330 10 — 300
Cs <6 <6 — 750 9 — 98
Ba" 2.51 9.38 - 60.2 4.12 — 19.8
La <8 <8 — 3120 <200 — 6600
Hg <2 <3 — 420 450% -
Pb" 1.57 0.76 - 5.72 10 — 42.5
a: concentration in pg/g fresh weight 
b: only one value avilable 
c: Iyengar 1978 (133)
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as medians and ranges. Where any given element within a sample was at 
too low a concentration to be measured by ICP-MS (taking dilution 
factors into account), this is shown by stating the detection limit 
and quoting the result as "less than" (<) this value. In this table, 
literature data are also given for comparison, while Figure 53 shows 
the measured information graphically.
For many elements, only a limited number of studies have been carried 
out to characterise their content in bone tissue. Some of the values 
quoted as references in Table 31 are taken from just one or two 
studies, some of which contained a small number of samples (<5). Some 
references quote bone composition in "ashed" weight; these have been 
omitted from the table. For most elements,, agreement between this 
study and the published data is good, although a wide range of 
concentrations is visible in both groups.
Bone is composed of osseous tissue, a tissue made hard by the 
deposition of inorganic substances, or calcification. The inorganic 
fraction is made up of crystals deposited on collagen fibres. These 
crystals are mainly hydroxy-compounds of calcium phosphate, but also 
contain smaller quantities of magnesium eind zinc, for example. This 
agrees well with the high levels of magnesium eind zinc, in the order 
of 1000 and 50 jjg/g respectively, which were found in this study. The 
crystals are surrounded by a hydration shell which allows free ion-
229
Figure 53: Elemental content of bone; pg/g (fresh weight)
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exchange between the extracellular fluid and the crystal interior; 
inside the crystals, there is a slow turnover rate of ions. Some 
elements, such as strontium, barium and lead are known as "bone 
seekers" because they can be readily absorbed into the crystals (1). 
Thus a high concentration of these elements was expected, and was 
shown: mediein values in the order of 30, 3, and 2 pg/g respectively.
In addition, many other elements, such as manganese, copper and 
rubidium, are found to be at comparatively high levels of 
concentration; sizeable percentages of the total body content of these 
elements are stored in the skeleton (1), for exeumple, manganese was at 
levels of approximately 800ng/g, 200 times the level measured in
serum. Iron is found in appreciable quantities in bone, but this can 
vary greatly; ranges of 41-444pg/g were found in this study, with 3- 
2040jjg/g described in the literature (see Table 31). This depends on 
the bone marrow content of the sample under analysis.
Figure 54 shows the frequency distribution of magnesium, copper, zinc 
and strontium levels in the group of bone samples analysed in this 
study. Despite a few outliers at both ends of the concentration range, 
magnesium (Figure 54a) shows a very narrow, symmetrical curve. By 
contrast, copper (Figure 54b) displays a very wide scatter of data. 
This is either one broad, ill-defined peak, or two distinct maxima, 
with several outlying high values. Boron in bone also showed a 
tendency to "cluster" (section 3.2.2.5). A larger number of bone
231
Figure 54: Elemental frequency distribution in bone
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Figure 54 (con.): Elemental frequency distribution in bone
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samples would possibly aid in reducing these effects. Moreover, it 
must be remembered that bone is a inhomogenous sample matrix, and that 
samples were taken, from various sites, from patients of RA (a bone 
disorder) as well as controls. Therfore, a scattering of data points 
is not unexpected. Zinc (Figure 54c) also shows a broad peak, although 
much better defined and with fewer outlying values' than copper. 
Strontium (Figure 54d) in bone follows a relatively smooth curve, 
although there is the same tendency, as with zinc and particularly 
with copper, for the main peak to divide.
5.2.2.2. Regional variation
The sample group was too small to permit investigation into possible
effects of age or sex on the elemental content of bone.
The bone samples used in this study were mainly cross-sections taken
from the rib or from the knee joint. A comparison was made between
elemental data from these two subdivisions. First of all, the 
Student's t-test was used; from this, magnesium was shown to be at 
sigificantly lower levels (8: 5%) in the rib, compared to the knee.
Further investigation was carried out by superimposing one data 
distribution on the other. This showed that the peaks of both curves 
were in approximately the same place ; the deviation was mainly due to 
one or two outlying data points. Because of this, and because many of
234
the elements did not follow Gaussian statistics, a graph was plotted 
of the median and interquartile range ; see Figure 55.
There seems to be a general trend that cross-sections of rib are 
marginally lower in trace element content than the cross-sections of 
the knee joint. The one exception to this is copper, with a 
considerably higher median concentration in the rib. Such a large 
variation probably explains the large degree of scatter (and the 
apparent presence of two maxima) in the copper distribution graph 
(Figure 54b). That there should be a difference in elemental 
composition of bone samples is not surprising, since bone can be 
either spongy or compact in form, depending on the section of bone and 
its location within the body. Another factor is that rates of bone 
formation and resorption vary in different parts of the skeleton; this 
may also have some effect.
5.2.2.3.Comparison between rheumatoid arthritics and controls
Twelve bone samples were taken from RA subjects, and ten from 
controls. The groups were compared by using the Student's t-test and 
by plotting median and interquartile ranges. By the t-test, two 
elements show differences at the 5% level (S); these are iron, where 
RA bone samples have an elevated elemental content, and lithium, where 
the reverse is true. Antimony levels in RA bone are "highly
235
Figure 55: Regional variations in bone elemental content
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significantly" higher than in control samples (S*:l% level). At the 
0.1% level (S**), RA bone samples are depleted in boron and scandium, 
compared to the control group.
These results are shown graphically in Figure 56; in addition to those 
elements described above, many of the remaining show a slight, though 
perhaps not significantly, lower elemental content in RA bone. Of 
these, nickel seems to be severely depleted in bone from RA patients.
The finding for lithium in bone mirrors its behaviour in brain 
samples, while for iron, the situation is reversed i.e. decreased in 
brain and increased in bone. Increased nickel levels have been 
reported in the serum, urine and sweat of RA sufferers (227). Antimony 
and scandium are both inessential elements which have not, to date, 
shown anj?- essential role within the body. Recent studies for boron, 
however, have attempted to demonstrate that this element has a role to 
plaj^  in animals and humans ; interestingly, with regard to this study, 
it may be involved in calcium metabolism and thus in the maintenance 
of healthy bones (93). As previously described, some reports have 
suggested that boron supplementation can play an important part in the 
treatment of RA (91,203). Finally, these boron results confirm 
findings by Ward (128), where prompt gamma ray neutron activation 
analysis was used to measure bone and teeth from RA and control 
subjects.
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Figure 56; Comparison between rheumatoid arthritic
and control bone (I)
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Figure 56 (con.); Comparison between rheumatoid arthritic
and control bone (II)
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5.2,3. Synovial fluid
5.2.3.1. Elemental Levels
The trace elemental levels obtained from analysis of synovial fluid by 
ICP-MS is shown in Table 32. The data are presented as median and 
range (minimum to maximum). Where sample levels fell below the 
detection limit of this fluid by ICP-MS, the sample value was 
described as being "less than" the calculated limit of detection e.g. 
<0.36 ng/mL in the case of lithium ("instrumental" detection limit 
multiplied by the dilution factor). All results were quoted in ng/mL 
or jog/mL with volumes based on fresh samples i.e. no drying of samples 
was carried out. In 1962, a multielement study was carried out on 
synovial fluid, taken from RA subjects and post-mortem "controls", 
using emission spectography (206). These results, in ng/g fresh 
weight, are presented in comparison.
Figure 57 shows these experimental data graphically, in order of 
increasing median value. Some elements show a wide interquartile 
range, for example, lithium, barium, aluminium and lead, while other 
elements have a more narrow spread of values, such as calcium, 
magnesium, copper, rubidium, and caesium. This could be for a number 
of reasons. For example, the essentiality of a particular element may 
result in it being controlled within a range of values in the body.
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Table 32; Elemental content of synovial fluid with literature
comparison : ng/mL or g (fresh weight) unless stated.
This study 
Median Minimum-
ng/mL 
- Maximum
Literature*’ ng/g 
Minimum —  Maximum
Li 1.2 <0.4 -- 46.6
B 32.3 <7.8 -- 2410 - -
Mg“ 21.57 14.16 -- 35.86 -
A1 7.9 <0.4 - 618 40 —  1570
P“ 99.86 28.08 -- 295.4 - -
Ca= 93.84 36.46 -- 147.9 - -
Sc 1.5 <0.1 -- 61.1 - -
V 4.2 <0.9 -- 20.6 6 —  700
Cr 22.0 5.2 —  85.5 - -
Fe 477.0 22.4 -- 7049 20 -- 320
Mn 2.0 <0.1 -- 53.4 7 -- 400
Ni 1.2 <1.0 -- 52.2 - -
Co <0.2 <0.2 -—  10.1 - -
Cu 814.3 155.6 -—  3485 40 -- 1570
Zn 714.2 100.1 --  3160 247 —  1273
Ge 0.8 <0.7 -—  4.8 - -
As 13.9 3.0 --121.9 - -
Rb 100.9 50.5 —- 252.2 110 --1300
Sr 19.9 8.9 -- 70.2 - -
Mo 1.3 <1.0 -- 10.4 - -
Cd <0.9 <0.9 -- 12.0 - -
Sn 0.8 <0.5 -- 11.8 - -
8b <0.3 <0.3--- 235.3 - -
Cs 0.6 <0.3 - 3.8 40 —  560
Ba 3.9 <0.9 -- 47.5 90 -- 300
La <0.1 <0.1 -—  1.7 - -
Ce <0.1 <0.1 -—  11.3 - • -
Hg <0.7 <0.7 -- 29.7 - -
Pb 0.3 <0.1 -- 65.4 -
a: jJg/mL fresh 
b: Niedermeier 1962 (206)
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Figure 57; Elemental content of synovial fluid; ng/mL
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Moreover, these samples were taken from a group of subjects with 
various arthritic disorders, which may alter the magnitude and spread 
of an element within the body in general, and the synovial fluid in 
particular. A number of elements were not detected in more than half 
of the synovial fluid samples i.e. their median levels were below 
their respective detection limits. These elements included cerium, 
lanthamum, cobalt and mercury.
Table 33 shows a comparison of elemental levels between the synovial 
fluid and serum samples measured in this study. This is because 
synovial fluid and plasma or serum are very similar in composition; 
synovial fluid is a dialysate of plasma. Most of the synovial fluid 
data obtained here appears to be in the same order as the literature 
values for serum. Copper and zinc data are close to, but tend to be 
rather lower than expected in serum. The iron values in synovial fluid 
also seem to be considerably lower than the typical range in serum. 
These findings agree with some reports in the literature (206-8). In 
addition, one factor which may be involved here is the fact that the 
synovial fluid samples were not taken from a "control" or "healthy" 
population, but from patients suffering from arthritic disorders. Many 
individuals with RA are anaemic (226), so a lowered concentration of 
iron is perhaps not unexpected. Other values which deviate 
considerably from their serum equivalents are vanadium and chromium. 
That these elements are susceptible to polyatomic interferences when
243
Table 33: Comparison between concentrations of synovial fluid and
' serum measured in this study: ng/mL (fresh) unless stated.
Synovial
Minimum
. fluid 
Maximum
Blood
Minimum
serum
Maximum
Li <0.4 46.6
B <7.8 2410 45.5 460
Mg“ 14.16 35.86 14.73 25.80
A1 <0.4 618 5.8 82.9pa 28.08 295.4 124 222
Ca“ 36.46 147.9 91.50 169
Sc <0.1 61.1 7.3 68.6
V <0.9 20.6 <0.1»
Cr 5.2 85.5 0.4»
Fe 22.4 7049 88 3100
Mn <0.1 53.4 1.2 6.5
Ni <1.0 52.2 6.4 21.1
Co <0.2 10.1 <0.4 1.2
Cu 155.6 3485 650 2200
Zn 100.1 3160 520 1450
Ge <0.7 4.8 <1.1 2.6
Rb 50.5 252.2 81.5 152
Sr 8.9 70.2 14.8 67.6
Mo <1.0 10.4 <2 11.5
Cd <0.9 12.0 <0.2 0.8
Sn <0.5 11.8 <1 19.9
Sb <0.3 235.3 <0.1 0.5
Cs <0.3 3.8 0.2 1.2
Ba <0.9 47.5 91.4 296
La <0.1 1.7 0.9 4.0
Ce <0.1 11.3 15.4 66.5
Hg <0.7 29.7 <0.3 1.5
Pb <0.1 65.4 0.3 4.0
a: jig/mL fresh 
b: literature values (77)
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using ICP-MS has been described earlier (section 2.1.5.); this is the 
probable explanation for the disparity in serum and synovial fluid 
values. A polyatomic interference between argon and chlorine is also 
likely to be the cause of the high values obtained in this study for 
the element arsenic, even though the amount of comparative data is 
small. These values are presented as reference data, only, for future 
comparison using an alternative technique. There was little 
comparative data available for a number of other elements in addition 
to arsenic, particularly those at nanogram or subnanogram levels, for 
instance, lithium, germanium, barium, tin and lanthanum. Most of these 
elements have not yet demonstrated a useful role within the body.
As it has been postulated that essential elements follow normal or 
Gaussian statistics within the body (4,5), the distribution of values 
obtained for several elements in synovial fluid have been plotted. 
Those of magnesium, calcium, iron, copper, zinc, rubidium, strontium 
and caesium are shown in Figure 58. True normal distributions were not 
necessarily expected because the samples were taken from arthritic 
patients and not from healthy individuals. In fact, magnesium and 
calcium data. Figures 58a and b, are quite symmetrical in form, while 
the other elements show a greater or lesser degree of positive skew. 
As previously described, RA patients tend to suffer from anaemia, 
which may partly explain why the peak of the iron-distribution curve, 
Figure 58c, is further to the left than expected. Literature suggests
245
Figure 58: Elemental frequency distribution in synovial fluid
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Figure 58 (con.): Elemental frequency distribution in synovial fluid
c) Iron
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Figure 58 (con.): Elemental frequency distribution in synovial fluid
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Figure 58 (con.): Elemental frequency distribution in synovial fluid
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that copper and zinc may be increased in the synovial fluid of RA 
sufferers (207,208); this factor may result in the scatter of data 
around and gentle gradient of the downward slope of both copper and 
zinc curves (Figure 58d and e). Little is known about strontium and 
rubidium in humans, neither of which are essential elements; in 
synovial fluid, both elements show smooth and steep upward curves, 
with a more gradual and scattered decrease (Figure 58f and g).
Elevated strontium has been noted in the granulocytes of sufferers
from inflammatory disorders (209). Caesium is an example of an element
whose levels in some samples were too low to be determined; see Figure 
58h. Hiis means that the upward slope of the graph is rather unclear; 
the data, however, still appears to have a positive skew.
5.2.3.2. Cellular and acellular synovial fluid
Following aspiration of synovial fluid from the knee joint, samples 
were divided into two. One aliquot was stored directly; the other was 
spun down, and the supernatant removed and stored prior to sample 
preparation. These samples were then analysed by ICP-MS, to compare 
synovial fluid with and without cells.
Statistical analysis was carried out in two ways. Firstly, the 
"matched pair" t-test was used (Equation 5, section 5.2.1.2). Using 
this method of comparison, significant differences in elemental
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composition were seen for three elements. For phosphorus, the 
acellular fluid had a "highly significantly" (S*: at the 1% level)
lower elemental content than the "whole", cellular synovial fluid. 
There were very highly significant differences (8**: at the 0.1%
level) for rubidium and barium. Compared to cellular synovial fluid, 
the fluid without cells was lower in rubidium but higher in barium.
To study the data graphically, the median, upper eind lower quartiles 
of cellular and non-cellular synovial fluid were plotted, and are 
shown in Figure 59. The inter-group distinction is still clear for 
barium, but less obvious for phosphorus and rubidium. For most of the 
other elements, the median value of spun fluid samples tends to be 
lower than the whole fluid, although the differences are not 
statistically important because of the size of the interquartile 
range. This is not surprising, since it is likely that some fraction 
of the trace element content of synovial fluid would be bound within 
the fluid cells.
Data distribution curves for cellular and acellular fluid were drawn 
for the three elements mentioned specifically in this section. Those 
for barium and rubidium are shown in Figure 60. The difference between 
the sample groups for barium is very clear, whereas it is considerably 
less so for for rubidium (and was worse still for phosphorus). The 
result for barium is rather strange since the cellular sample is
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Figure 59: Variation between cellular and acellular
synovial fluid (I)
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Figure 59 (con.): Variation between cellular and acellular
synovial fluid (II)
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Figure 60: Frequency distributions of cellularand acellular synovial fluid
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"whole", untreated ssoiovial fluid, which is then spun to give the 
acellular fluid by removal of the cell fraction. This suggests that 
there is a source of barium contamination somewhere in the spinning- 
down or in the separation of the acellular supernatant, for example, 
from the glass pipette used in separation. Errors might also be 
introduced from the sample tubes used (although plastic or 
pols’propylene vessels were always utilised to try and prevent this), 
or perhaps, by contact with the sides of the tubes during
centrifugation.
5.2.3.3. Variations due to age and disease duration
The subjects, from which synovial fluid was taken, ranged in age from 
14 to 86 years. Regression analysis was carried out on the data to 
establish if there was any correlation between age and elemental
concentration. Values of regression coefficient, r, were again 
substituted into Equation 4 (section 3.2.3.2) to give a t-value and
thus establish significance. The only element to show any association
with the age of the individual was molybdenum, significant at the 5% 
level. Figure 61 shows the measured molybdenum values plotted against 
age in years, with a calculated regression line drawn through the data 
points. The data appear to be widely scattered; the trend, as shown by 
the line, is very hard to see.
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Elemental concentrations were also correlated against disease 
duration, which varied fron a few days to 20 years. No significant 
associations were found. Disease duration was also plotted against the 
white blood cell count of the fluid (clinical parameters measured in 
the Department of Rheumatology, University of Manchester), which is a 
measure of the degree of inflammation. Again, no correlation was 
found, indicating that disease duration is not necessarily an 
indicator of disease severity.
5.2.3.4. Variations due to sex
In the study population used, there were 56 samples taken from females 
and 67 from males. The average white blood cell count of the two 
groups was similar (11.4 and 10.7 x 10®/mm^ respectively), enabling a 
reasonable comparison to be made between the two groups on the grounds 
of sex. The Student's t-test was used to quantify any distinctions 
between the two sets of data by using the arithmetic mean; no 
significant differences were found. To check these results, the 
medians and interquartile ranges were evaluated and compared. Again, 
no obvious distinction between groups was noted - the elements showing 
the greatest variation are shown in Figure 62. Not unexpectedly, iron 
is lower in females than in males; female individuals, however, show 
an interesting increased level of zinc, although this is accompanied 
by an extremely large interquartile range. Despite the fact that women
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Figure 61; Variation in synovial fluid due to age
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have been found to display consistently higher serum copper levels 
than men (1), this is not echoed by the synovial fluid data.
5.2.3.5. Variations due to crystal content
The crystal content of the synovial fluids were measured (Department 
of Rheumatology, University of Manchester) , and were classified 
according to whether they were rare or numerous in number, intra- or 
extra-cellular in location, and bone-derived, apatite, calcium 
pyrophophate or monosodium urate in type. Samples containing crystals 
were compared with those absent of crystal formation. The student's t- 
test was used; in addition, the elemental variation between the two 
groups was shown graphically, in Figure 63.
Significant differences are displayed for scandium, strontium and 
caesium; in all these cases, the synovial fluids containing crystals 
show higher elemental levels than the non-crystalline. This is the 
basic trend for most of the elements, although in the majority of 
cases, the differences between the two groups are quite small.
A number of causes have been suggested for formation for calcium 
pyrophosphate crystals, including elevated levels of either calcium or 
inorganic pyrophosphate, cheinges in the matrix that promote crystal 
formation, or a combination of these. An influx of magnesium, thus
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Figure 63: Variations between crystal- and non-crystal- containing synovial fluid
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altering the matrix composition, has been shown to induce the 
formation of crystals, while iron can slow this process (132). 
Despite this, there were no significant changes in synovial fluid 
levels of magnesium, phosphorus, calcium or iron demonstrated in this 
study. Of course, numerous other factors may be involved, such as 
inorganic matrix components acting as nucleating agents (132).
5.2.3.6. Variations due to white blood cell count
The white blood cell count in synovial fluid increases as a joint 
becomes inflamed; in some ways, therefore, the increase in white blood 
cell count can be seen as a sign of disease severity (199-201). 
Elemental concentrations obtained in this study were correlated 
against the white blood cell count (measured in the Department of 
Rheumatology, University of Manchester) of the synovial fluids using 
regression analysis. As before, the regression coefficient, r, was 
used to calculate a t-value, and the significance of the data 
obtained. There was a highly significant association (1%) between 
caesium and white blood cells, while magnesium, phosphorus, copper, 
zinc and rubidium all showed very highly significant correlations 
(0.1%). These data are shown, with calculated regression lines, in 
Figure 64. In the case of copper and zinc, these results agree with 
findings that sufferers of RA (an inflammatory disorder) have elevated 
levels of these elements compared with osteoarthritic (OA) subjects
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Figure 64; Variations in elemental content of synovial fluid
with white blood cell levels
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Figure 64 (con.): Variations in elemental content of synovial fluid
with white blood cell levels
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Figure 64 (con.): Variations in elemental content of synovial fluidwith white blood cell levels
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(207,208). It is known that "inflammatory" synovial fluid contains 
more proteins than "non-inflammatory" i.e. it becomes closer to serum 
or plasma in composition. It is possible that the increase in trace 
element levels in synovial fluid with a high white blood cell count is 
due to the binding of some of these elements to the plasma proteins.
5.2.3.?. Comparison of different arthritic disorders
In this section, the trace element content of synovial fluid from OA, 
RA and sero-positive RA (S+RA) subjects are compared. As has been 
already explained, it proved impossible to obtain synovial fluid from 
healthy individuals to act as "controls", due to the small quantity of 
available fluid, its viscosity, and the discomfort which would be 
suffered by healthy people unnecessarily (132). Osteoarthritic, 
noninflammatory fluid was used as a comparison with the groups of RA 
fluid, instead. The samples in each sub-group are chosen according to 
the clinical diagnosis for each subject. Even so, the results are 
likely to be similar to those in section 5.2.3.6., where the degree of 
inflammation, assessed by the white blood cell count, was utilised.
Comparison between sets of data were made using the Student’s t-test, 
and this yielded the elemental variations shown in Table 34. These 
results were checked by plotting median, and interquartile ranges; 
this ensured that any effect of outliers on the t-value (calculated
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Table 34: Comparison of osteoarthritic, rheumatoid arthritic, and
seropositive rheumatoid arthritic subjects
Disorder
S : 5%
Level of significance 
level S*: 1% level S**:0.l%level
OA / RA -Mg“,-P,-Cu,-Rb
OA / S+RA -Rb -Mg,-P -Cu
RA / S+RA +Bb
a: Mg(OA) < Mg(RA) 
b: B(RA) > B(S+RA)
from arithmetic means and standard deviations) would be noticed. These 
graphs (see Figure 65) compare the elemental levels for the three 
arthritic subject groups, for the elements that were sho^ vn to be 
significant by the t-test i.e. boron, magnesium, phosphorus, copper 
and rubidium. Iron, zinc, molybdenum, tin and caesium are also shown; 
the variations in their median values were noted even though the t- 
test showed no significant variations. Finally, calcium and strontium 
are included as comparisons; these elements show very little variation 
between the different disorders investigated here.
By reference to Figures 65a and b, it can be seen that magnesium, 
phosphorus, copper, zinc and rubidium confirm the findings of the last
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Figure 65: Elemental variations in synovial fluid from
different arthritic disorders
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Figure 65 (con.)* Elemental variations in synovial fluid from
different arthritic disorders
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section i.e. that their levels are elevated in an inflammatory 
disorder, such as RA or S+RA compared to OA. Of these five elements, 
copper is the only one to show any degree of variation between RA and 
S+RA subjects. The average value of white blood cells may be 
significant here; S+RA has a value slightly above RA (16.0 compared to 
12.7 X 10®/mra®) while both these groups are considerably above OA (0.6 
X 10®/mm®).
An interesting fact to note is that caesium shows decreased levels in 
the RA and S+RA compared with OA, whereas it displayed a highly 
significant positive correlation with white blood cells (section 
S.2.3.6.). The reason for this is that RA is not the only inflammatory 
disease; gout is an example of another in which the white blood cell 
count is raised. In the latter disorder, the inflammation is due to 
the presence of crystals within the joint tissues and fluid. Caesium 
levels were raised in all crystal-containing synovial fluids (section 
5.2.3.5.), and particularly so in the sub-division of individuals 
suffering from gout.
One element which shows a depletion in its levels in RA subjects, 
compared to OA, is iron. This tallies with the reports that a high 
proportion of RA sufferers are anaemic (226), although it disagrees 
with an earlier finding (206). Variations in iron concentrations were 
also noticed in brain and bone samples between RA and control subjects
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(sections 5.2.1.5. and 5.2.2.3.). Decreased levels, for individuals 
with RA, were observed in other elements including caesium and tin, as 
shown in Figure 65d. Boron shows a depleted level in S+RA compared to 
the other groups, but with an extremely wide interquartile range for 
OA and RA groups. Boron was also found to be at lower levels in the 
bone of RA patients (section S.2.2.3.). Molybdenum also displays 
strange behaviour. A sharp drop in its levels in the RA group is 
followed by an equally abrupt rise in the S+RA sub-division.
5.2.4. Summary
Having analysed brain and bone from rheumatoid arthritics and 
controls, and synovial fluid from a group of arthritic disorders, the 
following findings can be summarised:-
i) The multielemental capabilities of ICP-MS allowed a full 
description of the elemental content of brain, bone and synovial fluid 
to be made. In the 27 years since the last study of synovial fluid was 
made, the developments in analytical technology have provided the 
opportunity to measure, and obtain data for many elements which were 
previously unreported, such as, lithium, boron, scandium, germanium, 
molybdenum and lead et al..
ii) It was interesting to be able to report reduced levels of boron 
in the bone of arthritic subjects compared to controls (0.84±0.77jug/g 
c.f. 1.57±0.86jjg/g), thus confirming clinical observations of the
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improved condition of bone material after boron supplementation 
(91,203), and experimental observations (128).
iii) The alteration of trace element levels in synovial fluid teiken 
from inflamed joints was quite evident. Previously reported findings 
concerning elevated copper and zinc were confirmed (206,207); other 
elements, such as phosphorus, rubidium and caesium were also shown to 
demonstrate altered behaviour. Caesium, in particular, was interesting 
since it displayed differences in behaviour between two inflammatory 
disorders i.e. increased in gout, but decreased in RA, both with 
respect to OA.
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6. CONCLUSIONS
This study has illustrated that ICP-MS provides an accurate and 
precise technique for the measurement of elements in biological 
tissues and fluids, and biological standard reference materials. The 
concentrations of these elements range from subnanogram/gram (or mL) 
to percentage levels (%w/w), demonstrating the wide dyneunic range of 
the technique.
One of the main aims of this study was to carry out analysis of the 
element boron within clinical specimens. The detection limit of 2.6 
ng/mL ("instrumental" detection limit) was less good than for many 
other elements using ICP-MS (boron has a comparatively low degree of 
ionisation as calculated from the Saha equation; section 2.I.I.2.). It 
was, however, still suitable for most samples measured in this study, 
even taking into account the dilution factors involved. From 
measurement of NIST 1577A bovine liver, the only available standard 
reference material used which had accompanying information values, it 
appears that the precision in analysis of boron by ICP-MS is slightly 
less impressive. One factor here is probably the relatively high boron 
blank value, as measured by ICP-MS. It would appear that there were 
some sources of contamination in the instrumental system itself, due 
to elemental adhesion to the plastic tubing of the nebuliser and in 
the spray chamber. This also led to memory effects if great care was
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not taken to wash out the system between samples. In addition, despite 
the use of ultra-pure, doubly distilled deionised water (DDW), there 
appeared to be a residual boron content of 7,7ng/mL (242). In 1% HNOa, 
there was a higher level, possibly due to the glass bottle in which 
the concentrated acid is stored; this was 13.8ng/mL (242). Because of 
the high levels of boron known to be in glass or plastic, 
polypropy1ene was used in sample or standard preparation or storage 
whenever possible.
Despite these problems associated with measurement of boron, 
successful analysis of this element was carried out in a wide range of 
tissues and fluids. This contributed valuable data to the continuing 
investigation into the possibility of this element having an essential 
role in animals and humans. Of particular interest here was the way in 
which boron was positively correlated with magnesium, copper, calcium 
and phosphorus in whole blood. It has been suggested that changes in 
dietary boron may have an effect on the role in the metabolism of all 
these elements (93,127).
One important factor which has been noticed during the course of this 
study is that samples collected, however carefully, in a clinical 
environment, may show some slight alterations due to contamination. 
How this affects boron has been impossible to quantify; however, this 
study showed how barium levels were altered in acellular synovial
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fluid (probably due to the use of a glass pipette in the separation 
stage) and manganese in serum (partly due to a stainless 
steel needle; perhaps some rupturing of red cells had also taken 
place). These difficulties will probably continue until research 
analysts are provided with an opportunity to work in a clinical 
setting, and are better able to monitor collection procedures.
One aspect concerning the essentiality of elements, which has been 
under scrutiny in this study, is the frequently quoted statement that 
essential elements are characterised by normal frequency distributions 
in human tissues. On the other hand, non-essential elements follow the 
environmental pattern, producing skewed curves (4,5,145). It appears 
from this study that this is not universally true for all biological 
tissues and fluids, but is dependent on the nature of the sample and 
its role in the body. In brain tissue, for example,essential elements 
such as magnesium and copper were considerably more symmetrical in 
their distribution than the non-essential aluminium and lead. In whole 
blood, however, all elements seemed to be undergoing some degree of 
regulation or homeostasis. Ihis is probably due to the fact that many 
of its components, for example erythrocytes to which elements like 
mercury and lead are strongly bound, have a limited life span. Blood 
also acts as a means of transporting numerous substances, including 
chemical elements, to storage depots or functional areas within the 
body. In contrast, urine and saliva showed log-normal distributions
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for most elements, indicating a dependence on external factors, not 
internal regulation. Thus, it would seem that for the elements and 
readily accessible (not autopsy) clinical samples analysed, the shape 
of the frequency distribution curve is a measure of homeostasis, not 
essentiality.
The investigation of elemental levels in various types of samples from 
arthritic and control individuals was also carried out in this study. 
Of particular interest, since a large portion of the work was 
concentrated on boron, was to find reduced levels of boron in the bone 
of RA patients, confirming earlier findings (128). This was not, 
however, accompanied by any significant variations in the boron 
content of synovial fluid. Other elements showing differences between 
RA and control tissues were lithium in bone and brain, and iron in 
bone, brain and synovial fluid, amongst others. A number of elements 
were at increased levels in "inflammatory" synovial fluid; these 
included copper, zinc and phosphorus, while caesium was unique in that 
it was elevated in fluid from sufferers of gout and hot RA. These 
alterations in elemental levels are more likely to be symptoms of the 
inflammation, rather than causes of it. Further study of arthritic and 
control (or OA) specimens, perhaps on the smaller scale of separated 
cell fractions instead of the bulk material, should be able to suggest 
if trace elements might have a therapeutic as well as a 
pathophysiological role. For example, some findings in analysis of
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blood cells have suggested that redistribution of cellular metals is a 
marker of hidden inflammatory disease (209).
In summary, ICP-MS was shown to be a very useful analytical tool for 
the measurement of biological specimens, enabling analysis of boron 
and other elements to be carried out, and in investigating certain 
aspects of human health and disease.
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